study_id,segment,code_main_cat,code_main,code_identifiers
10020,63,patient,age,
10020,ertapenem,NA,drug resisted,
10020,imipenem,NA,drug resisted,
10020,fluoroquinolones,NA,drug resisted,
10020,co-trimoxazole,NA,drug resisted,
10020,tobramycin,NA,drug resisted,
10020,gentamicin,NA,drug resisted,
10020,k. pneumoniae,bacteria,binomial (genus species),
10020,amoxicillin,NA,drug resisted,a
10020,.32,NA,mic,a
10020,man,patient,sex,
10020,amoxicillin+clavulanic acid,NA,drug resisted,b
10020,.32,NA,mic,b
10020,cefuroxime,NA,drug resisted,c
10020,.64,NA,mic,c
10020,ceftriaxone,NA,drug resisted,d
10020,new delhi,location,city,
10020,ceftazidime,NA,drug resisted,e
10020,.64,NA,mic,e
10020,gentamicin,NA,drug resisted,f
10020,.16,NA,mic,f
10020,tobramycin,NA,drug resisted,g
10020,india,location,country,
10020,india,location,place traveled to,
10020,.16,NA,mic,g
10020,meropenem,NA,drug resisted,h
10020,.16,NA,mic,h
10020,imipenem,NA,drug resisted,i
10020,8 ,NA,mic,i
10020,ertapenem,NA,drug resisted,j
10020,.16,NA,mic,j
10020,the netherlands,patient,country of residence,
10020,tension pneumothorax,patient,symptoms,
10020,cephalosporins,NA,drug resisted,
10020,meropenem,NA,drug resisted,
10081,case report,NA,article/study aim,
10081,man,patient,sex,
10081,advanced aids,patient,comorbidities,
10081,persistent productive cough,patient,symptoms/disease,
10081,worsening dyspnea,patient,symptoms/disease,
10081,fever,patient,symptoms/disease,
10081,weight loss of 7.3 kg over the past 4 weeks,patient,symptoms/disease,
10081,mexico,patient,country of residence,
10081,isoniazid,NA,drug resisted,
10081,rifampin,NA,drug resisted,
10081,pyrazinamide,NA,drug resisted,
10081,ethambutol,NA,drug resisted,
10081,mycobacterium szulgai,bacteria,binomial (genus species),
10081,this is the first reported case of m. szulgai with resistance to all primary antituberculosis drugs,NA,notes,
10081,california,location,state/province/district,
10081,37-year-old,patient,age,
10083,81,patient,age,
10083,april,NA,event month,
10083,2012,NA,event year,
10083,streptococcus pneumoniae,bacteria,binomial (genus species),
10083,amoxicillin,NA,drug resisted,b
10083,16,NA,mic,b
10083,amoxicillin-clavulanate,NA,drug resisted,a
10083,16/8,NA,mic,a
10083,man,patient,sex,
10083,ceftriaxone,NA,drug resisted,c
10083,16,NA,mic,c
10083,cefuroxime,NA,drug resisted,d
10083,32,NA,mic,d
10083,erythromycin,NA,drug resisted,e
10083,"samsung medical center,",location,hospital name,
10083,64,NA,mic,e
10083,clarithromycin,NA,drug resisted,f
10083,32,NA,mic,f
10083,tetracycline,NA,drug resisted,g
10083,16,NA,mic,g
10083,seoul,location,city,
10083,levofloxacin,NA,drug resisted,h
10083,16,NA,mic,h
10083,moxifloxacin,NA,drug resisted,i
10083,4,NA,mic,i
10083,gatifloxacin,NA,drug resisted,j
10083,republic of korea,location,country,
10083,8,NA,mic,j
10083,high fever,patient,symptoms,
10083,decreased consciousness,patient,symptoms,
10083,25 april 2012,NA,event date,
10083,25,NA,event day,
10209,this is the first study demonstrated the occurrence of shv-12 in nigeria,NA,article/study aim,
10209,this is the first study demonstrated the occurrence of shv-12 in nigeria,NA,notes,
10209,gentamicin,NA,drug resisted,e
10209,tobramycin,NA,drug resisted,f
10209,μg/ml,NA,notes,
10209,≥256,NA,mic,a
10209,128,NA,mic,c
10209,64,NA,mic,
10209,>16,NA,mic,e
10209,8,NA,mic,f
10209,≥256,NA,mic,b
10209,1999,NA,event year,
10209,november,NA,event month,
10209,enterobacter aerogenes,bacteria,binomial (genus species),
10209,shv-12,bacteria,resistance marker,
10209,ean146,bacteria,strain,
10209,nigeria,location,country,
10209,twoyear-old,patient,age,
10209,male,patient,sex,
10209,8,NA,event day,
10209,8th november 1999,NA,event date,
10209,ampicillin,NA,drug resisted,a
10209,ampicillin/clav,NA,drug resisted,b
10209,ceftazidime,NA,drug resisted,c
10209,ceftazidime/clav,NA,drug resisted,d
10221,"we report the first outbreak of colonizations and infections due to a k. pneumoniae strain producing vim-1 mbl in a french university hospital,",NA,article/study aim,
10221,>128,NA,mic,a
10221,32,NA,mic,d
10221,03,NA,event year,
10221,klebsiella pneumoniae,bacteria,binomial (genus species),
10221,vim-1,bacteria,resistance marker,
10221,shv-5,bacteria,resistance marker,
10221,france,location,country,
10221,paul brousse hospital,location,hospital name,
10221,greece,location,place traveled to,
10221,liver transplantation,NA,notes,
10221,12,NA,event month,
10221,02,NA,event day,
10221,12.02.03,NA,event date,
10221,aztreonam,NA,drug resisted,a
10221,imipenem,NA,drug resisted,d
10221,clavulanic acid,NA,drug resisted,b
10221,tazobactam,NA,drug resisted,c
10246,2.5,patient,age,
10246,vomit,patient,symptoms/disease,
10246,tonic–clonic seizures,patient,symptoms/disease,
10246,first report of xdr pediatric tb case in greece,NA,first surveillance study (of a particular resistance) in countr,
10246,girl,patient,sex,
10246,rifampicin,NA,drug resisted,
10246,isoniazid,NA,drug resisted,
10246,cure,patient,outcome,
10246,18,patient,age,
10246,boy,patient,sex,
10246,fever,patient,symptoms/disease,
10246,cough,patient,symptoms/disease,
10248,bacteroides fragilis,bacteria,binomial (genus species),
10248,lymphoma,patient,comorbidities,
10248,ciprofloxacin,NA,drug resisted,
10248,gentamicin,NA,drug resisted,
10248,tobramycin,NA,drug resisted,
10248,amikacin,NA,drug resisted,
10248,75,patient,age,
10248,man,patient,sex,
10248,athens,location,city,
10248,greece,location,country,
10248,died,patient,outcome,
10248,71,patient,age,
10248,laikon general hospita,location,hospital name,
10248,39°c,patient,symptoms/disease,
10248,diarrhea,patient,symptoms/disease,
10248,crohn’s disease,patient,comorbidities,
10259,neisseria gonorrhoeae,bacteria,binomial (genus species),
10259,tetracycline,NA,drug resisted,b
10259,2.0 lg/ml,NA,mic,b
10259,2011,NA,event year,
10259,january,NA,event month,
10259,28,NA,event day,
10259,28 january 2011,NA,event date,
10259,strain h11s8,bacteria,strain,
10259,azithromycin,NA,drug resisted,a
10259,sequence type (st) 649,bacteria,strain,
10259,mutation a2059g,bacteria,resistance marker,
10259,"gonococcal isolates with high-level resistance to azithromycin (mics .256 lg/ml) have previously been identified from argentina in 2001 [10], scotland in 2004 [11], england and wales in 2007 [12], and ireland in 2008 [13]. isolates with mics $128 lg/ml were also identified from italy in 2007 [14]",NA,references for follow up,
10259,"galarza pg, alcala´ b, salcedo c, et al. emergence of high level azithromycin-resistant neisseria gonorrhoeae strain isolated in argentina. sex transm dis 2009; 36:787–8",NA,references for follow up,
10259,"palmer hm, young h, winter a, dave j. emergence and spread of azithromycin-resistant neisseria gonorrhoeae in scotland. j antimicrob chemother 2008; 62:490–4",NA,references for follow up,
10259,"chisholm sa, neal tj, alawattegama ab, birley hd, howe ra, ison ca. emergence of high-level azithromycin resistance in neisseria gonorrhoeae in england and wales. j antimicrob chemother 2009; 64:353–8",NA,references for follow up,
10259,"cole mj, chisholm sa, hoffmann s, et al. european surveillance of antimicrobial resistance in neisseria gonorrhoeae. sex transm infect 2010; 86:427–32",NA,references for follow up,
10259,united states,location,country,
10259,"this report discusses the epidemiologic case investigation, the molecular studies of resistance-associated mutations and n. gonorrhoeae multiantigen sequence typing, and challenges posed by emerging gonococcal antimicrobial resistance",NA,article/study aim,
10259,asymptomatic,patient,symptoms/disease,
10259,21,patient,age,
10259,woman,patient,sex,
10259,.512 lg,NA,mic,a
10260,we report on the first neisseria gonorrhoeae isolate in the united states identified with high-level resistance to azithromycin.,NA,article/study aim,
10260,neisseria gonorrhoeae,bacteria,binomial (genus species),
10260,(st) 649,bacteria,strain,
10260,united states,location,country,
10260,hawaii,location,state/province/district,
10260,honolulu,location,city,
10260,california|san francisco,location,place traveled to,
10260,2011,NA,event year,
10260,21-year-old,patient,age,
10260,woman,patient,sex,
10260,attending college,patient,occupation,
10260,"she sought care because 1 day earlier, her male sex partner had been seen for symptoms of dysuria and urethral discharge at a private clinic in honolulu.",NA,notes,
10260,january,NA,event month,
10260,28,NA,event day,
10260,28 january 2011,NA,event date,
10260,azithromycin,NA,drug resisted,
10260,tetracycline,NA,drug resisted,b
10260,.512 lg/ml.,NA,mic,a
10260,2.0 lg/ml,NA,mic,b
10300,pipc,NA,drug resisted,a
10300,[16,NA,mic,c
10300,[16,NA,mic,d
10300,[8,NA,mic,e
10300,[32,NA,mic,g
10300,cfpm,NA,drug resisted,b
10300,japan,location,country,
10300,11-year-old,patient,age,
10300,czop,NA,drug resisted,c
10300,girl,patient,sex,
10300,metastatic neuroblastoma,patient,symptoms/disease,
10300,neutropenia,patient,symptoms/disease,
10300,fever,patient,symptoms/disease,
10300,azt,NA,drug resisted,d
10300,gm,NA,drug resisted,e
10300,tob,NA,drug resisted,f
10300,amk,NA,drug resisted,g
10300,[64,NA,mic,a
10300,[16,NA,mic,b
10323,70,patient,age,
10323,amoxicillin/clavulanic acid,NA,drug resisted,a
10323,(16 µg/ml,NA,mic,a
10323,man,patient,sex,
10323,pharyngeal hemorrhage,patient,symptoms/disease,
10323,gastrointestinal bleeding,patient,symptoms/disease,
10323,respiratory distress,patient,symptoms/disease,
10323,meropenem,NA,drug resisted,
10323,fatal,patient,outcome,
10323,died,patient,outcome,
10323,all ß-lactam antibiotic,NA,drug resisted,
10335,"multiyear, multinational survey of the incidence and global distribution of metallo--lactamase-producing enterobacteriaceae and pseudomonas aeruginosa",NA,first surveillance study (of a particular resistance) in countr,
10443,this is the first report of emergence blavim‑2 in r. pickettii in india,NA,article/study aim,
10443,trimethoprim/sulfamethoxazole,NA,drug resisted,g
10443,piperacillin/tazobactam,NA,drug resisted,i
10443,cefepime,NA,drug resisted,j
10443,cefoperazone/sulbactam,NA,drug resisted,k
10443,: ceftazidime,NA,drug resisted,m
10443,ceftriaxone,NA,drug resisted,l
10443,64,NA,mic,a
10443,128,NA,mic,b
10443,2012,NA,event year,
10443,>16,NA,mic,c
10443,16,NA,mic,e
10443,nov,NA,event month,
10443,320,NA,mic,g
10443,amikacin,NA,drug resisted,a
10443,ralstonia pickettii,bacteria,binomial (genus species),
10443,vim‑2,bacteria,resistance marker,
10443,india,location,country,
10443,ticarcillin,NA,drug resisted,b
10443,55‑year‑old,patient,age,
10443,female,patient,sex,
10443,multiple episodes of vomiting for 2 days,patient,symptoms/disease,
10443,fever for 5 days,patient,symptoms/disease,
10443,generalized tonic clonic seizures (gtcs),patient,symptoms/disease,
10443,persistent leucopenia (700‑2100/cu mm3 ),patient,symptoms/disease,
10443,"after 2 weeks of tigecycline therapy in addition to intensive  daily wound care, patient recovered well",patient,outcome,
10443,gentamicin,NA,drug resisted,c
10443,tobramycin,NA,drug resisted,d
10443,moxifloxacin,NA,drug resisted,f
10443,levofloxacin,NA,drug resisted,e
10445,"we are reporting the emergence of the p.  aeruginosa carrying ndm-1gene, which exhibited resistance to  imipenem and meropenem, for the first time from india.",NA,article/study aim,
10445,gentamicin,NA,drug resisted,e
10445,tobramycin,NA,drug resisted,f
10445,ciprofloxacin,NA,drug resisted,g
10445,levofloxacin,NA,drug resisted,h
10445,moxifloxacin,NA,drug resisted,i
10445,tigecycline,NA,drug resisted,j
10445,trimethoprim/sulfamethoxazole,NA,drug resisted,k
10445,ampicillin/sulbactam,NA,drug resisted,l
10445,piperacillin/tazobactam,NA,drug resisted,m
10445,cefoperazone/sulbactam,NA,drug resisted,o
10445,we have also  reported the first instance of the detection of the blandm-1 gene in  a clinical isolate of raoultella ornitholytica [14].,NA,references for follow up,
10445,cefepime,NA,drug resisted,n
10445,tetracycline,NA,drug resisted,r
10445,ceftazidime,NA,drug resisted,q
10445,ceftriaxone,NA,drug resisted,p
10445,32,NA,mic,a
10445,128,NA,mic,c
10445,8,NA,mic,g
10445,16,NA,mic,h
10445,320,NA,mic,k
10445,64,NA,mic,l
10445,"[14] khajuria a, praharaj ak, grover n, kumar m. first report of blandm-1 in raoultella ornithinolytica. antimicrob. agents chemother. 2013;  57: 1092-1093.",NA,references for follow up,
10445,august 2011 to july 2012,NA,event date,
10445,(mg/l),NA,notes,
10445,imipenem,NA,drug resisted,a
10445,pseudomonas aeruginosa,bacteria,binomial (genus species),
10445,ndm – 1,bacteria,resistance marker,
10445,india,location,country,
10445,pune,location,city,
10445,meropenem,NA,drug resisted,b
10445,66 year old,patient,age,
10445,male,patient,sex,
10445,necrotizing soft tissue infection (nsti),patient,symptoms/disease,
10445,septicaemia,patient,symptoms/disease,
10445,ps m1134,NA,notes,
10445,ticarcillin,NA,drug resisted,d
10445,amikacin,NA,drug resisted,c
10450,6,patient,age,
10450,kafr el-sheikh city,location,city,
10450,egypt,location,country,
10450,public hospital,location,hospital name,
10450,tachypnea,patient,symptoms/disease,
10450,tachycardia,patient,symptoms/disease,
10450,pneumonia,patient,symptoms/disease,
10450,his,patient,sex,
10450,k. pneumoniae,bacteria,binomial (genus species),
10450,kpe127,bacteria,strain,
10450,-lactam antibiotics,NA,drug resisted,
10450,gentamicin,NA,drug resisted,
10450,tetracycline,NA,drug resisted,
10450,nalidixic acid,NA,drug resisted,
10450,norfloxacin,NA,drug resisted,
10622,"to our knowledge, this report represents the first description of an esbl-producing stec o103 strain, indicating that antibiotic resistance plasmids can be successfully transferred to pathogenic stec that have not been considered as a reservoir of esbls",NA,article/study aim,
10622,cefotaxime,NA,drug resisted,
10622,16 g/ml],NA,mic,
10622,extended-spectrum lactamase (esbl)-producer,bacteria,resistance marker,
10622,14-year-old,patient,age,
10622,female,patient,sex,
10622,uncomplicated diarrhoea,patient,symptoms,
10622,shiga toxin 1 (stx1a),bacteria,resistance marker,
10622,intimin (eae-ε),bacteria,resistance marker,
10622,"the isolate also carried a variety of stec virulence genes, including stec-specific haemolysins (hlya, clya and ehxa), type iii secretion proteins (espa, espb, espd and tir) and bacterial adhesions (iha and efa1).",NA,notes,
10622,blatem,bacteria,resistance marker,
10622,escherichia coli,bacteria,binomial (genus species),
10622,blactx-m-3a,bacteria,resistance marker,
10622,cefotaxime resistance (blactx-m-3a) encoded on a plasmid was successfully transferred to a recipient straine. colij53 by conjugation,NA,notes,
10622,shiga toxin-producing,bacteria,strain,
10622,stec o103:h2,bacteria,strain,
10622,june 2015,NA,event date,
10622,2015,NA,event year,
10622,june,NA,event month,
10622,first description of ctx-m-3 extended-spectrum -lactamase in an outbreak strain of shiga toxin-producing escherichia coli o103:h2,NA,article/study aim,
10622,strain 201501610,bacteria,strain,
10634,"in this study, we described four patients colonized by ndm-1producing k. pneumoniae (ndmkp) who were hospitalized at a 2,700-bed tertiary care hospital in seoul, south korea",NA,article/study aim,
10634,ceftazidime,NA,drug resisted,e
10634,cefoxitin,NA,drug resisted,f
10634,cefepime,NA,drug resisted,g
10634,imipenem,NA,drug resisted,h
10634,meropenem,NA,drug resisted,i
10634,ciprofloxacin,NA,drug resisted,j
10634,mic (g/ml),NA,notes,
10634,128,NA,mic,a
10634,128,NA,mic,g
10634,32,NA,mic,j
10634,2010,NA,event year,
10634,november,NA,event month,
10634,5,NA,event day,
10634,klebsiella pneumoniae,bacteria,binomial (genus species),
10634,ndm-1,bacteria,resistance marker,
10634,sequence type (st) 340,bacteria,strain,
10634,south korea,location,country,
10634,seoul,location,city,
10634,71,patient,age,
10634,f,patient,sex,
10634,pyogenic spondylitis,patient,symptoms/disease,
10634,improved,patient,outcome,
10634,5 november 2010,NA,event date,
10634,ampicillin,NA,drug resisted,a
10634,piperacillin,NA,drug resisted,b
10634,cephalothin,NA,drug resisted,c
10634,cefotaxime,NA,drug resisted,d
10703,"this is the first study to report ctx-m-3, ctx-m-27, ctx-m-40, shv-27, shv-71, and shv-75 in thailand and to show that ctx-m esbl is highly endemic in the country.",NA,first surveillance study (of a particular resistance) in countr,
1080,this is the first study to report the emergence of vancomycinand linezolid-resistant s aureus in egypt.,NA,first surveillance study (of a particular resistance) in countr,
1080,this study analyzed the distribution and the antimicrobial resistance of gram-positive bacteria isolated from cancer patients in egypt.,NA,first surveillance study (of a particular resistance) in countr,
11176,e report the first case of a pulmonary infection with n. mexicana in a 61-year-old japanese woman with a history of hyperlipidaemia and bronchiectasis and a 6month history of non-productive hacking cough,NA,article/study aim,
11176,16/32 µg ml 1,NA,mic,a
11176,> 8 µg ml 1,NA,mic,b
11176,4 µg ml 1,NA,mic,c
11176,>16 µg ml 1,NA,mic,e
11176,>8/152 µg ml 1,NA,mic,h
11176,amoxicillin-clavulanic acid,NA,drug resisted,a
11176,clarithromycin,NA,drug resisted,b
11176,nocardia mexicana,bacteria,binomial (genus species),
11176,ifm 11616,bacteria,strain,
11176,japan,location,country,
11176,japan,patient,country of residence,
11176,61-year-old,patient,age,
11176,woman,patient,sex,
11176,hacking cough,patient,symptoms/disease,
11176,hyperlipidaemia,patient,symptoms/disease,
11176,bronchiectasis,patient,symptoms/disease,
11176,minocycline,NA,drug resisted,c
11176,smoking history of 20 packs per year,patient,comorbidities,
11176,her work exposed her to organic solvents for many years,patient,occupation,
11176,symptoms eventually improved,patient,outcome,
11176,doxycycline,NA,drug resisted,d
11176,gentamycin,NA,drug resisted,e
11176,tobramycin,NA,drug resisted,f
11176,ciprofloxacin,NA,drug resisted,g
11176,trimethoprim-sulphamethoxazole,NA,drug resisted,h
11201,", we would also like to present the case of a patient with p. aeruginosa-bacteremia, in which the first ndm-1positive strain was detected.",NA,article/study aim,
11201,sulperazon,NA,drug resisted,h
11201,aztreonam,NA,drug resisted,i
11201,meropenem,NA,drug resisted,j
11201,gentamicin,NA,drug resisted,k
11201,tobramycin,NA,drug resisted,l
11201,amikacin,NA,drug resisted,m
11201,tetracycline,NA,drug resisted,n
11201,colistin,NA,drug resisted,o
11201,trimethoprim/ sulfamethoxazole,NA,drug resisted,p
11201,ciprofloxacin,NA,drug resisted,q
11201,2012,NA,event year,
11201,> 32,NA,mic,a
11201,64,NA,mic,e
11201,32,NA,mic,f
11201,> 64,NA,mic,h
11201,> 16,NA,mic,k
11201,16,NA,mic,o
11201,> 4,NA,mic,p
11201,mic (mg/l),NA,notes,
11201,ceftazidime,NA,drug resisted,a
11201,cefepime,NA,drug resisted,b
11201,cefotaxime,NA,drug resisted,c
11201,cefoperazone,NA,drug resisted,d
11201,seudomonas aeruginosa,bacteria,binomial (genus species),
11201,ndm-1,bacteria,resistance marker,
11201,slovakia,location,country,
11201,bratislava,location,city,
11201,"university hospital (tertiary hospital in bratislava, slovakia)",location,hospital name,
11201,44-year-old,patient,age,
11201,acute respiratory failure,patient,symptoms/disease,
11201,ventilator-associated pneumonia,patient,symptoms/disease,
11201,piperacillin,NA,drug resisted,e
11201,the patient survived and was discharged,patient,outcome,
11201,piperacillin/ tazobactam,NA,drug resisted,f
11201,ampicillin/ sulbactam,NA,drug resisted,g
11202,the aim of this study was to assess the distribution of carbapenemase producers among multidrug-resistant gram-negative bacteria isolated from blood cultures.,NA,first surveillance study (of a particular resistance) in countr,
11202,this is the first report of ndm-1-producing strains in slovakia and it contributes to a number of studies mapping the distribution of carbapenemase producers in europe,NA,first surveillance study (of a particular resistance) in countr,
11303,"we describe the isolation ndm-1–producing organisms from two patients in toronto, ontario. to the best of our knowledge, this is the first report of an organism producing ndm-1 that was locally acquired in canada.",NA,article/study aim,
11303,toronto,location,city,aa
11303,india|india,location,place traveled to,bb
11303,86-year-old,patient,age,aa
11303,man,patient,sex,aa
11303,type 2 diabetes mellitus,patient,comorbidities,aa
11303,hypertension,patient,comorbidities,aa
11303,atrial fibrillation,patient,comorbidities,aa
11303,colon cancer,patient,comorbidities,aa
11303,prostate cancer,patient,comorbidities,aa
11303,colonization with methicillin-resistant staphylococcus aureus (mrsa),patient,comorbidities,aa
11303,condition improved after several days,patient,outcome,aa
11303,71-year-old,patient,age,bb
11303,female,patient,sex,bb
11303,multiple sclerosis,patient,comorbidities,bb
11303,morganella morganii,bacteria,binomial (genus species),aa
11303,neurogenic bladder,patient,comorbidities,bb
11303,febrile,patient,symptoms/disease,bb
11303,this is the first reported instance in which an ndm-1–producing organism was locally acquired in canada,NA,notes,
11303,providencia rettger,bacteria,binomial (genus species),bb
11384,canada,location,country,
11384,64,NA,mic,b
11384,trimethoprim-sulfamethoxazole,NA,drug resisted,c
11384,16/304,NA,mic,c
11384,escherichia fergusonii,bacteria,binomial (genus species),
11384,76,patient,age,
11384,woman,patient,sex,
11384,ampicillin,NA,drug resisted,a
11384,32,NA,mic,a
11384,aztreonam,NA,drug resisted,b
11395,this study demonstrates the first description of tem-116 in  the p. stuartii species in the world and the first one in a tunisian hospital.,NA,article/study aim,
11395,chloramphenicol,NA,drug resisted,g
11395,nalidixic acid,NA,drug resisted,h
11395,ciprofloxacin,NA,drug resisted,i
11395,tetracyclin,NA,drug resisted,j
11395,streptomycin,NA,drug resisted,k
11395,>512,NA,mic,a
11395,512,NA,mic,d
11395,128,NA,mic,e
11395,256,NA,mic,i
11395,2009,NA,event year,
11395,febuary,NA,event month,
11395,ticarcillin,NA,drug resisted,a
11395,providencia stuartii,bacteria,binomial (genus species),
11395,tem-116,bacteria,resistance marker,
11395,tunisia,location,country,
11395,79-year-old,patient,age,
11395,igestive hemorrhage,patient,symptoms/disease,
11395,cefotaxime,NA,drug resisted,b
11395,ceftazidime,NA,drug resisted,c
11395,cefoxitin,NA,drug resisted,d
11395,cefpirome,NA,drug resisted,e
11395,aztreonam,NA,drug resisted,f
11406,klebsiella oxytoca,bacteria,binomial (genus species),
11406,carbapenems,NA,drug resisted,a
11406,ertapenem,NA,drug resisted,a
11406,imipenem,NA,drug resisted,a
11406,meropenem,NA,drug resisted,a
11406,doripenem,NA,drug resisted,a
11406,16–64 μg/ml,NA,mic,a
11406,new delhi metallo-β-lactamase1,bacteria,resistance marker,
11406,aminoglycosides,NA,drug resisted,b
11406,≥256 μg/ml,NA,mic,b
11406,fosfomycin,NA,drug resisted,c
11406,≥256 μg/ml,NA,mic,c
11406,taiwan,location,country,
11406,we report the first case of hospital-acquired infection caused by ndm-1–producing k. oxytoca in taiwan.,NA,article/study aim,
11406,abdominal pain,patient,symptoms,
11406,dysuria,patient,symptoms,
11406,china,location,place traveled to,
11406,56,patient,age,
11406,man,patient,sex,
11406,ertapenem-resistant,bacteria,resistance marker,
11406,ertapenem,NA,drug resisted,
11406,blandm-1,bacteria,resistance marker,
11413,case report,NA,article/study aim,
11413,metastatic angiosarcoma,patient,comorbidities,
11413,1-week history of mild respiratory distress,patient,symptoms,
11413,chest pain,patient,symptoms,
11413,fever,patient,symptoms,
11413,purulent discharge,patient,symptoms,
11413,acute respiratory failure with shock,patient,outcome,
11413,patient was intubated because of hypoxemic respiratory failure,patient,outcome,
11413,"n. abscessus was first proposed as a new species by yassin et al in 20018 ; however, little is known about its clinical significance.",NA,notes,
11413,imipenem,NA,drug resisted,
11413,>32 mg/ml,NA,mic,
11413,nocardia abscessus,bacteria,binomial (genus species),
11413,taiwan,location,country,
11413,54-year-old,patient,age,
11413,man,patient,sex,
11413,angiosarcoma status,patient,comorbidities,
11413,chemotherapy with paciltaxel,patient,comorbidities,
11508,rhodococcus equi,bacteria,binomial (genus species),
11508,october,NA,event month,
11508,2006,NA,event year,
11508,"january 23, 2007",NA,event date,
11508,female,patient,age,
11508,5,patient,age,
11508,male,patient,sex,
11508,6,patient,age,
11508,unresponsive,patient,symptoms/disease,
11508,limp,patient,symptoms/disease,
11508,trimethoprim/sulfamethoxazole,NA,drug resisted,a
11508,4/76,NA,mic,a
11508,17,patient,age,
11508,female,patient,sex,
1151,the aim of this study was to investigate for the first time the resistance patterns and the strain lineages of a sample of m. tuberculosis complex (mtbc) isolates collected in the two main cities of congo,NA,article/study aim,
1151,congo,location,country,
1151,mycobacterium tuberculosis,bacteria,binomial (genus species),
1151,by conducting the first phenotypic and molecular investigation of m. tuberculosis clinical isolates in circulation in congo we have revealed the presence of mdr-tb in this country,NA,first surveillance study (of a particular resistance) in countr,
11510,we describe the first case of invasive human infection (a nosocomial septicemia) caused by cupriavidus metallidurans.,NA,article/study aim,
11510,cupriavidus metallidurans,bacteria,binomial (genus species),
11510,canada,location,country,
11510,que´bec,location,city,
11510,74-year-old,patient,age,
11510,man,patient,sex,
11510,ype 2 diabetes,patient,comorbidities,
11510,arteriosclerotic heart disease,patient,comorbidities,
11510,dyslipidemia,patient,comorbidities,
11510,rterial hypertension,patient,comorbidities,
11510,obesity,patient,comorbidities,
11510,gentamicin,NA,drug resisted,a
11510,died,patient,outcome,
11510,bacteremia,patient,symptoms/disease,
11510,septicemia,patient,symptoms/disease,
11510,tobramycin,NA,drug resisted,b
11510,8,NA,mic,a
11510,mic (mg/liter),NA,notes,
11797,here we report the first case of disseminated infection caused by n. concava– in a patient with a history of glucocorticoid use–in south korea.,NA,article/study aim,
11797,seoul,location,city,
11797,64-year-old,patient,age,
11797,man,patient,sex,
11797,alcoholic liver cirrhosis of child-pugh classification b,patient,comorbidities,
11797,membranous glomerulopathy,patient,comorbidities,
11797,fever,patient,symptoms/disease,
11797,chills,patient,symptoms/disease,
11797,discharged on the 26th hospital day,patient,comorbidities,
11797,"a new nocardia species, n. concava, was first reported in japan in 2005. to date, there have been only 3 case reports of n. concava infection worldwide (2 in japan and 1 in china), and only 1 of these reports has detailed the clinical characteristics of n. concava, in china.",NA,notes,
11797,moxicillin-clavulanic acid,NA,drug resisted,
11797,cefepime,NA,drug resisted,
11797,clarithromycin,NA,drug resisted,
11797,ceftriaxone,NA,drug resisted,
11797,imipenem,NA,drug resisted,
11797,nocardia concav,bacteria,binomial (genus species),
11797,south korea,location,country,
1198,63,patient,age,
1198,hypertensive cardiopathy,patient,comorbidities,
1198,he,patient,sex,
1198,ulcer,patient,symptoms/disease,
1198,painful swelling of the lower left leg,patient,symptoms/disease,
1198,s. maria degli angeli regional hospital,location,hospital name,
1198,pordenone,location,city,
1198,italy,location,country,
1198,obese,patient,comorbidities,
1198,diabetes mellitus,patient,comorbidities,
11983,"to describe the phenotypic and genetic characteristics of the first two cases of extended-spectrum cephalosporin (esc)-resistant neisseria gonorrhoeae in south africa, one of which was associated with verified cefixime treatment failure",NA,article/study aim,
11983,4 mg/l,NA,mic,c
11983,4 mg/l,NA,mic,d
11983,2012,NA,event year,
11983,neisseria gonorrhoeae,bacteria,binomial (genus species),
11983,mlst sequence type (st1901),bacteria,strain,
11983,south africa,location,country,
11983,johannesburg,location,city,
11983,50s,patient,age,
11983,msm,patient,sex,
11983,both patients were lost to follow-up,patient,outcome,
11983,may,NA,event month,
11983,cefixime,NA,drug resisted,a
11983,ciprofloxacin,NA,drug resisted,b
11983,penicillin,NA,drug resisted,c
11983,tetracycline,NA,drug resisted,d
11983,0.25 mg/l,NA,mic,a
11983,16 mg/l,NA,mic,b
12065,"the findings of this study are notable for several reasons. first, this report is the first demonstration of a treatment-emergent mic increase from 1 mg/l to 64 mg/l for tig. second, in vivo tig data from longitudinal series are rare and data from xdr e. coli carrying blandm-5 have not been previously reported. third, information regarding high-level tig-resistant e. coli is uncommon in vivo.",NA,notes,
12065,ceftazidime,NA,drug resisted,e
12065,cefepime,NA,drug resisted,f
12065,ceftriaxone,NA,drug resisted,g
12065,ciprofloxacin,NA,drug resisted,h
12065,ertapenem,NA,drug resisted,i
12065,"this study is the first report to demonstrate high-level tig resistance in e. coli in vivo. in addition, we report the first treatment-emergent minimum inhibitory concentration (mic) development of tig from 1 mg/l to 64 mg/l in e. coli",NA,article/study aim,
12065,gentamicin,NA,drug resisted,j
12065,cefotetan,NA,drug resisted,k
12065,imipenem,NA,drug resisted,l
12065,levofloxacin,NA,drug resisted,m
12065,nitrofurantoin,NA,drug resisted,n
12065,amikacin,NA,drug resisted,a
12065,piperacillin/tazobactam,NA,drug resisted,o
12065,tobramycin,NA,drug resisted,p
12065,trimethoprim/sulfamethoxazole,NA,drug resisted,q
12065,tetracycline,NA,drug resisted,r
12065,≥64,NA,mic,a
12065,≥32,NA,mic,b
12065,≥4,NA,mic,h
12065,≥8,NA,mic,i
12065,≥16,NA,mic,j
12065,128,NA,mic,n
12065,≥128,NA,mic,o
12065,≥320,NA,mic,q
12065,≥256,NA,mic,r
12065,ampicillin/sulbactam,NA,drug resisted,b
12065,escherichia coli,bacteria,binomial (genus species),
12065,st167,bacteria,strain,
12065,ndm-5,bacteria,resistance marker,
12065,china,location,country,
12065,ampicillin,NA,drug resisted,c
12065,hangzhou,location,city,
12065,43-year-old,patient,age,
12065,female,patient,sex,
12065,"at the end of the treatment, the patient died of respiratory failure",patient,occupation,
12065,bone marrow transplantation for plasma cell leukaemia,patient,comorbidities,
12065,bacteraemia,patient,symptoms/disease,
12065,aztreonam,NA,drug resisted,d
1216,eigh,patient,age,
1216,>16,NA,mic,b
1216,aztreonam,NA,drug resisted,c
1216,>16,NA,mic,c
1216,cefepime,NA,drug resisted,d
1216,>16,NA,mic,d
1216,girl,patient,sex,
1216,cefotaxime,NA,drug resisted,e
1216,>32,NA,mic,e
1216,cefoxitin,NA,drug resisted,f
1216,>16,NA,mic,f
1216,imipenem,NA,drug resisted,g
1216,swelling,patient,symptoms/disease,
1216,>8,NA,mic,g
1216,meropenem,NA,drug resisted,h
1216,>8,NA,mic,h
1216,cured,patient,outcome,
1216,erythema,patient,symptoms/disease,
1216,amoxicillin-clavulanate,NA,drug resisted,a
1216,>16,NA,mic,a
1216,ampicillin,NA,drug resisted,b
12188,79,patient,age,
12188,japanese,location,country,
12188,man,patient,sex,
12188,chronic obstructive pulmonary disease,patient,comorbidities,
12188,respiratory failure,patient,outcome,
12188,expired,patient,outcome,
12188,gentamycin,NA,drug resisted,
12188,ciprofloxacin,NA,drug resisted,
12188,levofloxacin,NA,drug resisted,
12188,ceftazidime,NA,drug resisted,
12344,report the first oxa-181-producing strain in china.,NA,article/study aim,
12344,cefepime,NA,drug resisted,
12344,cefotaxime,NA,drug resisted,
12344,cefoxitin,NA,drug resisted,
12344,ceftriaxone,NA,drug resisted,
12344,ertapenem,NA,drug resisted,
12344,gentamicin,NA,drug resisted,
12344,evofloxacin,NA,drug resisted,
12344,nitrofurantoin,NA,drug resisted,
12344,piperacillin-tazobactam,NA,drug resisted,
12344,tobramycin,NA,drug resisted,
12344,2014,NA,event year,
12344,trimethoprim-sulfamethoxazole,NA,drug resisted,
12344,16 g/ml,NA,mic,a
12344,32 g/ml,NA,mic,b
12344,128 g/ ml,NA,mic,c
12344,64 g/ml,NA,mic,d
12344,imipenem,NA,drug resisted,a
12344,escherichia coli,bacteria,binomial (genus species),
12344,oxa-181,bacteria,resistance marker,
12344,st410,bacteria,strain,
12344,china,location,country,
12344,leukemia,patient,comorbidities,
12344,she,patient,sex,
12344,"the patient in this study had no recent travel history to the indian subcontinent, and it remains unclear how and where she acquired this oxa-181producing strain.",NA,notes,
12344,meropenem,NA,drug resisted,b
12344,ceftazidime,NA,drug resisted,c
12344,ciprofloxacin,NA,drug resisted,d
12344,ampicillin-sulbactam,NA,drug resisted,
12344,aztreonam,NA,drug resisted,
12344,cefazolin,NA,drug resisted,
12359,.,NA,article/study aim,
12359,imipenem,NA,drug resisted,g
12359,meropenem,NA,drug resisted,h
12359,ceftazidime,NA,drug resisted,i
12359,piperacillin-tazobactam,NA,drug resisted,j
12359,cefotetan,NA,drug resisted,k
12359,tobramycin,NA,drug resisted,l
12359,gentamicin,NA,drug resisted,m
12359,ciprofloxacin,NA,drug resisted,n
12359,levofloxacin,NA,drug resisted,o
12359,amikacin,NA,drug resisted,p
12359,september,NA,event month,
12359,trimethoprim-sulfamethoxazole,NA,drug resisted,q
12359,.256,NA,mic,a
12359,256,NA,mic,
12359,32,NA,mic,g
12359,16,NA,mic,
12359,.32/608,NA,mic,q
12359,2011,NA,event year,
12359,ampicilin,NA,drug resisted,a
12359,ampicillin-sulbactam,NA,drug resisted,b
12359,cefazolin,NA,drug resisted,c
12359,escherichia coli,bacteria,binomial (genus species),
12359,st224,bacteria,strain,
12359,ndm-1,bacteria,resistance marker,
12359,china,location,country,
12359,beijing,location,city,
12359,75-year-old,patient,age,
12359,china,patient,country of residence,
12359,discharged from the hospital,patient,outcome,
12359,diabetes,patient,comorbidities,
12359,aztreonam,NA,drug resisted,d
12359,ceftriaxone,NA,drug resisted,e
12359,cefepime,NA,drug resisted,f
12395,34,patient,age,
12395,ertapenem,NA,drug resisted,
12395,boy,patient,sex,
12395,diarrhea,patient,symptoms,
12395,decreased p.o. intake,patient,symptoms,
12395,fever,patient,symptoms,
12395,seizure,patient,symptoms,
12395,premature,patient,comorbidities,
12395,developmental delay.,patient,comorbidities,
12395,imipenem,NA,drug resisted,
12403,52,patient,age,
12403,trimethoprim,NA,drug resisted,
12403,sulfamethoxazole,NA,drug resisted,
12403,man,patient,sex,
12403,senegal,location,country,
12403,"saint louis,",location,city,
12403,pale mucous,patient,symptoms/disease,
12403,pus,patient,symptoms/disease,
12403,favorable,patient,outcome,
12403,c. aurimucosum,bacteria,binomial (genus species),
12403,penicillin,NA,drug resisted,
12482,"lthough prior studies have identified eight ceftaroline-resistant methicillin-resistant staphylococcus aureus (mrsa) isolates in europe and asia with mics ranging from 4 to 8 mg/liter, high-level resistance to ceftaroline (>32 mg/liter) has not been described in mrsa strains isolated in the united states.",NA,notes,
12482,linezolid,NA,drug resisted,d
12482,methicillin,NA,drug resisted,e
12482,penicillin,NA,drug resisted,f
12482,32,NA,mic,a
12482,2),NA,mic,b
12482,4),NA,mic,c
12482,we identified the molecular mechanism of ceftaroline resistance in the first mrsa strain with high-level ceftaroline resistance isolated in the united states.,NA,article/study aim,
12482,staphylococcus aureus,bacteria,binomial (genus species),
12482,st5,bacteria,strain,
12482,2013,NA,event year,
12482,united states,location,country,
12482,houston,location,city,
12482,houston methodist hospital,location,hospital name,
12482,texas,location,state/province/district,
12482,20-year-old,patient,age,
12482,male,patient,sex,
12482,cystic fibrosis,patient,comorbidities,
12482,pancreatic insufficiency,patient,comorbidities,
12482,steroid-induced diabetes,patient,comorbidities,
12482,21,NA,event day,
12482,1,NA,event month,
12482,1/21/2013,NA,event date,
12482,ceftaroline,NA,drug resisted,a
12482,clindamycin,NA,drug resisted,b
12482,erythromycin,NA,drug resisted,c
1288,"the occurrence in uruguay of esbl-producing salmonella isolates is an extremely rare event; in this sense, in the year 2006, we reported the presence of blatem-144 carried in a transferable plasmid in salmonella enterica serotype derby obtained from eggs (29), but the clinical relevance of such a finding is still unknown. nevertheless, so far in our country, there have been no reports of esbls in salmonella enteritidis of human origin",NA,notes,
1288,32,NA,mic,
1288,64,NA,mic,c
1288,64,NA,mic,d
1288,this is the first report of blactx-m-14 in salmonella enteritidis of human origin in south america,NA,article/study aim,
1288,salmonella enterica,bacteria,binomial (genus species),
1288,st11,bacteria,strain,
1288,blactx-m-14,bacteria,resistance marker,
1288,uruguay,location,country,
1288,montevideo,location,city,
1288,hospital pasteur of montevideo,location,hospital name,
1288,67-year-old,patient,age,
1288,chronic renal failure,patient,comorbidities,
1288,gastroenterocolitis,patient,comorbidities,
1288,2011,NA,event year,
1288,january,NA,event month,
1288,ampicillin,NA,drug resisted,a
1288,sulbactam-ampicillin,NA,drug resisted,b
1288,cephalothin,NA,drug resisted,c
1288,cefotaxime,NA,drug resisted,d
1288,32,NA,mic,a
12887,"aim of this study was to show the emergence of the qnr genes among fluoroquinolone-resistant, ampc and  esbl (extended-spectrum-beta-lactamase) co-producing morganella morganii isolate",NA,article/study aim,
12887,tetracycline,NA,drug resisted,f
12887,ofloxacin,NA,drug resisted,g
12887,512,NA,mic,a
12887,256,NA,mic,b
12887,64,NA,mic,d
12887,chloramphenicol,NA,mic,
12887,tetracycline,NA,mic,
12887,32,NA,mic,g
12887,cephalothin,NA,drug resisted,c
12887,>512,NA,mic,c
12887,2008,NA,event year,
12887,april,NA,event month,
12887,morganella morganii,bacteria,binomial (genus species),
12887,sm12012,bacteria,strain,
12887,dha-1,bacteria,resistance marker,
12887,ctx-m-15,bacteria,resistance marker,
12887,tunisia,location,country,
12887,48-year-old,patient,age,
12887,4,NA,event day,
12887,man,patient,sex,
12887,the patient showed clinical  improvement and treatment was completed after 14 days.,patient,outcome,
12887,grave  cranial traumatism,patient,comorbidities,
12887,"april 4th, 2008",NA,event date,
12887,amoxicillin,NA,drug resisted,a
12887,ticarcillin,NA,drug resisted,b
12887,cefoxitin,NA,drug resisted,d
12887,chloramphenicol,NA,drug resisted,e
12905,we report the first case of infection caused by a unique carbapenem-resistant e. cloacae st89 producing oxa-48 carbapenemase in central europe (poland),NA,article/study aim,
12905,cefepime,NA,drug resisted,g
12905,ceftazidime,NA,drug resisted,h
12905,meropenem,NA,drug resisted,i
12905,trimethoprim–sulfamethoxazole,NA,drug resisted,j
12905,ciprofloxacin,NA,drug resisted,k
12905,colistin,NA,drug resisted,l
12905,tigecycline,NA,drug resisted,m
12905,64,NA,mic,a
12905,16,NA,mic,b
12905,128,NA,mic,d
12905,2012,NA,event year,
12905,16,NA,mic,h
12905,320,NA,mic,j
12905,4,NA,mic,k
12905,12,NA,mic,l
12905,4,NA,mic,m
12905,august,NA,event month,
12905,amikacin,NA,drug resisted,a
12905,gentamicin,NA,drug resisted,b
12905,nterobacter cloacae,bacteria,binomial (genus species),
12905,st89,bacteria,strain,
12905,oxa-48,bacteria,resistance marker,
12905,poland,location,country,
12905,bialystok,location,city,
12905,medical university of bialystok,location,hospital name,
12905,76-year-old,patient,age,
12905,male,patient,sex,
12905,mitral and tricuspid valve regurgitation,patient,symptoms/disease,
12905,tobramycin,NA,drug resisted,c
12905,coronary artery disease,patient,comorbidities,
12905,hypertension,patient,comorbidities,
12905,bradycardia–tachycardia syndrome,patient,symptoms/disease,
12905,third stage of chronic kidney disease,patient,comorbidities,
12905,cardiac decompensation,patient,symptoms/disease,
12905,coagulation disorders,patient,symptoms/disease,
12905,acute renal failure,patient,symptoms/disease,
12905,multiple organ dysfunction syndrome,patient,symptoms/disease,
12905,cardiac arrest,patient,symptoms/disease,
12905,died,patient,outcome,
12905,piperacillin,NA,drug resisted,d
12905,piperacillin–tazobactam,NA,drug resisted,e
12905,aztreonam,NA,drug resisted,f
13015,"we detected a strain that was  negative for extended-spectrum β-lactamase and positive  for the ampc disk test, modifi ed hodge test, and edta disk  synergy test and harbored the bladha-1 and blandm-1 genes.",NA,article/study aim,
13015,hk-01,bacteria,strain,
13015,bladha-1,bacteria,resistance marker,
13015,blandm-1,bacteria,resistance marker,
13015,india,location,country,
13015,puducherry,location,city,
13015,jawaharlal institute of postgraduate  medical education and research (jipmer),location,hospital name,
13015,2-year-old,patient,age,
13015,the child was treated successfully with intravenous fl uid  supplements and ciprofl oxacin,patient,outcome,
13015,vibrio cholerae resistance to third-generation cephalosporins is rarely reported.,NA,notes,
13015,ampicillin,NA,drug resisted,
13015,ceftriaxone,NA,drug resisted,a
13015,cotrimoxazole,NA,drug resisted,
13015,furoxone,NA,drug resisted,
13015,16 μg/ml,NA,mic,a
13015,vibrio cholerae,bacteria,binomial (genus species),
13129,case report,NA,article/study aim,
13129,imipenem,NA,drug resisted,
13129,meropenem,NA,drug resisted,
13129,ciprofloxacin,NA,drug resisted,
13129,gentamicin,NA,drug resisted,
13129,amikacin,NA,drug resisted,
13129,klebsiella pneumoniae,bacteria,binomial (genus species),
13129,venezuela,location,country,
13129,caracas,location,city,
13129,hospital de niños ―j.m de los ríos‖,location,hospital name,
13129,7-year-old,patient,age,
13129,2005,NA,event year,
13129,female,patient,sex,
13129,history of a left urethral implant,patient,comorbidities,
13129,neurogenic  bladder,patient,comorbidities,
13129,urethrocystoplasty,patient,comorbidities,
13129,repeated urinary  infections since april 2005,patient,comorbidities,
13129,july,NA,event month,
13129,ampicillin,NA,drug resisted,
13129,amoxicillin/clavulanic acid,NA,drug resisted,
13129,cefoxitin,NA,drug resisted,
13129,cefotaxime,NA,drug resisted,
13129,ceftazidime,NA,drug resisted,
13129,cefpodoxime,NA,drug resisted,
13223,"we describe the first outbreak of klebsiella pneumoniae carbapenemase-producing k. pneumoniae (kpc-kp), the infection control measures adopted and the shift in resistance patterns of isolates during antibiotic treatment.",NA,article/study aim,
13223,ciprofloxacin,NA,drug resisted,d
13223,colistin,NA,drug resisted,e
13223,≥128/4,NA,mic,a
13223,mic lg ml1,NA,notes,
13223,≥64,NA,mic,b
13223,≥16,NA,mic,c
13223,≥4,NA,mic,d
13223,≥16,NA,mic,
13223,2011,NA,event year,
13223,klebsiella pneumoniae,bacteria,binomial (genus species),
13223,st258,bacteria,strain,
13223,february,NA,event month,
13223,kpc,bacteria,resistance marker,
13223,uruguay,location,country,
13223,punta del este,location,city,
13223,the ‘sanatorio mautone’,location,hospital name,
13223,30-year-old,patient,age,
13223,man,patient,sex,
13223,severe enteric sepsis caused by a salmonella sp.,patient,comorbidities,
13223,evans syndrome associated with systemic lupus erythematosus,patient,comorbidities,
13223,fever,patient,symptoms,
13223,septic shock,patient,symptoms,
13223,20,NA,event day,
13223,he progressed to refractory septic shock and died on 7 april.,patient,outcome,
13223,20 february 2011,NA,event date,
13223,patient a,NA,notes,
13223,piperacillin-tazobactam,NA,drug resisted,a
13223,cefoxitin,NA,drug resisted,b
13223,gentamicin,NA,drug resisted,c
13308,"human infections caused by r. aquatilis are infrequent and had not been previously reported in brazil,",NA,notes,
13308,autoimmune encephalopathy associated to lyme disease,patient,comorbidities,
13308,developed various infections (respiratory and urinary),patient,symptoms/disease,
13308,meropenem therapy was introduced and clinical improvement was observed seven days thereafter,patient,outcome,
13308,cephalothin,NA,drug resisted,
13308,128g/ml,NA,mic,
13308,rahnella aquatilis,bacteria,binomial (genus species),
13308,rahn-1,bacteria,resistance marker,
13308,brazil,location,country,
13308,são paulo,location,city,
13308,64 y-o,patient,age,
13308,male,patient,sex,
13370,this is the first report of p. aeruginosa with blandm-1 identified in north america and the first report of blaoxa-181 in p. rettgeri,NA,article/study aim,
13370,amikacin,NA,drug resisted,g
13370,gentamicin,NA,drug resisted,h
13370,tobramycin,NA,drug resisted,i
13370,ciprofloxacin,NA,drug resisted,j
13370,tigecycline,NA,drug resisted,l
13370,trimethoprim-sulfamethoxazole,NA,drug resisted,k
13370,64/4,NA,mic,a
13370,16,NA,mic,b
13370,32,NA,mic,c
13370,8,NA,mic,f
13370,2015,NA,event year,
13370,8,NA,mic,h
13370,2,NA,mic,j
13370,2/38,NA,mic,k
13370,march,NA,event month,
13370,piperacillin-tazobactam,NA,drug resisted,a
13370,pseudomonas aeruginosa,bacteria,binomial (genus species),
13370,st654,bacteria,strain,
13370,ndm-1,bacteria,resistance marker,
13370,cefoxitin,NA,drug resisted,b
13370,oxa-50,bacteria,resistance marker,
13370,pdc-3,bacteria,resistance marker,
13370,canada,location,country,
13370,canada,patient,country of residence,
13370,alberta,location,state/province/district,
13370,calgary,location,city,
13370,india|new delhi,location,place traveled to,
13370,late 70s,patient,age,
13370,male,patient,sex,
13370,ceftriaxone,NA,drug resisted,c
13370,slurred speech,patient,symptoms/disease,
13370,left-sided weakness,patient,symptoms/disease,
13370,decreased level of consciousness,patient,symptoms/disease,
13370,respiratory distress,patient,symptoms/disease,
13370,nosocomial pneumonia,patient,symptoms/disease,
13370,ceftazidime,NA,drug resisted,d
13370,cefepime,NA,drug resisted,e
13370,meropenem,NA,drug resisted,f
13376,we report the first two clinical cases of oxa-48-type carbapenemase-producing enterobacteriaceae in the united states from patients recently hospitalized in saudi arabia and india.,NA,article/study aim,
13376,ciprofloxacin,NA,drug resisted,f
13376,tobramycin,NA,drug resisted,g
13376,trimethoprim-sulfamethoxazole,NA,drug resisted,h
13376,tetracycline,NA,drug resisted,i
13376,tigecycline,NA,drug resisted,j
13376,ertapenem,NA,drug resisted,k
13376,16,NA,mic,a
13376,16,NA,mic,
13376,64,NA,mic,e
13376,2,NA,mic,f
13376,2012,NA,event year,
13376,8,NA,mic,g
13376,2/38,NA,mic,h
13376,16,NA,mic,i
13376,8,NA,mic,j
13376,april,NA,event month,
13376,cav1543,NA,notes,
13376,g/ml,NA,notes,
13376,klebsiella pneumoniae,bacteria,binomial (genus species),
13376,st199,bacteria,strain,
13376,oxa-48,bacteria,resistance marker,
13376,ampicillin,NA,drug resisted,a
13376,tem,bacteria,resistance marker,
13376,shv,bacteria,resistance marker,
13376,ctx-m-9,bacteria,resistance marker,
13376,united states,location,country,
13376,virginia,location,state/province/district,
13376,charlottesville,location,city,
13376,university of virginia medical center (uvamc),location,hospital name,
13376,"riyadh, saudi arabia",location,place traveled to,
13376,55-year-old,patient,age,
13376,woman,patient,sex,
13376,aztreonam,NA,drug resisted,b
13376,acute kidney injury,patient,symptoms/disease,
13376,metabolic acidosis,patient,symptoms/disease,
13376,she expired on hospital day 10,patient,outcome,
13376,liver failure,patient,symptoms/disease,
13376,septic shock,patient,symptoms/disease,
13376,ceftazidime,NA,drug resisted,c
13376,cefepime,NA,drug resisted,d
13376,piperacillin-tazobactam,NA,drug resisted,e
13399,linezolid,NA,drug resisted,
13399,"cefoxitin,",NA,drug resisted,
13399,gentamicin,NA,drug resisted,
13399,erythromycin,NA,drug resisted,
13399,clindamycin,NA,drug resisted,
13399,"vmmc and associated safdarjung hospital,",location,hospital name,
13399,ndia,location,country,
13399,staphylococcus haemolyticus,bacteria,binomial (genus species),
13399,delhi,location,city,
13399,sepsis,patient,comorbidities + risk factors,
13399,55-year-old,patient,age,
13399,man,patient,sex,
13399,subarachnoid hemorrhages with multiple contusions.,patient,symptoms/disease,
13399,sepsis,patient,symptoms/disease,
13399,"penicillin,",NA,drug resisted,
13465,we report the isolation of multidrug resistant s.  paratyphi a producing ctx-m-15-type extended-spectrum beta-lactamase (esbl) from a traveller returning  from india.,NA,article/study aim,
13465,trimethoprim/sulfamethoxazole,NA,drug resisted,g
13465,>16,NA,mic,a
13465,64,NA,mic,b
13465,>16,NA,mic,c
13465,>2,NA,mic,g
13465,2013,NA,event year,
13465,salmonella enterica,bacteria,binomial (genus species),
13465,july,NA,event month,
13465,ctx-m-15,bacteria,resistance marker,
13465,india,location,country,
13465,manali,location,city,
13465,china|india|myanmar|thailand|nepal,location,place traveled to,
13465,japan,patient,country of residence,
13465,fever,patient,symptoms/disease,
13465,ampicillin,NA,drug resisted,a
13465,diarrhoea,patient,symptoms/disease,
13465,anorexia,patient,symptoms/disease,
13465,typhoid fever,patient,symptoms/disease,
13465,discharged,patient,outcome,
13465,cefotaxime,NA,drug resisted,b
13465,ceftazidime,NA,drug resisted,c
13465,ceftriaxone,NA,drug resisted,d
13465,nalidixic acid,NA,drug resisted,d
13465,aztreonam,NA,drug resisted,d
13490,this is the first report of a c. botulinum isolate resistant to penicillins.,NA,first surveillance study (of a particular resistance) in countr,
13490,sulfamethoxazole,NA,drug resisted,
13490,aminoglycosides,NA,drug resisted,
13490,penicillin g,NA,drug resisted,
13490,amoxicillin,NA,drug resisted,
13490,ticarcillin,NA,drug resisted,
13490,mezlocillin,NA,drug resisted,
13490,cephalothin,NA,drug resisted,
13490,>256 mg/l,NA,mic,a
13490,france,location,country,
13490,amoxicillin,NA,drug resisted,b
13490,>256,NA,mic,b
13490,2,patient,age,
13490,girl,patient,sex,
13490,progressive floppiness,patient,symptoms/disease,
13490,hypotonia,patient,symptoms/disease,
13490,b-lactams,NA,drug resisted,
13490,224-13,bacteria,strain,
13490,trimethoprim,NA,drug resisted,
13548,this is  the first reported isolation of an ndm-1-producing  enterobacteriaceae strain in ireland.,NA,article/study aim,
13548,cefoxitin,NA,drug resisted,
13548,aztreonam,NA,drug resisted,
13548,amoxicillin/clavulanic acid,NA,drug resisted,
13548,piperacillin/tazobactam,NA,drug resisted,
13548,sulphonamides,NA,drug resisted,
13548,streptomycin,NA,drug resisted,
13548,gentamicin,NA,drug resisted,
13548,nalidixic acid,NA,drug resisted,
13548,trimethoprim,NA,drug resisted,
13548,klebsiella pnemoniae,bacteria,binomial (genus species),
13548,2011,NA,event year,
13548,ndm-1,bacteria,resistance marker,
13548,ireland,location,country,
13548,kolkata,location,place traveled to,
13548,six-month old,patient,age,
13548,low-grade fever,patient,symptoms/disease,
13548,the child received a  five-day course of trimethoprim and remains clinically  well.,patient,symptoms/disease,
13548,may,NA,event month,
13548,amikacin,NA,drug resisted,
13548,kanamycin,NA,drug resisted,
13548,ampicillin,NA,drug resisted,
13548,ceftazidime,NA,drug resisted,
13548,cefotaxime,NA,drug resisted,
13548,cefpodoxime,NA,drug resisted,
13557,february 2012 to april 2013,NA,event date,
13557,patient recovered well,patient,outcome,
13557,"the objective of this study was to investigate the observation of daptomycin  resistance in corynebacterium striatum, both in vivo and in vitro.",NA,article/study aim,
13557,daptomycin,NA,drug resisted,
13557,corynebacterium striatum,bacteria,binomial (genus species),
13557,mo,location,state/province/district,
13557,st. louis,location,city,
13557,61-year-old,patient,age,
13557,male,patient,sex,
13557,>256,NA,mic,
13557,ischemic cardiomyopathy,patient,comorbidities,
13592,10,patient,age,
13592,mycobacterium tuberculosis,bacteria,binomial (genus species),
13592,not been seen,patient,outcome,
13592,boy,patient,sex,
13592,western province,location,state/province/district,
13592,papua new guinea,location,country,
13592,leprosy,patient,comorbidities,
13592,rifampicin,NA,drug resisted,
13592,isoniazid,NA,drug resisted,
13592,streptomycin,NA,drug resisted,
13592,ethionamide,NA,drug resisted,
1360,12,patient,age,
1360,acute cystiti,patient,comorbidities,
1360,gentamicin,NA,drug resisted,
1360,ciprofloxacin,NA,drug resisted,
1360,colistin,NA,drug resisted,
137,mycobacterium septicum,bacteria,binomial (genus species),
137,hypertension,patient,comorbidities,
137,afebrile,patient,symptoms,
137,chronic cough,patient,symptoms,
137,two years later,NA,event year,
137,d13 strain,bacteria,strain,
137,azithromycin,NA,drug resisted,
137,erythromycin,NA,drug resisted,
137,vancomycin,NA,drug resisted,
137,tobramycin,NA,drug resisted,
137,"moreover, the type strain was susceptible to azithromycin, erythromycin and vancomycin, but isolate d13 was resistant to those antimicrobial agents.",NA,article/study aim,
137,we herein report an additional m. septicum isolate from a patient suffering from hemoptoic pneumonia.,NA,article/study aim,
137,azithromycin,NA,drug resisted,a
137,>256,NA,mic,a
137,erythromycin,NA,drug resisted,b
137,>256,NA,mic,b
137,vancomycin,NA,drug resisted,c
137,>256,NA,mic,c
137,"this case illustrates the first isolation from sputum of m. septicum, a member of the mycobacterium fortuitum group previously isolated once from bacteremia.",NA,article/study aim,
137,78-year-old,patient,age,
137,woman,patient,sex,
137,february,NA,event month,
137,2002,NA,event year,
137,acute bronchitis,patient,symptoms,
137,hypothyroidism,patient,comorbidities,
13741,male,patient,sex,
13741,mic>8,NA,mic,a
13741,amikacin,NA,drug resisted,b
13741,mic>32,NA,mic,b
13741,gentamicin,NA,drug resisted,
13741,>8,NA,mic,c
13741,6,patient,age,
13741,meropenem,NA,drug resisted,
13741,piperacillin-tazobactam,NA,drug resisted,d
13741,>64,NA,mic,d
13741,imipenem,NA,drug resisted,e
13741,>8,NA,mic,e
13741,fever,patient,symptoms/disease,
13741,aztreonam,NA,drug resisted,f
13741,>16,NA,mic,f
13741,cefotaxime,NA,drug resisted,g
13741,32,NA,mic,g
13741,brazil,location,country,
13741,swelling,patient,symptoms/disease,
13741,são paulo,location,city,
13741,escola paulista de medicina da universidade federal de são paulo,location,hospital name,
13741,sphingobacterium multivorum,bacteria,binomial (genus species),
13741,carbapenemic antibiotics,NA,drug resisted,
13741,aminoglycosides,NA,drug resisted,
13741,good outcome,patient,outcome,
13741,tobramycin,NA,drug resisted,a
13772,"we report the isolation and identification, by 16s rrna amplification and sequencing, of two emerging pathogens resistant to colistin, brevundimonas diminuta and ochrobactrum anthropi, in a 17-year-old woman with cystic fibrosis and pneumonia",NA,article/study aim,
13772,ticarcillin,NA,drug resisted,b
13772,ticarcillin/clavulanic acid,NA,drug resisted,b
13772,ceftriaxone,NA,drug resisted,b
13772,piperacillin/tazobactam,NA,drug resisted,b
13772,2006,NA,event year,
13772,brevundimonas diminuta,bacteria,binomial (genus species),a
13772,ochrobactrum anthropi,bacteria,binomial (genus species),b
13772,october,NA,event month,
13772,france,location,country,
13772,marseille,location,city,
13772,hôpital timone,location,hospital name,
13772,17-year-old,patient,age,
13772,woman,patient,sex,
13772,cystic fibrosis,patient,comorbidities,
13772,diabetes,patient,comorbidities,
13772,persistent colonization of the respiratory tract with staphylococcus aureus since childhood,patient,comorbidities,
13772,amoxicillin,NA,drug resisted,a
13772,respiratory infection with dark sputum,patient,symptoms/disease,
13772,asthenia,patient,symptoms/disease,
13772,fever,patient,symptoms/disease,
13772,diffuse bronchitis syndrome,patient,symptoms/disease,
13772,bronchial distension,patient,symptoms/disease,
13772,ramatic improvement,patient,outcome,
13772,amoxicillin/clavulanic acid,NA,drug resisted,a
13772,ceftazidime,NA,drug resisted,a
13772,ciprofloxacin,NA,drug resisted,a
13772,trimethoprim/sulphamethoxazole,NA,drug resisted,a
13772,colistin,NA,drug resisted,a
13794,this is the first reported outbreak of oxa-23-producing a. baumannii isolates in spain,NA,article/study aim,
13794,tobramicin,NA,drug resisted,g
13794,amikacin,NA,drug resisted,h
13794,ciprofloxacin,NA,drug resisted,i
13794,mic (mg/l)a,NA,notes,
13794,> 64,NA,mic,a
13794,> 32,NA,mic,b
13794,> 16,NA,mic,c
13794,> 8,NA,mic,
13794,> 2,NA,mic,i
13794,2011,NA,event year,
13794,july,NA,event month,
13794,acinetobacter baumannii,bacteria,binomial (genus species),
13794,oxa-23,bacteria,resistance marker,
13794,st118,bacteria,strain,
13794,piperacillin/tazobactam,NA,drug resisted,a
13794,spain,location,country,
13794,a corun˜ a,location,city,
13794,university hospital a corun˜ a,location,hospital name,
13794,portugal,location,place traveled to,
13794,49-year-old,patient,age,
13794,man,patient,sex,
13794,left pneumothorax,patient,symptoms/disease,
13794,the patient died a few days later after admission to the icu,patient,outcome,
13794,headache,patient,symptoms/disease,
13794,malaise,patient,symptoms/disease,
13794,ceftazidime,NA,drug resisted,b
13794,respiratory failure,patient,symptoms/disease,
13794,cefepime,NA,drug resisted,c
13794,imipenem,NA,drug resisted,d
13794,meropenem,NA,drug resisted,e
13794,gentamicin,NA,drug resisted,f
13804,enterococcus gallinarum,bacteria,binomial (genus species),
13804,tetracycline,NA,drug resisted,
13804,vancomycin,NA,drug resisted,
13804,gentamicin,NA,drug resisted,
13804,.256 mg m,NA,mic,a
13804,vancomycin,NA,drug resisted,a
13804,96 mg ml,NA,mic,b
13804,70,patient,age,
13804,brazil,location,country,
13804,rio de janeiro,location,city,
13804,man,patient,sex,
13804,cerebrovascular accident,patient,comorbidities,
13804,alcoholism,patient,comorbidities,
13804,febrile,patient,symptoms/disease,
13804,chloramphenicol,NA,drug resisted,
13804,erythromycin,NA,drug resisted,
13804,teicoplanin,NA,drug resisted,
13994,chloramphenicol,NA,drug resisted,a
13994,4,NA,mic,d
13994,16,NA,mic,
13994,4/76,NA,mic,f
13994,clindamycin,NA,drug resisted,b
13994,corynebacterium diphtheriae,bacteria,binomial (genus species),
13994,st136,bacteria,strain,
13994,canada,location,country,
13994,38-year-old,patient,age,
13994,male,patient,sex,
13994,erythromycin,NA,drug resisted,c
13994,india,location,place traveled to,
13994,abscess on his left second toe,patient,symptoms/disease,
13994,telithromycin,NA,drug resisted,d
13994,tetracycline,NA,drug resisted,e
13994,trimethoprim-sulfamethoxazole,NA,drug resisted,f
13994,32,NA,mic,a
13994,2.0,NA,mic,b
13994,2.0,NA,mic,c
14082,nocardia yamanashiensis,bacteria,binomial (genus species),
14082,> 16,NA,mic,a
14082,ciprofloxacin,NA,drug resisted,b
14082,> 4.00,NA,mic,b
14082,34,patient,age,
14082,male,patient,sex,
14082,january,NA,event month,
14082,2011,NA,event year,
14082,lihir medical center,location,hospital name,
14082,lihir island,location,city,
14082,papua new guinea,location,country,
14082,tobramycin,NA,drug resisted,a
14126,"to report an outbreak due to providencia stuartii isolates carrying blaoxa-48, blaper-1, blacmy-4 and qnra6 in a tunisian hospital in 2011",NA,article/study aim,
14126,nalidixic acid,NA,drug resisted,d
14126,.256,NA,mic,a
14126,.256,NA,mic,b
14126,.64,NA,mic,c
14126,.256,NA,mic,d
14126,mic (mg/l),NA,notes,
14126,2011,NA,event year,
14126,providencia stuartii,bacteria,binomial (genus species),
14126,oxa-48,bacteria,resistance marker,
14126,tunisia,location,country,
14126,sfax habib bourguiba hospital,location,hospital name,
14126,sfax,location,city,
14126,34,patient,age,
14126,03,NA,event month,
14126,m,patient,sex,
14126,23,NA,event day,
14126,23/03/2011,NA,event date,
14126,1 (m/34),NA,notes,
14126,ticarcillin,NA,drug resisted,a
14126,ceftazidime,NA,drug resisted,b
14126,cefepime,NA,drug resisted,c
14130,we report the first case of an enterobacteriaceae strain harboring the ndm-1 metallo--lactamase in a pediatric patient in the united states.,NA,article/study aim,
14130,meropenem,NA,drug resisted,i
14130,piperacillin-tazobactam,NA,drug resisted,j
14130,tobramycin,NA,drug resisted,k
14130,trimethoprim-sulfamethoxazole,NA,drug resisted,l
14130,32,NA,mic,a
14130,2,NA,mic,f
14130,8,NA,mic,g
14130,10,NA,mic,h
14130,16,NA,mic,i
14130,128,NA,mic,j
14130,amikacin,NA,drug resisted,a
14130,4/80,NA,mic,l
14130,aztreonam,NA,drug resisted,b
14130,cefepime,NA,drug resisted,c
14130,klebsiella pneumoniae,bacteria,binomial (genus species),
14130,ndm-1,bacteria,resistance marker,
14130,pakistan,location,place traveled to,
14130,united states,location,country,
14130,13-month-old,patient,age,
14130,ceftazidime,NA,drug resisted,d
14130,boy,patient,sex,
14130,3-day history of worsening cough,patient,symptoms/disease,
14130,audible wheezing,patient,symptoms/disease,
14130,tachycardic,patient,symptoms/disease,
14130,low-grade fever,patient,symptoms/disease,
14130,reactive airway disease,patient,comorbidities,
14130,congenital skeletal abnormalities,patient,comorbidities,
14130,hydrocele,patient,comorbidities,
14130,hypotonia,patient,comorbidities,
14130,developmental delay,patient,comorbidities,
14130,ceftriaxone,NA,drug resisted,e
14130,discharged,patient,outcome,
14130,ciprofloxacin,NA,drug resisted,f
14130,ertapenem,NA,drug resisted,g
14130,gentamicin,NA,drug resisted,h
14233,we report the first case of azithromycin resistance and treatment failure in a patient with s. paratyphi a infection,NA,article/study aim,
14233,rigors,patient,symptoms/disease,
14233,fever,patient,symptoms/disease,
14233,lethargy,patient,symptoms/disease,
14233,diarrhea,patient,symptoms/disease,
14233,hypercholesterolemia,patient,comorbidities,
14233,full recovery,patient,outcome,
14233,azithromycin,NA,drug resisted,
14233,56 mg/liter,NA,mic,
14233,salmonella enterica,bacteria,binomial (genus species),
14233,pakistan,location,country,
14233,islamabad,location,city,
14233,48-year-old,patient,age,
14233,male,patient,sex,
14233,doctor,patient,occupation,
14287,we report the first case of multiple brain abscesses caused by nocardia paucivorans in  a patient suffering from multiple myeloma on treatment with lenalidomide and dexamethasone.,NA,article/study aim,
14287,2-yearhistory of iga myeloma,patient,comorbidities,
14287,"the patient is doing well, his painful  hypoesthesias have disappeared; no more seizure  episodes and adverse effects due to long term antibiotic  therapy occurred. the brain ct-scan monitoring  showed a progressive reduction of all cerebral lesions",patient,outcome,
14287,amoxicillin plus clavulanic  acid,NA,drug resisted,
14287,>256 µg/ml,NA,mic,
14287,"ceftriaxone (0.75 µg/ml),  cefepime (6 µg/ml), ciprofloxacin (0.047 µg/ml),  clarithromycin (1 µg/ml), gentamicin (8 µg/ml),  imipenem (0.19 µg/ml), linezolid (0.125 µg/ml),  tobramycin (0.047 µg/ml), trimethoprim plus  sulfonamide (0.002 µg/ml).",NA,notes,
14287,nocardia paucivorans,bacteria,binomial (genus species),
14287,italy,location,country,
14287,70-year-old,patient,age,
14287,male,patient,sex,
14287,sudden onset clonic  seizures,patient,symptoms/disease,
14404,we report the first verified treatment failure of gonorrhoea with 2 g of azithromycin (extended-release formulation) in japan,NA,article/study aim,
14404,neisseria gonorrhoeae,bacteria,binomial (genus species),
14404,mlst st1901/ng-mast st1407,bacteria,strain,
14404,japan,location,country,
14404,osaka,location,city,
14404,late teens,patient,age,
14404,woman,patient,sex,
14404,2013,NA,event year,
14404,early 2013,NA,event date,
14404,azithromycin,NA,drug resisted,a
14404,ciprofloxacin,NA,drug resisted,b
14404,4 mg/l,NA,mic,a
14404,≥32 mg/l,NA,mic,b
14571,76,patient,age,
14571,chloramphenicol,NA,drug resisted,
14571,consciousness had deteriorated,patient,symptoms/disease,
14571,diarrhea,patient,symptoms/disease,
14571,congestive heart failure,patient,symptoms/disease,
14571,hypertension,patient,symptoms/disease,
14571,died,patient,outcome,
14571,woman,patient,sex,
14571,vancouver,location,city,
14571,british  columbia,location,state/province/district,
14571,canada,location,country,
14571,2010,NA,event year,
14571,k. pneumoniae,bacteria,binomial (genus species),
14571,n10–0469,bacteria,strain,
14616,15,patient,age,
14616,streptomycin,NA,drug resisted,
14616,mycobacterium tuberculosis,bacteria,binomial (genus species),
14616,female,patient,sex,
14616,buenaventura,location,city,
14616,colombian,location,country,
14616,sickle cells anemia,patient,comorbidities,
14616,death,patient,outcome,
14616,rifampin,NA,drug resisted,
14616,isoniazid,NA,drug resisted,
14616,ethambutol,NA,drug resisted,
14740,november,NA,event month,
14740,2012,NA,event year,
14740,60s,patient,age,
14740,kanto,location,city,
14740,southeast asian country,location,place traveled to,
14740,k. pneumoniae,bacteria,binomial (genus species),
14740,escherichia coli,bacteria,binomial (genus species),
14740,piperacillin,NA,drug resisted,
14740,tazobactam,NA,drug resisted,
14751,"in lebanon, s. pneumoniae isolates have shown increasing resistance to penicillin, macrolides, and other antimicrobial agents, but to our knowledge, none so far have been reported against fq",NA,notes,
14751,american university of beirut medical center,location,hospital name,
14751,78-year-old,patient,age,
14751,male,patient,sex,
14751,fever,patient,symptoms/disease,
14751,productive cough,patient,symptoms/disease,
14751,dyspnea,patient,symptoms/disease,
14751,patient improved,patient,outcome,
14751,"we report the first three cases of levofloxacin resistant s. pneumoniae isolates in a tertiary medical center in beirut, lebanon.",NA,article/study aim,
14751,2006,NA,event year,
14751,september,NA,event month,
14751,levofloxacin,NA,drug resisted,
14751,> 32 g/ml,NA,mic,
14751,streptococcus pneumoniae,bacteria,binomial (genus species),
14751,lebanon,location,country,
14751,beirut,location,city,
14823,"to date, three ndm-1positive cases have been detected in japan, and this is the first case of a. baumannii-producing ndm-1 in japan.",NA,notes,
14823,aztreonam,NA,drug resisted,e
14823,64 lg/ml,NA,mic,a
14823,32 lg/ml,NA,mic,b
14823,16 lg/ml,NA,mic,c
14823,2011,NA,event year,
14823,acinetobacter baumannii,bacteria,binomial (genus species),
14823,ndm-1,bacteria,resistance marker,
14823,japan,location,country,
14823,tokyo,location,city,
14823,jikei university hospital,location,hospital name,
14823,india,location,place traveled to,
14823,february,NA,event month,
14823,52-year-old,patient,age,
14823,man,patient,sex,
14823,businessman,patient,occupation,
14823,japan,patient,country of residence,
14823,disturbance of consciousness,patient,symptoms/disease,
14823,massive cerebral bleeding,patient,symptoms/disease,
14823,st222,bacteria,strain,
14823,3,NA,event day,
14823,"february 3, 2011",NA,event date,
14823,imipenem,NA,drug resisted,a
14823,meropenem,NA,drug resisted,b
14823,ciprofloxacin,NA,drug resisted,c
14823,amikacin,NA,drug resisted,d
14906,this is the first discovery of kpc-2 in e. coli and the first report of this enzyme originating outside the united states.,NA,article/study aim,
14906,32 g/ml,NA,mic,
14906,75-year-old,patient,age,
14906,woman,patient,sex,
14906,tel aviv medical center,location,hospital name,
14906,syncope,patient,symptoms/disease,
14906,kpc-2,bacteria,resistance marker,
14906,"hong, t., s. moland, b. abdalhamid, n. d. hanson, j. wang, c. sloan, d. fabian, a. farajallah, j. levine, and k. s. thomson. 2005. escherichia coli: development of carbapenem resistance during therapy. clin. infect. dis. 40:e84–e86.",NA,references for follow up,
14906,"stapleton, p. d., k. p. shannon, and g. l. french. 1999. carbapenem resistance in escherichia coli associated with plasmid-determined cmy-4 -lactamase production and loss of an outer membrane protein. antimicrob. agents chemother. 43:1206–1210.",NA,references for follow up,
14906,february,NA,event month,
14906,2005,NA,event year,
14906,imipenem,NA,drug resisted,
14906,escherichia coli,bacteria,binomial (genus species),
14906,carbapenem,NA,drug resisted,
14906,israel,location,country,
1495,"in our review of the literature, the three most common susceptible antibiotic therapies were tmp/ smx, quinolones and tetracycline; however, in our case, there was resistance to tmp/smx",NA,notes,
1495,67-year-old,patient,age,
1495,woman,patient,sex,
1495,american,patient,country of residence,
1495,obesity,patient,comorbidities,
1495,chronic active smoker,patient,comorbidities,
1495,chronic obstructive pulmonary disease,patient,comorbidities,
1495,obstructive sleep apnea,patient,comorbidities,
1495,severe pulmonary hypertension,patient,comorbidities,
1495,atrial fibrillation,patient,comorbidities,
1495,type 2 diabetes,patient,comorbidities,
1495,case report,NA,article/study aim,
1495,hypertension and dyslipidemia,patient,comorbidities,
1495,sudden-onset generalized weakness,patient,symptoms/disease,
1495,lightheadedness,patient,symptoms/disease,
1495,shortness of breath,patient,symptoms/disease,
1495,the patient was clinically stable to be discharged with a total of 10 days of ciprofloxacin,patient,outcome,
1495,ceftazidime,NA,drug resisted,
1495,trimethoprim/sulfamethoxazole (tmp/smx),NA,drug resisted,
1495,sphingobacterium multivorum,bacteria,binomial (genus species),
1495,usa ,location,country,
1495,nj,location,state/province/district,
1495,newark,location,city,
1495,saint michael’s medical center,location,hospital name,
15,40,patient,age,
15,29 january 2015,NA,event date,
15,clindamycin,NA,drug resisted,
15,f. hominis,bacteria,binomial (genus species),
15,woman,patient,sex,
15,casamance hospital,location,hospital name,
15,marseille,location,city,
15,france,location,country,
15,pain,patient,symptoms/disease,
15,29,NA,event day,
15,january,NA,event month,
15,2015,NA,event year,
15256,"the aim of this study was to analyze carbapenem-resistant isolates of enterobacter cloacae that have emerged for the first time in the intensive care unit (icu) at the university hospital centre split, croatia.",NA,article/study aim,
15256,tobramycin,NA,drug resisted,
15256,netilmicin,NA,drug resisted,
15256,gentamicin,NA,drug resisted,
15256,trimethoprim–sulfamethoxazole,NA,drug resisted,
15256,enterobacter cloacae,bacteria,binomial (genus species),
15256,vim-,bacteria,resistance marker,
15256,croatia,location,country,
15256,university hospital centre split,location,hospital name,
15256,split,location,city,
15256,65,patient,age,
15256,2012,NA,event year,
15256,m,patient,sex,
15256,death,patient,outcome,
15256,oft palate neoplasm with metastases,patient,comorbidities,
15256,case 1,NA,notes,
15256,06,NA,event month,
15256,18,NA,event day,
15256,18.06.2012,NA,event date,
15256,cephalosporins,NA,drug resisted,
15256,piperacillin/tazobactam,NA,drug resisted,
15256,ampicillin/clavulanic acid,NA,drug resisted,
15256,quinolones,NA,drug resisted,
15268,this is the first report of ndm-1-positive escherichia coli from serbia,NA,article/study aim,
15268,cefepime,NA,drug resisted,g
15268,meropenem,NA,drug resisted,h
15268,imipenem,NA,drug resisted,i
15268,trimethoprim/ sulfamethoxazole,NA,drug resisted,j
15268,amikacin,NA,drug resisted,k
15268,gentamicin,NA,drug resisted,l
15268,‡32,NA,mic,a
15268,‡128,NA,mic,c
15268,‡4,NA,mic,e
15268,‡16,NA,mic,f
15268,2015,NA,event year,
15268,‡64,NA,mic,k
15268,mic (lg/ml),NA,notes,
15268,march,NA,event month,
15268,ampicillin,NA,drug resisted,a
15268,escherichia coli,bacteria,binomial (genus species),
15268,st5123,bacteria,strain,
15268,ndm-1,bacteria,resistance marker,
15268,serbia,location,country,
15268,ampicillin/ sulbactam,NA,drug resisted,b
15268,belgrade,location,city,
15268,institute for mother and child healthcare,location,hospital name,
15268,16-year-old,patient,age,
15268,boy,patient,sex,
15268,febrile,patient,symptoms/disease,
15268,complete agranulocytosis,patient,symptoms/disease,
15268,e is currently in complete remission,patient,outcome,
15268,piperacillin/ tazobactam,NA,drug resisted,c
15268,cefuroxime,NA,drug resisted,d
15268,cefotaxime,NA,drug resisted,e
15268,ceftazidime,NA,drug resisted,f
15331,this is the first documented outbreak of cfr-mediated linezolid-resistant s. epidermidis in the republic of ireland,NA,article/study aim,
15331,>8,NA,mic,a
15331,128,NA,mic,b
15331,>16,NA,mic,c
15331,rifampicin,NA,drug resisted,g
15331,>2,NA,mic,g
15331,2013,NA,event year,
15331,staphylococcus epidermidis,bacteria,binomial (genus species),
15331,april,NA,event month,
15331,st2,bacteria,strain,
15331,ireland,location,country,
15331,limerick,location,city,
15331,university hospital limerick (uhl),location,hospital name,
15331,m,patient,sex,
15331,62,patient,age,
15331,28/04/2013,NA,event date,
15331,discharged,patient,outcome,
15331,gentamicin,NA,drug resisted,b
15331,oxacillin,NA,drug resisted,c
15331,penicillin,NA,drug resisted,d
15331,clindamycin,NA,drug resisted,e
15331,ciprofloxacin,NA,drug resisted,f
15331,linezolid,NA,drug resisted,a
15337,2014,NA,event year,
15337,between february and september 2014,NA,event date,
15337,linezolid,NA,drug resisted,
15337,enterococcus faecium,bacteria,binomial (genus species),
15337,ireland,location,country,
15337,this is the first report of an outbreak of linezolid-resistant vancomycin-resistant enterococcus in ireland,NA,notes,
15378,this study provides the first report of multidrug-resistant vref isolates belonging to clonal complex 17 from a tertiary care center in mexico city.,NA,article/study aim,
15378,rifampin,NA,drug resisted,h
15378,erythromycin,NA,drug resisted,i
15378,vancomycin,NA,drug resisted,j
15378,teicoplanin,NA,drug resisted,k
15378,mic μg/ml,NA,notes,
15378,128,NA,mic,
15378,512,NA,mic,c
15378,64,NA,mic,e
15378,32,NA,mic,
15378,4,NA,mic,
15378,from july 2009 to april 2011,NA,event date,
15378,16,NA,mic,
15378,ampicillin,NA,drug resisted,a
15378,amoxacillin/clavulanate,NA,drug resisted,b
15378,enterococcus faecium,bacteria,binomial (genus species),
15378,757,bacteria,strain,
15378,133h,NA,notes,
15378,méxico,location,country,
15378,mexico city,location,city,
15378,hospital infantil de méxico federico gómez (himfg),location,hospital name,
15378,ciprofloxacin,NA,drug resisted,c
15378,clindamycin,NA,drug resisted,d
15378,chloramphenicol,NA,drug resisted,e
15378,gentamicin,NA,drug resisted,f
15378,streptomycin,NA,drug resisted,g
15475,sa 100rc3 (st45),NA,notes,
15475,gentamicin,NA,drug resisted,
15475,salmonella enterica,bacteria,binomial (genus species),
15475,st45,bacteria,strain,
15475,ctx-m-2,bacteria,resistance marker,
15475,france,patient,country of residence,
15475,france,location,country,
15475,hajj pilgrimage in saudi arabia|mecca|medina,location,place traveled to,
15475,"this study shows that pilgrims acquired salmonella bacteria, including anovelmdrclone, during the hajj pilgrimage",NA,article/study aim,
15475,2013,NA,event year,
15475,colistin,NA,drug resisted,
15475,amoxicillin,NA,drug resisted,
15475,amoxicillin/clavulanic acid,NA,drug resisted,
15475,ceftriaxone,NA,drug resisted,
15475,aztreonam,NA,drug resisted,
15475,ceftazidime,NA,drug resisted,
15632,klebsiella pneumoniae,bacteria,binomial (genus species),
15632,helsinki university central hospital,location,hospital name,
15632,died,patient,outcome,
15632,multiorgan failure,patient,outcome,
15632,pneumonia,patient,symptoms/disease,
15632,acute myocardial  ischemia,patient,symptoms/disease,
15632,piperacillin/tazobactam,NA,drug resisted,a
15632,carbapenemase-producing  (kpc),bacteria,resistance marker,
15632,cefuroxime,NA,drug resisted,
15632,ceftazidime,NA,drug resisted,c
15632,cefotaxime,NA,drug resisted,d
15632,aztreonam,NA,drug resisted,e
15632,type 2 strains,bacteria,strain,
15632,ertapenem,NA,drug resisted,f
15632,imipenem,NA,drug resisted,g
15632,8,NA,mic,g
15632,meropenem,NA,drug resisted,h
15632,st258,bacteria,strain,
15632,colistin,NA,drug resisted,i
15632,24,NA,mic,i
15632,doxicycline,NA,drug resisted,j
15632,6,NA,mic,j
15632,4,NA,mic,
15632,finland,location,country,
15632,minocycline,NA,drug resisted,k
15632,2,NA,mic,l
15632,tigecycline,NA,drug resisted,l
15632,amikacin,NA,drug resisted,m
15632,48,NA,mic,m
15632,june,NA,event month,
15632,16,NA,mic,n
15632,tobramycin,NA,drug resisted,n
15632,blakpc-2,bacteria,resistance marker,
15632,"kpc-producing klebsiella pneumoniae was first detected in  north carolina, usa, in 1996",NA,references for follow up,
15632,"yigit h, queenan am, anderson gj, domenech-sanchez a, biddle jw, steward cd,  et al. novel carbapenem-hydrolyzing β -lactamase, kpc-1, from a carbapenemresistant strain of klebsiella pneumoniae. antimicrob agents chemother.  2001;45(4):1151–61.",NA,references for follow up,
15632,it has also been found in norway and  sweden in patients transferred from greece and israel in 2007,NA,references for follow up,
15632,2009,NA,event year,
15632,"samuelsen ø, naseer u, tofteland s, skutlaberg dh, onken a, hjetland r, et  al. emergence of clonally related klebsiella pneumoniae isolates of sequence  type 258 producing plasmid-mediated kpc carbapenemase in norway and  sweden. j antimicrob. chemother. 2009;63:654–8.",NA,references for follow up,
15632,in an outbreak strain in israel,NA,references for follow up,
15632,"kitchel b, rasheed jk, patel jb, srinivasan a, navon-venezia s, carmeli y, et  al. molecular epidemiology of kpc-producing klebsiella pneumoniae isolates  in the united states: clonal expansion of multilocus sequence type 258.  antimicrob agents chemother. 2009;53(8):3365–70.",NA,references for follow up,
15632,as well as in isolates in  poland [8],NA,references for follow up,
15632,and italy [9],NA,references for follow up,
15632,"baraniak a, izdebski r, herda m, hryniewics w, gniadkowski m, kern-zdanowicz  i, et al. the emergence of klebsiella pneumoniae st258 with kpc-2 in poland.  antimicrob agents chemother. 2009;53(10):4565-7.",NA,references for follow up,
15632,"giani t, d’andrea mm, pecile p, borgianni l, nicoletti p, tonelli f, et al.  emergence of klebsiella pneumoniae sequence type 258 producing kpc-3  carbapenemase, italy. j clin microbiol. 2009 sep 16 [epub ahead of print]",NA,references for follow up,
15632,greece|italy,location,place traveled to,
15654,2015,NA,event year,
15654,nimd,bacteria,resistance marker,
15654,danish,patient,country of residence,
15654,70-year-old,patient,age,
15654,woman,patient,sex,
15654,diverticulitis,patient,comorbidities,
15654,chronic bronchitis,patient,comorbidities,
15654,osteoporosis,patient,comorbidities,
15654,abdominal pain,patient,symptoms,
15654,discharged 23 days after hospitalization,patient,outcome,
15654,she has not been hospitalized during one year of follow-up,patient,outcome,
15654,february,NA,event month,
15654,denmark,location,country,
15654,metronidazole,NA,drug resisted,
15654,64mg/l,NA,mic,
15654,bacteroides stercoris,bacteria,binomial (genus species),
15654,is1380,bacteria,strain,
15654,erm(f),bacteria,resistance marker,
15654,tet(x),bacteria,resistance marker,
15654,tet(q),bacteria,resistance marker,
1566,cotrimoxazole,NA,drug resisted,
1566,fever,patient,symptoms,
1566,headache,patient,symptoms,
1566,fluctuating mental status,patient,symptoms,
1566,altered consciousness,patient,symptoms,
1566,immunosuppressive,patient,comorbidities,
1566,conditions improved  ,patient,outcome,
1566,fever disappeared,patient,outcome,
1566,ceftriaxone,NA,drug resisted,
1566,clindamycin,NA,drug resisted,
1566,tetracycline,NA,drug resisted,
1566,listeria monocytogenes,bacteria,binomial (genus species),
1566,italy,location,country,
1566,59-year-old,patient,age,
1566,woman,patient,sex,
1566,arterial hypertension,patient,comorbidities,
15760,66,patient,age,
15760,male,patient,sex,
15760,june,NA,event month,
15760,2015,NA,event year,
15760,fever,patient,symptoms/disease,
15760,dizziness,patient,symptoms/disease,
15760,weight loss,patient,symptoms/disease,
15902,51,patient,age,
15902,cefazolin,NA,drug resisted,
15902,man,patient,sex,
15902,ocular pain,patient,symptoms/disease,
15902,reduced vision,patient,symptoms/disease,
15902,amikacin,NA,drug resisted,
15902,gentamicin,NA,drug resisted,
15902,erythromycin,NA,drug resisted,
15902,tobramycin,NA,drug resisted,
15902,penicillin,NA,drug resisted,
15936,12,patient,age,
15936,e. coli,bacteria,binomial (genus species),
15936,imipenem,NA,drug resisted,a
15936,meropenem,NA,drug resisted,b
15936,penicillins,NA,drug resisted,
15936,amikacin,NA,drug resisted,
15936,female,patient,sex,
15936,netilmicin,NA,drug resisted,
15936,tobramycin,NA,drug resisted,
15936,trimethoprim-sulfamethoxazole,NA,drug resisted,
15936,athens,location,city,
15936,aglaia kyriakou pediatric hospital,location,hospital name,
15936,fever,patient,symptoms,
15936,nasal discharge,patient,symptoms,
15936,pre-existing heart murmur,patient,comorbidities,
15936,carbapenems,NA,drug resisted,
15936,discharged,patient,outcome,
15946,this is a first report of a meningitis case due to penicillin-resistant n. lactamica in greece.,NA,article/study aim,
15946,neisseria lactamica,bacteria,binomial (genus species),
15946,greece,location,country,
15946,athens,location,city,
15946,“iatrikon athinon” medical center,location,hospital name,
15946,5-year-old,patient,age,
15946,boy,patient,sex,
15946,fever,patient,symptoms/disease,
15946,headache,patient,symptoms/disease,
15946,general malaise,patient,symptoms/disease,
15946,photophobia,patient,symptoms/disease,
15946,penicillin,NA,drug resisted,a
15946,somnolence,patient,symptoms/disease,
15946,vomiting,patient,symptoms/disease,
15946,diarrhea,patient,symptoms/disease,
15946,nuchal rigidity,patient,symptoms/disease,
15946,discharged,patient,outcome,
15946,erythromycin,NA,drug resisted,b
15946,8 µg/ml,NA,mic,a
15946,64 µg/ml,NA,mic,b
16248,enterobacteriaceae,bacteria,binomial (genus species),
16248,alberta,location,city,
16248,improved,patient,outcome,
16248,amoxicillin/clavulanic acid,NA,drug resisted,
16248,piperacillin/tazobactam,NA,drug resisted,
16248,cefoxitin,NA,drug resisted,
16248,ceftriaxone,NA,drug resisted,
16248,ceftazidime,NA,drug resisted,
16248,aztreonam,NA,drug resisted,
16248,meropenem,NA,drug resisted,
16248,ertapenem,NA,drug resisted,
16248,32,patient,age,
16248,amikacin,NA,drug resisted,
16248,gentamicin,NA,drug resisted,
16248,tobramycin,NA,drug resisted,
16248,ciprofl oxacin,NA,drug resisted,
16248,trimethoprim/sulfamethoxazole,NA,drug resisted,
16248,man,patient,sex,
16248,mysore,location,city,
16248,india,location,country,
16248,india,location,place traveled to,
16248,2010,NA,event year,
16248,diabetes mellitus,patient,comorbidities,
16248,canada,patient,country of residence,
16251,his is the fi rst report of vim-1-producing k. pneumoniae outside europe,NA,article/study aim,
16251, 4 μg/ ml,NA,mic,c
16251, 16 μg/ml,NA,mic,d
16251, 4 μg/ml,NA,mic,e
16251, 1 μg/ml,NA,mic,f
16251,piperacillin – tazobactam,NA,drug resisted,a
16251,klebsiella pneumoniae,bacteria,binomial (genus species),
16251,vim-1,bacteria,resistance marker,
16251,st569,bacteria,strain,
16251,south africa,location,country,
16251,cefoxitin,NA,drug resisted,b
16251,gauteng,location,state/province/district,
16251,pretoria,location,city,
16251,70-y-old,patient,age,
16251,male,patient,sex,
16251,acute abdominal pain,patient,symptoms/disease,
16251,severe  hypotension,patient,symptoms/disease,
16251,cardiac arrest,patient,symptoms/disease,
16251,ceftriaxone,NA,drug resisted,c
16251,ceftazidime,NA,drug resisted,d
16251,meropenem,NA,drug resisted,e
16251,ertapenem,NA,drug resisted,f
16251, 128/4 μg/ml,NA,mic,a
16251, 32 μg/ml,NA,mic,b
16264,we describe the first emergence of carbapenem-resistant acinetobacter baumannii in australia.,NA,article/study aim,
16264,"ninety a. baumannii isolates recovered from cultures of blood specimens from 69 patients were analyzed. overall, 58 isolates (64%) were resistant to meropenem. the x2 test for linear trend revealed that emergence of carbapenem resistance was statistically significant during the 32-month study period.",NA,first surveillance study (of a particular resistance) in countr,
16267,university of pittsburgh medical center,location,hospital name,
16267,ampicillin/sulbactam,NA,drug resisted,
16267,cefepime,NA,drug resisted,
16267,ciprofloxacin,NA,drug resisted,
16267,aminoglycosides,NA,drug resisted,
16267,60,patient,age,
16267,man,patient,sex,
16267,pittsburgh,location,city,
16267,pennsylvania,location,state/province/district,
16267,usa,location,country,
16267,a. baumannii,bacteria,binomial (genus species),
16267,76,patient,age,
16267,woman,patient,sex,
16267,hypertension,patient,comorbidities,
16267,diabetes,patient,comorbidities,
16438,81,patient,age,
16438,erythromycin,NA,drug resisted,b
16438,2.0 g/ml,NA,mic,b
16438,ciprofloxacin,NA,drug resisted,c
16438,2.0 g/ml,NA,mic,c
16438,male,patient,sex,
16438,tetracycline,NA,drug resisted,d
16438,4.0 g/ml,NA,mic,d
16438,ampicillin,NA,drug resisted,e
16438,8.0 g/ml,NA,mic,e
16438,rifampin,NA,drug resisted,f
16438,"back pain,",patient,symptoms,
16438,2.0 g/ml,NA,mic,f
16438,trimethoprim-sulfamethoxazole,NA,drug resisted,g
16438,2 to 38 g/ ml,NA,mic,g
16438,imipenem,NA,drug resisted,h
16438,16 g/ml,NA,mic,h
16438,"acute confusion,",patient,symptoms,
16438,cellulosimicrobium funkei:,bacteria,binomial (genus species),
16438,fever,patient,symptoms,
16438,medtronic mosaic tissue aortic valve replacement,patient,comorbidities,
16438,died,patient,outcome,
16438,penicillin,NA,drug resisted,a
16438,4.0 g/ml,NA,mic,a
1652,67,patient,age,
1652,amoxicillin +cla,NA,drug resisted,b
1652,> 256,NA,mic,b
1652,ticarcillin,NA,drug resisted,c
1652,> 256,NA,mic,c
1652,ticarcillin + cla,NA,drug resisted,d
1652,german,patient,country of residence,
1652,> 256,NA,mic,d
1652,piperacillin,NA,drug resisted,e
1652,> 256,NA,mic,e
1652,piperacillin + tzb,NA,drug resisted,f
1652,> 256,NA,mic,f
1652,cuba,location,place traveled to,
1652,cuba,location,country,
1652,ceftazidime,NA,drug resisted,g
1652,cefotaxime,NA,drug resisted,h
1652,> 256,NA,mic,h
1652,cefepime,NA,drug resisted,i
1652,la havana,location,city,
1652,k. pneumoniae,bacteria,strain,
1652,amoxicillin,NA,drug resisted,a
1652,> 256,NA,mic,a
16584,acinetobacter baumannii,bacteria,binomial (genus species),
16713,enterococcus faecium,bacteria,binomial (genus species),
16713,diabetes mellitus,patient,comorbidities,
16713,38,patient,age,
16713,female,patient,sex,
16713,august,NA,event month,
16713,2008,NA,event year,
16713,september,NA,event month,
16713,hypertension,patient,comorbidities,
16713,40,patient,age,
16713,male,patient,sex,
16713,type 18,bacteria,strain,
16713,died,patient,outcome,
16713,recovery,patient,outcome,
16713,succumbed,patient,outcome,
16713,first in malaysia,NA,first surveillance study (of a particular resistance) in countr,
16713,malaysia,location,country,
16713,vancomycin,NA,drug resisted,
16713,kuala lumpur hospital,location,hospital name,
16713,58,patient,age,
16713,ischaemic heart disease,patient,comorbidities,
16715,"to analyse the mechanisms responsible for multidrug resistance in three carbapenem-resistant klebsiella pneumoniae isolates recovered from two hospitalized patients and an outpatient from the same hospital in rabat, morocco",NA,article/study aim,
16715,st15,bacteria,strain,
16715,morocco,location,country,
16715,rabat,location,city,
16715,"finally, this report identified the spread of ndm-1-producing k. pneumoniae isolates in morocco. two of the three patients were treated in the same hospital units (surgery and intensive care departments), which probably allowed for inter-patient spread of the strain. this report indicates that ndm-1 producers may circulate worldwide further than expected",NA,notes,
16715,ertapenem,NA,drug resisted,a
16715,aminoglycosides,NA,drug resisted,
16715,fluoroquinolones,NA,drug resisted,
16715,chloramphenicol,NA,drug resisted,
16715,sulphonamides,NA,drug resisted,
16715,rifampicin,NA,drug resisted,
16715,ndm-1,bacteria,resistance marker,
16715,4 mg/l,NA,mic,a
16726,this work corresponds to the first report of ndm-1 producers in africa,NA,article/study aim,
16726,fosfomycin,NA,drug resisted,
16726,nitrofurantoin,NA,drug resisted,
16726,imipenem,NA,drug resisted,a
16726,rifampin,NA,drug resisted,e
16726,klebsiella pneumoniae,bacteria,binomial (genus species),
16726,ndm-1,bacteria,resistance marker,
16726,st14,bacteria,strain,
16726,kenya,location,country,
16726,nairobi,location,city,
16726,aga khan university hospital,location,hospital name,
16726,meropenem,NA,drug resisted,b
16726,table 1.,NA,notes,
16726,58,patient,age,
16726,f,patient,sex,
16726,discharged,patient,outcome,
16726,isolate no,NA,notes,
16726,ertapenem,NA,drug resisted,c
16726,doripenem,NA,drug resisted,d
16726,aminoglycosides,NA,drug resisted,
16726,fluoroquinolones,NA,drug resisted,
16726,chloramphenicol,NA,drug resisted,
16726,sulfonamides,NA,drug resisted,
16801,"this is the first report of the co-production of kpc-3, vim-1, shv-12, oxa-9 and cmy-2 in a unique clinical multiresistant e. coli isolate.",NA,article/study aim,
16801,≥256 mg/l,NA,mic,
16801,escherichia coli,bacteria,binomial (genus species),
16801,st448,bacteria,strain,
16801,kpc-3,bacteria,resistance marker,
16801,vim-1,bacteria,resistance marker,
16801,shv-12,bacteria,resistance marker,
16801,oxa-9,bacteria,resistance marker,
16801,cmy-2,bacteria,resistance marker,
16801,spain,location,country,
16801,spain,patient,country of residence,
16801,logron˜o,location,city,
16801,ampicillin,NA,drug resisted,
16801,elderly,patient,age,
16801,woman,patient,sex,
16801,oliguria,patient,symptoms/disease,
16801,fever,patient,symptoms/disease,
16801,renal polycystosis,patient,comorbidities,
16801,chronic renal disease,patient,comorbidities,
16801,hypercapnic encephalopathy,patient,symptoms/disease,
16801,died,patient,symptoms/disease,
16801,cefotaxime,NA,drug resisted,
16801,ceftazidime,NA,drug resisted,
16801,cefoxitin,NA,drug resisted,
16801,cefepime,NA,drug resisted,
16801,aztreonam,NA,drug resisted,
16801,imipenem,NA,drug resisted,
16801,meropenem,NA,drug resisted,
16837,"to our knowledge, this is the first isolation of m. europaeum from human clinical specimens in asia to be reported",NA,article/study aim,
16837,high temperature,patient,symptoms/disease,
16837,cough,patient,symptoms/disease,
16837,productive cough,patient,symptoms/disease,
16837,case 1,NA,notes,
16837,ethambutol,NA,drug resisted,
16837,mycobacterium europaeum,bacteria,binomial (genus species),
16837,afp-0001,bacteria,strain,
16837,iran,location,country,
16837,48-year-old,patient,age,
16837,man,patient,sex,
16837,hiv,patient,comorbidities,
16837,intravenous drug use,patient,comorbidities,
17068,61,patient,age,
17068,s. marcescens,bacteria,binomial (genus species),
17068,imipenem,NA,drug resisted,
17068,cefoxitin,NA,drug resisted,
17121,"we describe the first detection of a. baumannii carrying the blandm-1 gene in lebanon, isolated from syrian patients wounded during the civil war",NA,article/study aim,
17121,ciprofloxacin;,NA,drug resisted,
17121,24,patient,age,
17121,m,patient,sex,
17121,table 1,NA,notes,
17121,acinetobacter baumannii,bacteria,binomial (genus species),
17121,st85,bacteria,strain,
17121,ndm-1,bacteria,resistance marker,
17121,lebanon,location,country,
17121,tripoli,location,city,
17121,government hospital of kobbe,location,hospital name,
17121,2012,NA,event year,
17121,syria,location,place traveled to,
17121,syria,patient,country of residence,
17121,05,NA,event month,
17121,29,NA,event day,
17121,29/05/2012,NA,event date,
17121,imipenem,NA,drug resisted,
17121,meropenem,NA,drug resisted,
17121,doripenem,NA,drug resisted,
17121,ceftazidime,NA,drug resisted,
17169,linezolid,NA,drug resisted,
17169,type ii diabetes,patient,comorbidities,
17169,open sore,patient,symptoms/disease,
17169,redness,patient,symptoms/disease,
17169,pus filled bumps.,patient,symptoms/disease,
17169,jcsc1435,bacteria,strain,
17169,linezolid,NA,drug resisted,a
17169,clindamycin,NA,drug resisted,b
17169,cfr­positive,bacteria,resistance marker,
17169,chloramphenicol,NA,drug resisted,c
17169,oxacillin,NA,drug resisted,d
17169,type i,bacteria,strain,
17169,recently cui et al and cai et al have described cfr carrying s. haemolyticus strains from clinical samples.,NA,references for follow up,
17169,staphylococcus haemolyticus,bacteria,binomial (genus species),
17169,"19. cui l, wang y, li y, he t, schwarz s, ding y, et al. cfr­mediated linezolid resistance among methicillin­resistant coagulase­negative staphylococci from infections of humans. plos one. 2013;8:e57096. [pmcid: pmc3577776] [pubmed: 23437319]",NA,references for follow up,
17169,"20. cai jc, hu yy, zhang r, zhou hw, chen gx. linezolid­resistant clinical isolates of meticillin resistant coagulase negative staphylococci and enterococcus faecium from china. j med microbiol. 2012;61:1568–73. [pubmed: 22899781]",NA,references for follow up,
17169,g t,bacteria,resistance marker,
17169,met thr,bacteria,resistance marker,
17169,penicillin,NA,drug resisted,
17169,cefoxitin,NA,drug resisted,
17169,gentamicin,NA,drug resisted,
17169,trimethoprim­sulphamethoxazole,NA,drug resisted,
17169,rifampicin,NA,drug resisted,
17169,60,patient,age,
17169,male,patient,sex,
17169,jss medical college,location,hospital name,
17169,mysore,location,city,
17169,india,location,country,
17169,hypertension,patient,comorbidities,
172,linezolid,NA,drug resisted,
172,vancomycin,NA,drug resisted,
172,vre,bacteria,strain,
172,g2576u,bacteria,resistance marker,
172,enterococcus faecium,bacteria,binomial (genus species),
172,g2576t,bacteria,resistance marker,
172,april,NA,event month,
172,2011,NA,event year,
172,66-year-old,patient,age,
172,paraplegic,patient,comorbidities + risk factors,
172,woman,patient,sex,
172,infected decubitis ulcer,patient,comorbidities + risk factors,
17611,"we report the first isolation in australia of a hypervirulent epidemic strain of clostridium difficile, pcr ribotype  027",NA,article/study aim,
17611,clostridium difficile,bacteria,binomial (genus species),
17611,pcr ribotype 027,bacteria,strain,
17611,australia,location,country,
17611,"perth|new york city|hawaii|vancouver, canada|honolulu",location,place traveled to,
17611,2009,NA,event year,
17611,43-year-old,patient,age,
17611,woman,patient,sex,
17611,inflamed ulcerated area close to the stoma,patient,symptoms/disease,
17611,pseudomembranous enteritis,patient,symptoms/disease,
17611,"her condition improved, and she has remained well since, with two negative cultures for c. difficile since cessation of vancomycin",patient,outcome,
17611,february,NA,event year,
17611,4,NA,event day,
17611,4 february 2009,NA,event date,
17611,levofloxacin,NA,drug resisted,a
17611,moxifloxacin,NA,drug resisted,b
17611,> 32 mg/l,NA,mic,a
17611,16 mg/l,NA,mic,b
17649,case report,NA,article/study aim,
17649,oxacillin,NA,drug resisted,
17649,stomatococcus mucilaginosus,bacteria,binomial (genus species),
17649,india,location,country,
17649,aligarh,location,city,
17649,jawaharlal nehru medical college,location,hospital name,
17649,2-month-old,patient,age,
17649,female,patient,sex,
17649,high grade fever of 5 days duration,patient,symptoms,
17649,"general tonic spasm of all four limbs with unconsciousness, neck retraction and uprolling of eyes for the previous 2 days.",patient,symptoms,
17649,"the child recovered well subsequently with no neurological sequelae abbreviation: csf, cerebrospinal fluid.",patient,outcome,
17649,gentamicin,NA,drug resisted,
17649,we describe what we believe is the first reported case of stomatococcus mucilaginosus meningitis in a healthy child,NA,notes,
17649,trimethoprim/sulfamethoxazole,NA,drug resisted,
17649,erythromycin,NA,drug resisted,
17649,tetracycline,NA,drug resisted,
17649,ciprofloxacin,NA,drug resisted,
17649,amikacin,NA,drug resisted,
17649,ampicillin,NA,drug resisted,
17649,cefazolin,NA,drug resisted,
17819,17,patient,age,
17819,female,patient,sex,
17819,cf,patient,comorbidities,
17819,staphylococcus aureus,bacteria,binomial (genus species),
17819,spain,location,country,
17819,linezolid,NA,drug resisted,
17819,(lrsa,bacteria,strain,
17819,rpld gen,bacteria,strain,
1786,this is the first report of a kpc-producing k. pneumoniae in croatia.,NA,article/study aim,
1786,ceftriaxone,NA,drug resisted,g
1786,cefepime,NA,drug resisted,h
1786,imipenem,NA,drug resisted,i
1786,meropenem,NA,drug resisted,j
1786,ertapenem,NA,drug resisted,k
1786,piperacillin/tazobactam,NA,drug resisted,l
1786,gentamicin,NA,drug resisted,m
1786,>256,NA,mic,
1786,16,NA,mic,d
1786,8,NA,mic,e
1786,2011,NA,event year,
1786,2,NA,mic,f
1786,128,NA,mic,l
1786,32,NA,mic,
1786,minimum inhibitory concentrations (mg/l),NA,notes,
1786,february,NA,event month,
1786,amoxycillin,NA,drug resisted,a
1786,cefazoline,NA,drug resisted,b
1786,klebsiella pneumoniae,bacteria,binomial (genus species),
1786,kpc-2,bacteria,resistance marker,
1786,st37,bacteria,strain,
1786,croatia,location,country,
1786,clinical hospital center zagreb,location,hospital name,
1786,"he did not travel abroad before admission, but was hospitalized in antoher medical centre in croatia for treatment of leukaemia.",location,place traveled to,
1786,78-year-old,patient,age,
1786,male,patient,sex,
1786,died,patient,outcome,
1786,acute myeloblastic leukaemia,patient,comorbidities,
1786,cefuroxime,NA,drug resisted,c
1786,purulent meningtis,patient,symptoms/disease,
1786,ceftazidime,NA,drug resisted,d
1786,cefotaxime,NA,drug resisted,e
1786,cefotaxime/clavulanate,NA,drug resisted,f
17942,10,patient,age,
17942,oxacillin,NA,drug resisted,
17942,discharged,patient,outcome,
17942,girl,patient,sex,
17942,rio de janeiro city,location,city,
17942,january,NA,event month,
17942,5,NA,event day,
17942,2007,NA,event year,
17942,"january 5, 2007.",NA,event date,
17942,s. aureus,bacteria,binomial (genus species),
17942,feeling good,patient,outcome,
17998,corynebacterium macginleyi,bacteria,binomial (genus species),
17998,84,patient,age,
17998,man,patient,sex,
17998,fuchs’ endothelial dystrophy,patient,comorbidities,
17998,parkinson’s syndrome,patient,comorbidities,
17998,first published account of clinical isolation of this organism in north america.,NA,first surveillance study (of a particular resistance) in countr,
17998,sulbenicillin,NA,drug resisted,
17998,fluoroquinolone,NA,drug resisted,
1806,burkholderia pseudomallei,bacteria,binomial (genus species),
1806,vomiting,patient,symptoms/disease,
1806,>16 毺 g/ml,NA,mic,a
1806,discharged,patient,outcome,
1806,ceftazidime,NA,drug resisted,
1806,39,patient,age,
1806,male,patient,sex,
1806,rajamundry,location,city,
1806,andhra pradesh,location,state/province/district,
1806,india,location,country,
1806,jaundice,patient,symptoms/disease,
1806,abdominal pain,patient,symptoms/disease,
18073,bacteroides thetaiotaomicron,bacteria,binomial (genus species),
18073,256 and 4 g/ml,NA,mic,a
18073,metronidazole,NA,drug resisted,b
18073,32 g/ml),NA,mic,b
18073,clindamycin,NA,drug resisted,c
18073,256 g/ml,NA,mic,c
18073,rochester,location,city,
18073,ertapenem,NA,drug resisted,d
18073,16 g/ml,NA,mic,d
18073,meropenem,NA,drug resisted,e
18073,32 g/ml,NA,mic,e
18073,improved,patient,outcome,
18073,minnesota,location,state/province/district,
18073,2014,NA,event year,
18073,43,patient,age,
18073,man,patient,sex,
18073,intractable sigmoid diverticulitis,patient,comorbidities,
18073,piperacillintazobactam,NA,drug resisted,a
18158,klebsiella pneumoniae,bacteria,binomial (genus species),
18158,medical hospital of tokyo medical and dental university,location,hospital name,
18158,brazilian,location,place traveled to,
18158,carbapenems,NA,drug resisted,
18158,imipenem,NA,drug resisted,
18158,meropenem,NA,drug resisted,
18158,kp3018,bacteria,strain,
18158,japan,location,country,
18158,73,patient,age,
18158,man,patient,sex,
18158,23,NA,event day,
18158,may,NA,event month,
18158,2012,NA,event year,
18158,23 may 2012,NA,event date,
18184,rifampicin,NA,drug resisted,a
18184,16 μg/m,NA,mic,c
18184,amikacin,NA,drug resisted,d
18184,≥16 μg/m,NA,mic,d
18184,kanamycin,NA,drug resisted,e
18184,≥40 μg/ml,NA,mic,e
18184,≥16 μg/m,NA,mic,a
18184,moxifl oxacin,NA,drug resisted,f
18184,4 μg/ml,NA,mic,f
18184,ofl oxacin,NA,drug resisted,g
18184,16 μg/ml,NA,mic,g
18184,2-,patient,age,
18184,girl,patient,sex,
18184,usa,patient,country of residence,
18184,india,location,place traveled to,
18184,fevers,patient,symptoms,
18184,drug-resistant tuberculosis,bacteria,binomial (genus species),
18184,isoniazid,NA,drug resisted,b
18184,2 μg/m,NA,mic,b
18184,rifabutin,NA,drug resisted,c
18265,this report describes the first kpc-producing klebsiella pneumoniae isolates identified in norway (n56) and the second isolate from sweden,NA,article/study aim,
18265,cefotetan/cloxacillin,NA,drug resisted,g
18265,aztreonam,NA,drug resisted,h
18265,.256,NA,mic,a
18265,mics of antibiotics are given in terms of mg/l,NA,notes,
18265,.256,NA,mic,b
18265,.16/.1,NA,mic,c
18265,.256,NA,mic,d
18265,.32/.4,NA,mic,e
18265,.16/.4,NA,mic,f
18265,.32/.32,NA,mic,g
18265,07,NA,event year,
18265,.256,NA,mic,h
18265,nov,NA,event month,
18265,klebsiella pneumoniae,bacteria,binomial (genus species),
18265,k47-25,NA,notes,
18265,st258,bacteria,strain,
18265,piperacillin/tazobactam,NA,drug resisted,a
18265,kpc-2,bacteria,resistance marker,
18265,norway,location,country,
18265,greece,location,place traveled to,
18265,cefpodoxime,NA,drug resisted,b
18265,cefotaxime/clavulanic acid,NA,drug resisted,c
18265,ceftazidime,NA,drug resisted,d
18265,ceftazidime/clavulanic acid,NA,drug resisted,e
18265,cefepime/clavulanic acid,NA,drug resisted,f
183,assess the frequency and diversity of carbapenemases and extended-spectrum βlactamases (esbl) produced by escherichia coli isolates from patients hospitalised in the regional military hospital of constantine (algeria).,NA,article/study aim,
183,minocycline,NA,drug resisted,
183,co-trimoxazole,NA,drug resisted,
183,blavim-19 was the only carbapenemase described to date in enterobacteriaceae in algeria.,NA,notes,
183,escherichia coli,bacteria,binomial (genus species),
183,st5,bacteria,strain,
183,oxa-48,bacteria,resistance marker,
183,algeria,location,country,
183,constantine,location,city,
183,military hospital of constantine,location,hospital name,
183,tunisia,location,place traveled to,
183,2012,NA,event year,
183,78-year-old,patient,age,
183,male,patient,sex,
183,march,NA,event month,
183,kanamycin,NA,drug resisted,
183,tobramycin,NA,drug resisted,
183,gentamicin,NA,drug resisted,
183,nalidixic acid,NA,drug resisted,
183,ofloxacin,NA,drug resisted,
183,ciprofloxacin,NA,drug resisted,
18418,we report the first autochthonous cases of infections caused by blandm-5 new delhi metallo--lactamase-producing escherichia coli strains recovered from urine and blood specimens of three patients from algeria between january 2012 and february 2013.,NA,article/study aim,
18418,cefuroxime,NA,drug resisted,f
18418,ceftazidime,NA,drug resisted,g
18418,aztreonam,NA,drug resisted,h
18418,imipenem,NA,drug resisted,i
18418,gentamicin,NA,drug resisted,j
18418,amikacin,NA,drug resisted,k
18418,tobramycin,NA,drug resisted,l
18418,ciprofloxacin,NA,drug resisted,m
18418,256,NA,mic,a
18418,32,NA,mic,i
18418,january 2012 and february 2013,NA,event date,
18418,512,NA,mic,j
18418,2012,NA,event year,
18418,2013,NA,event year,
18418,mic (g/ml),NA,notes,
18418,escherichia coli,bacteria,binomial (genus species),
18418,st2659,bacteria,strain,
18418,ampicillin,NA,drug resisted,a
18418,ndm-5,bacteria,resistance marker,
18418,algeria,location,country,
18418,annaba,location,city,
18418,university hospital of annaba,location,hospital name,
18418,5-month-old,patient,age,
18418,75-year-old man,patient,age,
18418,63-year-old,patient,age,n
18418,man,patient,sex,n
18418,amoxicillin-clavulanate,NA,drug resisted,b
18418,"a previous report on ndm-5-producing e. coli sequence type 648 (st648) (genbank accession no. jn104597) demonstrated that the strain was resistant to all available antimicrobials except tigecycline and colistin (4),",NA,references for follow up,
18418,"4. hornsey m, phee l, wareham dw. 2011. a novel variant, ndm-5, of the new delhi metallo--lactamase in a multidrug-resistant escherichia coli st648 isolate recovered from a patient in the united kingdom. antimicrob. agents chemother. 55:5952–5954. http://dx.doi.org/10.1128 /aac.05108-11",NA,references for follow up,
18418,"st2659 has been reported only once, from a domesticated cat",NA,references for follow up,p
18418,in germany (http://mlst.warwick.ac.uk/mlst/dbs/ecoli),NA,references for follow up,p
18418,piperacillin-tazobactam,NA,drug resisted,c
18418,cefoxitin,NA,drug resisted,d
18418,cefotaxime,NA,drug resisted,e
18437,b cenocepacia,bacteria,binomial (genus species),
18437,abdominal distress,patient,symptoms/disease,
18437,discharge,patient,outcome,
18437,imipenem,NA,drug resisted,
18437,j2315,bacteria,strain,
18437,2,patient,age,
18437,boy,patient,sex,
18437,fever,patient,symptoms/disease,
18437,vomiting,patient,symptoms/disease,
18437,recovered,patient,outcome,
18437,9,patient,age,
18438,so far extended-spectrum β-lactamases producing shigella has not been reported from pakistan,NA,notes,
18438,rawalpindi,location,city,
18438,children ward of the military hospital,location,hospital name,
18438,8-year old,patient,age,
18438,girl,patient,sex,
18438,high grade fever,patient,symptoms/disease,
18438,loose motions mixed with blood and mucus,patient,symptoms/disease,
18438,blood in stools,patient,symptoms/disease,
18438,discharged,patient,outcome,
18438,fully recovered,patient,outcome,
18438,"in 1999, shv-11 esbl-producing s. dysenteriae strain was first time reported in india.4",NA,references for follow up,
18438,case report,NA,article/study aim,
18438,"4. huang i, chiu c, wang m, wu c, hsieh k, chiou cc. outbreak of dysentery associated with ceftriaxone-resistant shigella sonnei: first report of plasmid-mediated cmy-2-type ampc β-lactamase in s.sonnei. j clin microbiol 2005; 43:2608-12.",NA,references for follow up,
18438,ampicillin,NA,drug resisted,
18438,chloramphenicol,NA,drug resisted,
18438,tetracycline,NA,drug resisted,
18438,moxicillin-clavulanate,NA,drug resisted,
18438,ceftriaxone,NA,drug resisted,
18438,shigella flexneri,bacteria,binomial (genus species),
18438,pakistan,location,country,
18469,enterococcus raffinosus,NA,drug resisted,
18469,meropenem,NA,drug resisted,
18469,ciprofloxacin,NA,drug resisted,
18469,clindamycin,NA,drug resisted,
18469,erythromycin,NA,drug resisted,
18469,cotrimoxazole,NA,drug resisted,
18469,tetracycline,NA,drug resisted,
18469,amikacin,NA,drug resisted,
18469,gentamicin,NA,drug resisted,
18469,netilmicin,NA,drug resisted,
18469,tobramicin,NA,drug resisted,
18469,50,patient,age,
18469,leukaemia,patient,comorbidities,
18469,penicillin,NA,drug resisted,
18469,ampicillin,NA,drug resisted,
18469,amoxicillin/clavulanate,NA,drug resisted,
18469,ampicillin/sulbactam,NA,drug resisted,
18469,piperacillin/tazobactam,NA,drug resisted,
18469,imipenem,NA,drug resisted,
18470,case report,NA,article/study aim,
18470,carbapenems,NA,drug resisted,
18470,gentamicin,NA,drug resisted,
18470,ciprofloxacin,NA,drug resisted,
18470,prulifloxacin,NA,drug resisted,
18470,clindamycin,NA,drug resisted,
18470,erythromycin,NA,drug resisted,
18470,tetracycline,NA,drug resisted,
18470,cotrimoxazole,NA,drug resisted,
18470,enterococcus raffinosus,bacteria,binomial (genus species),
18470,"little has been published about infections caused by e raffinosus and its resistance to antimicrobial drugs other than β-lactams, gentamicin, and ciprofloxacin.3,5,6 particularly, wound infections by a multidrug-resistant e raffinosus strain have never been reported and, to our knowledge, its resistance to carbapenems, cotrimoxazole, clyndamicin, and prulifloxacin has never been described thus far.",NA,notes,
18470,2007,NA,event year,
18470,italy,location,country,
18470,70-year-old,patient,age,
18470,male,patient,sex,
18470,presented with a decubitus ulcer in the sacral region,patient,symptoms,
18470,constant purulent discharge,patient,symptoms,
18470,surgical options for treating this ulcer had been considered but only surgical curettage was performed once-a-week. this never resulted in a remarkable clinical improvement,patient,outcome,
18470,january,NA,event month,
18470,penicillin,NA,drug resisted,
18470,ampicillin,NA,drug resisted,
18470,cefotaxime,NA,drug resisted,
18470,amoxicillin-clavulanate,NA,drug resisted,
18470,ampicillin-sulbactam,NA,drug resisted,
18470,piperacillin-tazobactam,NA,drug resisted,
18527,55,patient,age,
18527,man,patient,sex,
18527,iraq,location,place traveled to,
18527,grenade injury,patient,symptoms/disease,
18527,acinetobacter  baumannii  osteomyelitis,NA,drug resisted,
18527,methicillin,NA,drug resisted,
18631,46,patient,age,
18631,man,patient,sex,
18631,corynebacterium jeikeium,bacteria,binomial (genus species),
18631,daptomycin,NA,drug resisted,
18631,germany2,location,country,
18631,1087,bacteria,strain,
18631,256 g/ml,NA,mic,
18631,died,patient,outcome,
18674,"to the best  of our knowledge, this was the fi rst case of infection with an  ndm-1-positive strain in the state of santa catarina",NA,notes,
18674,meropenem,NA,drug resisted,
18674,sulfamethoxazole/trimethoprim,NA,drug resisted,
18674,ciprofl oxacin,NA,drug resisted,
18674,nitrofurantoi,NA,drug resisted,
18674,amikacin,NA,drug resisted,
18674,levofl oxacin,NA,drug resisted,
18674,piperacillin/tazobactam,NA,drug resisted,
18674,aztreonam,NA,drug resisted,
18674,acinetobacter spp.,bacteria,binomial (genus species),
18674,ndm1,bacteria,resistance marker,
18674,case report,NA,article/study aim,
18674,brazil,location,country,
18674,santa catarina,location,state/province/district,
18674,tubarão,location,city,
18674,hospital nossa  senhora da conceição,location,hospital name,
18674,20-year-old,patient,age,
18674,man,patient,sex,
18674,vestibular schwannoma,patient,comorbidities,
18674,hearing loss,patient,comorbidities,
18674,aspiration  pneumonia,patient,comorbidities,
18674,severe protein-calorie malnutrition,patient,symptoms,
18674,2013,NA,event year,
18674,anorexia,patient,symptoms,
18674,vomiting due to intolerance to a nasogastric tube,patient,symptoms,
18674,drop in oxygen saturation.,patient,symptoms,
18674,"the patient responded well to the antimicrobial  therapy, which resulted in cure of the infection and patient  discharge.",patient,outcome,
18674,november,NA,event month,
18674,amoxicillin/clavulanate,NA,drug resisted,
18674,cefadroxil,NA,drug resisted,
18674,ceftriaxone,NA,drug resisted,
18674,ertapenem,NA,drug resisted,
18674,imipinem,NA,drug resisted,
1874,18,patient,age,
1874,amikacin,NA,drug resisted,
1874,carbapenems,NA,drug resisted,
1874,israel,location,country,
1874,first,NA,first surveillance study (of a particular resistance) in countr,
1874,man,patient,sex,
1874,high fever,patient,symptoms/disease,
1874,chest pain,patient,symptoms/disease,
1874,shortness of breath,patient,symptoms/disease,
1874,k. pneumoniae,bacteria,binomial (genus species),
1874,cephalosporins,NA,drug resisted,
1874,"piperacillin/tazobactam,",NA,drug resisted,
1874,quinolones,NA,drug resisted,
18778,16,patient,age,
18778,male,patient,sex,
18778,fever,patient,symptoms/disease,
18778,pre-auricular swelling,patient,symptoms/disease,
18778,ampicillin,NA,drug resisted,
18778,staphylococcus aureus,bacteria,binomial (genus species),
18778,resolved,patient,outcome,
18778,"alexandra hospital,",location,hospital name,
18778,united kingdom,patient,country of residence,
18778,united kingdom,location,country,
18818,we reporf a case and review fhe liferafure in an immunocompromised hiv-1 individual wifh a firsf reported case of a rifampicin-resisfanf m. marinum organism in fhe liferafure.,NA,article/study aim,
18818,hiv-1,patient,comorbidities,
18818,bournemouth hospital,location,hospital name,
18818,o rifampic,NA,drug resisted,
18818,co-trimoxazole,NA,drug resisted,
18818,mycobacterium marinu,bacteria,binomial (genus species),
18818,uk,location,country,
18818,bournemouth,location,city,
18818,38-year-old,patient,age,
18818,man,patient,sex,
18818,pigmented lesions on his left arm,patient,symptoms/disease,
18833,we present the first report on the antimicrobial resistance in s.  pneumoniae and h. influenzae isolated from patients in the united arab emirates.,NA,first surveillance study (of a particular resistance) in countr,
18852,this is the first report in which the g2474t mutation has been detected in domain v of the 23s rrna gene of clinical s. epidermidis,NA,article/study aim,
18852,12,NA,mic,b
18852,2,NA,mic,c
18852,6,NA,mic,d
18852,2008,NA,event year,
18852,staphylococcus epidermidis,bacteria,binomial (genus species),
18852,spain,location,country,
18852,zaragoza,location,city,
18852,the hospital clínico ‘lozano blesa’,location,hospital name,
18852,"a total of 27 linezolid-resistant cns were recovered from 21 patients (10 males, 11 females) in the icu",NA,notes,
18852,02,NA,event month,
18852,03,NA,event day,
18852,oxacillin,NA,drug resisted,a
18852,linezolid,NA,drug resisted,b
18852,vancomycin,NA,drug resisted,c
18852,teicoplanin,NA,drug resisted,d
18852,256,NA,mic,a
1887,this is the first report of kpc carbapenemase in p. putida,NA,article/study aim,
1887,tobramycin,NA,drug resisted,i
1887,ertapenem,NA,drug resisted,j
1887,imipenem,NA,drug resisted,k
1887,meropenem,NA,drug resisted,l
1887,32,NA,mic,a
1887,128,NA,mic,e
1887,8,NA,mic,f
1887,16,NA,mic,g
1887,4,NA,mic,k
1887,cefepime,NA,drug resisted,a
1887,cefoxitin,NA,drug resisted,b
1887,ceftazidime,NA,drug resisted,c
1887,pseudomonas putida,bacteria,binomial (genus species),
1887,kpc-2,bacteria,resistance marker,
1887,texas,location,state/province/district,
1887,san antonio,location,city,
1887,university hospital,location,hospital name,
1887,54-year-old,patient,age,
1887,female,patient,sex,
1887,ceftriaxone,NA,drug resisted,d
1887,liver transplant,patient,comorbidities,
1887,hemorrhage,patient,symptoms/disease,
1887,acute renal failure,patient,symptoms/disease,
1887,pulmonary embolus,patient,symptoms/disease,
1887,right lobe liver infarct,patient,symptoms/disease,
1887,died,patient,outcome,
1887,piperacillin-tazobactam,NA,drug resisted,e
1887,ciprofloxacin,NA,drug resisted,f
1887,levofloxacin,NA,drug resisted,g
1887,gentamicin,NA,drug resisted,h
18940,26,patient,age,
18940,woman,patient,sex,
18940,hypothyroidism,patient,comorbidities,
18940,cystic fibrosis,patient,comorbidities,
18940,chryseobacterium indologenes,bacteria,binomial (genus species),
18945,pseudomonas aeruginosa,bacteria,binomial (genus species),
18945,we report the first instance of isolation of per1–producing and veb-1–producing strains of p. aeruginosa in iran.,NA,article/study aim,
18945,blaper-1,bacteria,resistance marker,
18945,per1–producing,bacteria,strain,
18945,veb-1–producing,bacteria,strain,
18945,"this is the first report on the existence of blaveb, and blaper in iran.",NA,notes,
18946,2011,NA,event year,
18946,amikacin,NA,drug resisted,
18946,kanamycin,NA,drug resisted,
18946,aztreonam,NA,drug resisted,
18946,trimethoprim-sulfamethoxazole,NA,drug resisted,
18946,ndm-1,bacteria,resistance marker,
18946,tem,bacteria,resistance marker,
18946,shv,bacteria,resistance marker,
18946,ctx-m,bacteria,resistance marker,
18946,klebsiella pneumoniae,bacteria,binomial (genus species),
18946,tehran,location,city,
18946,march,NA,event month,
18946,iran,location,country,
18946,52year-old,patient,age,
18946,male,patient,sex,
18946,fever,patient,symptoms/disease,
18946,india|pakistan,location,place traveled to,
18946,cefepime,NA,drug resisted,
18946,cefotaxime,NA,drug resisted,
18946,ceftazidime,NA,drug resisted,
18946,imipenem,NA,drug resisted,
18946,meropenem,NA,drug resisted,
18946,ertapenem,NA,drug resisted,
18946,ciprofloxacin,NA,drug resisted,
18947,iran,location,country,
18947,blandm-1,bacteria,resistance marker,
18947,blashv,bacteria,resistance marker,
18947,blactx-m,bacteria,resistance marker,
18947,52,patient,age,
18947,male,patient,sex,
18947,fever,patient,symptoms/disease,
18947,transplant rejection,patient,comorbidities,
18947,meropenem,NA,drug resisted,
18947,ertapenem,NA,drug resisted,
18947,cefepime,NA,drug resisted,
18947,klebsiella pneumoniae,bacteria,binomial (genus species),
18947,cefotaxime,NA,drug resisted,
18947,ceftazidime,NA,drug resisted,
18947,amikacin,NA,drug resisted,
18947,kanamycin,NA,drug resisted,
18947,ciprofloxacin,NA,drug resisted,
18947,aztreonam,NA,drug resisted,
18947,trimethoprim-sulfamethoxazole,NA,drug resisted,
18947,imipenem,NA,drug resisted,
18947,ndm-1,bacteria,resistance marker,
18947,new delhi metallo-beta-lactamase1,bacteria,binomial (genus species),
18947,tehran,location,city,
18947,blakpc,bacteria,binomial (genus species),
18947,2011,NA,event year,
18947,march,NA,event month,
18947,blatem,bacteria,resistance marker,
18963,35,patient,age,
18963,ceftazidime,NA,drug resisted,
18963,ceftriaxone,NA,drug resisted,
18963,cefotaxime,NA,drug resisted,
18963,ertapenem,NA,drug resisted,
18963,gentamicin,NA,drug resisted,
18963,tobramycin,NA,drug resisted,
18963,fully recovered,patient,outcome,
18963,man,patient,sex,
18963,georgia,location,state/province/district,
18963,ampicillin,NA,drug resisted,
18963,tetracycline,NA,drug resisted,
18963,amikacin,NA,drug resisted,
18963,aztreonam,NA,drug resisted,
18963,cefepime,NA,drug resisted,
18963,cefoxitin,NA,drug resisted,
19093,"susceptibility profiles can vary widely between different geographical locations and medical institutions. in the united states, multi-drug resistance is rare and anaerobic susceptibility testing is usually only pursued for specific surveillance purposes or due to extraordinary clinical circumstances.",NA,notes,
19093,meropenem,NA,drug resisted,h
19093,tigecycline,NA,drug resisted,i
19093,chloramphenicol,NA,drug resisted,j
19093,> 256,NA,mic,a
19093,> 128/64,NA,mic,b
19093,> 64/4,NA,mic,c
19093,> 128,NA,mic,d
19093,> 64,NA,mic,e
19093,> 32,NA,mic,g
19093,> 16,NA,mic,i
19093,2009,NA,event year,
19093,penicillin,NA,drug resisted,a
19093,ampicillin and sulbactam,NA,drug resisted,b
19093,bacteroides fragilis,bacteria,binomial (genus species),
19093,united states,location,country,
19093,walter reed army medical center (wramc),location,hospital name,
19093,germany|afghanistan,location,place traveled to,
19093,united states army soldier,patient,occupation,
19093,23 year-old,patient,age,
19093,he,patient,sex,
19093,united states,patient,country of residence,
19093,cervical fracture,patient,comorbidities,
19093,piperacillin and tazobactam,NA,drug resisted,c
19093,right femoral fracture,patient,comorbidities,
19093,bilateral open tibia and fibula fractures.,patient,comorbidities,
19093,discharge,patient,outcome,
19093,"washington, dc",location,state/province/district,
19093,clindamycin,NA,drug resisted,d
19093,metronidazole,NA,drug resisted,e
19093,cefoxitin,NA,drug resisted,f
19093,imipenem,NA,drug resisted,g
19152,2011,NA,event year,
19152,cefaclor,NA,drug resisted,
19152,cefotaxime,NA,drug resisted,
19152,cefixime,NA,drug resisted,
19152,cefoperazone,NA,drug resisted,
19152,amikacin,NA,drug resisted,
19152,gentamicin,NA,drug resisted,
19152,tobramycin,NA,drug resisted,
19152,trimethoprim-sulfamethoxazole,NA,drug resisted,i
19152,32,NA,mic,
19152,128,NA,mic,
19152,august,NA,event month,
19152,16,NA,mic,
19152,64,NA,mic,
19152,16,NA,mic,
19152,320,NA,mic,
19152,29,NA,event day,
19152,leclercia adecarboxylata,bacteria,binomial (genus species),
19152,kbn0601918,bacteria,strain,
19152,blatem-1,bacteria,resistance marker,
19152,blactx-m group 1,bacteria,resistance marker,
19152,29 august 2011,NA,event date,
19152,dfra12-orff-aada2,bacteria,resistance marker,
19152,south korea,location,country,
19152,jeonju,location,city,
19152,chonbuk national university hospital,location,hospital name,
19152,47-year-old,patient,age,
19152,female,patient,sex,
19152,guided antibiotic therapy was successful,patient,outcome,
19152,breast cancer,patient,comorbidities,
19152,fever,patient,symptoms,
19152,myalgia,patient,symptoms,
19152,ampicillin,NA,drug resisted,
19152,case report,NA,article/study aim,
19152,piperacillin,NA,drug resisted,
19152,aztreonam,NA,drug resisted,
19152,cephalothin,NA,drug resisted,
19152,cefazolin,NA,drug resisted,
19196,"although the correct taxonomical delineation of n. cyriacigeorgica/n. asteroides drug pattern vi strains remains to be clarified, we decided to report our cases since to the best of our knowledge there has not been any reports on isolation of this organism, whatever it may be called, from developing countries.",NA,notes,
19196,penicillin g,NA,drug resisted,
19196,ampicillin,NA,drug resisted,
19196,amoxicillin-clavulanic acid,NA,drug resisted,
19196,kanamycin,NA,drug resisted,
19196,clarithromycin,NA,drug resisted,
19196,ciprofloxacin,NA,drug resisted,
19196,nocardia cyriacigeorgica,bacteria,binomial (genus species),
19196,iran,location,country,
19267,"this report compares the clinical characteristics, epidemiologic investigations, infection-control evaluations, and microbiologic findings of all 7 of the cases of vancomycin-resistant staphylococcus aureus (vrsa) infection in the united states during the period 2002–2006",NA,article/study aim,
19267,teicoplanin,NA,drug resisted,h
19267,vancomycin,NA,drug resisted,i
19267,18,NA,mic,
19267,64,NA,mic,
19267,116,NA,mic,d
19267,16,NA,mic,
19267,12,NA,mic,
19267,rif,NA,drug resisted,
19267,32,NA,mic,
19267,2002,NA,event year,
19267,1024,NA,mic,
19267,june,NA,event month,
19267,staphylococcus aureus,bacteria,binomial (genus species),
19267,clindamycin,NA,drug resisted,a
19267,usa100,bacteria,strain,
19267,united states,location,country,
19267,michigan,location,state/province/district,
19267,40,patient,age,
19267,female,patient,sex,
19267,"mic, mg/ml",NA,notes,
19267,nfection cleared,patient,outcome,
19267,diabetes,patient,comorbidities,
19267,chronic renal failure,patient,comorbidities,
19267,"15. weigel lm, clewell db, gill sr, et al. genetic analysis of a high-level vancomycin-resistant isolate of staphylococcus aureus. science 2003; 302:1569–71",NA,references for follow up,
19267,erythromycin,NA,drug resisted,b
19267,"16. chang s, sievert dm, hageman jc, et al. infection with vancomycinresistant staphylococcus aureus containing the vana resistance gene. n engl j med 2003; 348:1342–7",NA,references for follow up,
19267,gentamicin,NA,drug resisted,c
19267,oxacillin,NA,drug resisted,d
19267,levofloxacin,NA,drug resisted,e
19267,penicillin,NA,drug resisted,f
19568,april 2008,NA,event date,
19568,lesion,patient,symptoms/disease,
19568,obese,patient,comorbidities,
19568,tetracycline,NA,drug resisted,
19568,staphylococcus  aureus,bacteria,binomial (genus species),
19568,st398,bacteria,strain,
19568,april,NA,event month,
19568,2008,NA,event year,
19568,52,patient,age,
19568,man,patient,sex,
19568,manerbio,location,city,
19568,italy,location,country,
19568,severe sepsis,patient,symptoms/disease,
19568,ulcerative,patient,symptoms/disease,
19607,first description of an escherichia coli strain producing ndm-1 carbapenemase in spain,NA,article/study aim,
19607,doripenem,NA,drug resisted,j
19607,ertapenem,NA,drug resisted,k
19607,imipenem,NA,drug resisted,h
19607,aztreonam,NA,drug resisted,l
19607,gentamicin,NA,drug resisted,m
19607,amikacin,NA,drug resisted,n
19607,tobramycin,NA,drug resisted,o
19607,ciprofloxacin,NA,drug resisted,p
19607,mic (g/ml),NA,notes,
19607,256,NA,mic,a
19607,amoxicillin,NA,drug resisted,a
19607,32,NA,mic,b
19607,256,NA,mic,g
19607,8,NA,mic,h
19607,16,NA,mic,
19607,6,NA,mic,j
19607,24,NA,mic,k
19607,8,NA,mic,m
19607,32,NA,mic,n
19607,8,NA,mic,o
19607,amoxicillin  clavulanate,NA,drug resisted,b
19607,piperacillin  tazobactam,NA,drug resisted,c
19607,cefoxitin,NA,drug resisted,d
19607,cefotaxime,NA,drug resisted,e
19607,escherichia col,bacteria,binomial (genus species),
19607,ndm-1,bacteria,resistance marker,
19607,st156,bacteria,strain,
19607,spain,location,country,
19607,spain,patient,country of residence,
19607,barcelona,location,city,
19607,the hospital clinic of barcelona,location,hospital name,
19607,40-year-old,patient,age,
19607,male,patient,sex,
19607,ceftazidime,NA,drug resisted,f
19607,india,location,place traveled to,
19607,abdominal discomfort,patient,symptoms/disease,
19607,fever,patient,symptoms/disease,
19607,bloody diarrhea,patient,symptoms/disease,
19607,cefepime,NA,drug resisted,g
19607,meropenem,NA,drug resisted,i
19609,amoxicillin,NA,drug resisted,a
19609,doripenem,NA,drug resisted,j
19609,ertapenem,NA,drug resisted,k
19609,aztreonam,NA,drug resisted,l
19609,gentamicin,NA,drug resisted,m
19609,amikacin,NA,drug resisted,n
19609,tobramycin,NA,drug resisted,o
19609,ciprofloxacin,NA,drug resisted,p
19609,256,NA,mic,a
19609,32,NA,mic,b
19609,256,NA,mic,g
19609,amoxicillin  clavulanate,NA,drug resisted,b
19609,8,NA,mic,h
19609,16,NA,mic,i
19609,6,NA,mic,j
19609,24,NA,mic,k
19609,8,NA,mic,m
19609,32,NA,mic,n
19609,8,NA,mic,o
19609,piperacillin  tazobactam,NA,drug resisted,c
19609,cefoxitin,NA,drug resisted,d
19609,cefotaxime,NA,drug resisted,e
19609,mic (g/ml),NA,notes,
19609,ceftazidime,NA,drug resisted,f
19609,escherichia coli,bacteria,binomial (genus species),
19609,ndm-1,bacteria,resistance marker,
19609,st156,bacteria,strain,
19609,spain,location,country,
19609,spain,patient,country of residence,
19609,barcelona,location,city,
19609,hospital clinic of barcelona,location,hospital name,
19609,india,location,place traveled to,
19609,40-year-old,patient,age,
19609,male,patient,sex,
19609,cefepime,NA,drug resisted,g
19609,intermittent abdominal discomfort,patient,symptoms/disease,
19609,fever,patient,symptoms/disease,
19609,bloody diarrhea,patient,symptoms/disease,
19609,imipenem,NA,drug resisted,h
19609,meropenem,NA,drug resisted,i
19615,the first ndm-5-producing carbapenem-resistant e. coli isolate identified in egypt is described herein,NA,article/study aim,
19615,amoxicillin,NA,drug resisted,e
19615,cefotaxime,NA,drug resisted,f
19615,ceftazidime,NA,drug resisted,g
19615,cefoperazone,NA,drug resisted,h
19615,ceftriaxone,NA,drug resisted,i
19615,gentamicin,NA,drug resisted,j
19615,nalidixic acid,NA,drug resisted,k
19615,tetracycline,NA,drug resisted,l
19615,norfloxacin,NA,drug resisted,m
19615,2014,NA,event year,
19615,june,NA,event month,
19615,minimum inhibitory concentration (mg/ml),NA,notes,
19615,32,NA,mic,a
19615,512,NA,mic,d
19615,256,NA,mic,j
19615,128,NA,mic,m
19615,16,NA,event day,
19615,"june 16, 2014",NA,event date,
19615,escherichia coli,bacteria,binomial (genus species),
19615,ndm-5,bacteria,resistance marker,
19615,sequence type (st) 5018,bacteria,strain,
19615,egypt,location,country,
19615,kafr el-sheikh,location,city,
19615,65-year-old,patient,age,
19615,man,patient,sex,
19615,right femur fracture,patient,symptoms/disease,
19615,recovered,patient,outcome,
19615,imipenem,NA,drug resisted,a
19615,meropenem,NA,drug resisted,b
19615,doripenem,NA,drug resisted,c
19615,aztreonam,NA,drug resisted,d
202,this is the first isolation of oxa-48producing k. pneumoniae in algeria.,NA,article/study aim,
202,cefalothin,NA,drug resisted,g
202,cefoxitin,NA,drug resisted,h
202,cefotaxime,NA,drug resisted,i
202,imipenem,NA,drug resisted,j
202,ertapenem,NA,drug resisted,k
202,>256,NA,mic,a
202,4,NA,mic,i
202,>32,NA,mic,j
202,2011,NA,event year,
202,october,NA,event month,
202,amoxicillin,NA,drug resisted,a
202,klebsiella pneumoniae,bacteria,binomial (genus species),
202,st-307,bacteria,strain,
202,oxa-48,bacteria,resistance marker,
202,algeria,location,country,
202,algiers,location,city,
202,hoˆpital central de l’arme´e of algiers,location,hospital name,
202,18 months,patient,age,
202,male,patient,sex,
202,myeloblastic acute leukemia,patient,comorbidities,
202,fever,patient,symptoms/disease,
202,amoxicillin + cla,NA,drug resisted,b
202,ticarcillin,NA,drug resisted,c
202,ticarcillin +cla,NA,drug resisted,d
202,piperacillin,NA,drug resisted,e
202,piperacillin + taz,NA,drug resisted,f
20331,this is the first report describing ndm-1and ndm-8-producing gram-negative pathogens in nepal,NA,article/study aim,
20331,cephradine,NA,drug resisted,h
20331,imipenem,NA,drug resisted,i
20331,meropenem,NA,drug resisted,j
20331,penicillin g,NA,drug resisted,k
20331,piperacillin,NA,drug resisted,l
20331,piperacillin-tazobactam,NA,drug resisted,m
20331,ticarcillin,NA,drug resisted,n
20331,ticarcillin-clavulanic acid,NA,drug resisted,o
20331,mic (g/ml),NA,notes,
20331,"1,024",NA,mic,a
20331,2012,NA,event year,
20331,"1,024",NA,mic,d
20331,256,NA,mic,i
20331,512,NA,mic,o
20331,ampicillin,NA,drug resisted,a
20331,ampicillin-sulbactam,NA,drug resisted,b
20331,aztreonam,NA,drug resisted,c
20331,escherichia coli,bacteria,binomial (genus species),
20331,st101,bacteria,strain,
20331,ndm-8,bacteria,resistance marker,
20331,nepal,location,country,
20331,kathmandu,location,city,
20331,tribhuvan university teaching hospital,location,hospital name,
20331,cefepime,NA,drug resisted,d
20331,cefotaxime,NA,drug resisted,e
20331,cefoxitin,NA,drug resisted,f
20331,ceftazidime,NA,drug resisted,g
20332,this is the first report describing multidrug-resistant p. rettgeri strains harboring blandm-1 or blaoxa-72 and arma isolated from patients in nepal.,NA,article/study aim,
20332,meropenem,NA,drug resisted,g
20332,aztreonam,NA,drug resisted,h
20332,arbekacin,NA,drug resisted,i
20332,amikacin,NA,drug resisted,j
20332,gentamicin,NA,drug resisted,k
20332,ciprofloxacin,NA,drug resisted,l
20332,colistin,NA,drug resisted,m
20332,fosfomycin;,NA,drug resisted,n
20332,tigecycline,NA,drug resisted,o
20332,"1,024",NA,mic,a
20332,2012,NA,event year,
20332,512,NA,mic,b
20332,">1,024",NA,mic,c
20332,64,NA,mic,d
20332,32,NA,mic,e
20332,16,NA,mic,
20332,64,NA,mic,g
20332,"1,024",NA,mic,h
20332,">1,024",NA,mic,i
20332,">1,024",NA,mic,j
20332,128,NA,mic,l
20332,may,NA,event month,
20332,>128,NA,mic,m
20332,4,NA,mic,o
20332,piperacillin,NA,drug resisted,a
20332,piperacillin/tazobactam,NA,drug resisted,b
20332,ceftazidime,NA,drug resisted,c
20332,providencia rettgeri,bacteria,binomial (genus species),
20332,"ndm-1,",bacteria,resistance marker,
20332,oxa-10,bacteria,resistance marker,
20332,veb-1,bacteria,resistance marker,
20332,tem-1,bacteria,resistance marker,
20332,"adc-67,",bacteria,resistance marker,
20332,nepal,location,country,
20332,kathmandu,location,city,
20332,cefepime,NA,drug resisted,d
20332,tribhuvan university teaching hospital,location,hospital name,
20332,mic (mg/l),NA,notes,
20332,iomtu1,NA,notes,
20332,imipenem,NA,drug resisted,e
20332,doripenem,NA,drug resisted,f
20339,52,patient,age,
20339,woman,patient,sex,
20339,april,NA,event month,
20339,2008,NA,event year,
20339,paraplegia,patient,comorbidities,
20339,neurogenic bladder,patient,comorbidities,
20350,we report here on a case of wound infection due to shewanella algae in the navel area of a patient.,NA,article/study aim,
20350,ampicillin,NA,drug resisted,
20350,tetracycline,NA,drug resisted,
20350,cephalothin,NA,drug resisted,
20350,ceftizoxime,NA,drug resisted,
20350,shewanella algae,bacteria,binomial (genus species),
20350,iran,location,country,
20350,bushehr,location,city,
20350,24-year-old,patient,age,
20350,man,patient,sex,
20350,pilonidal cyst,patient,symptoms/disease,
20350,first clinical case report – first clinical case in emerging country,NA,notes,
20350,purulent discharge,patient,symptoms/disease,
20350,persian gulf,location,place traveled to,
20350,"to the best of our knowledge, this is first case of wound infection clearly caused by s. algae to be reported in iran.",NA,notes,
20350,2010,NA,event year,
20350,december,NA,event month,
20350,amoxicillin,NA,drug resisted,
20350,vancomycin,NA,drug resisted,
20350,doxycycline,NA,drug resisted,
20350,cephalexin,NA,drug resisted,
20373,"in this study, we wanted to assess the level of antimicrobial resistance, the presence of genes encoding resistance to cephalosporins and plasmid-mediated quinolone resistance (pmqr), and genetic relatedness among shigella isolates obtained from iranian patients.",NA,first surveillance study (of a particular resistance) in countr,
20373,: this is the first known description of esbl-producing and ampc b-lactamase-producing shigella and of pmqr shigella in iran.,NA,first surveillance study (of a particular resistance) in countr,
20401,"to investigate the trends of antimicrobial resistance in pathogens isolated from surgical site infections (ssi), a japanese surveillance committee conducted the first nationwide survey.",NA,first surveillance study (of a particular resistance) in countr,
20553,first report,NA,article/study aim,
20553,penicillin,NA,drug resisted,
20553,ampicillin,NA,drug resisted,
20553,amoxicillin/clavulanic acid,NA,drug resisted,
20553,oxacillin,NA,drug resisted,
20553,cefazolin,NA,drug resisted,
20553,cefotaxime,NA,drug resisted,
20553,erythromycin,NA,drug resisted,
20553,clindamycin,NA,drug resisted,
20553,chloramphenicol,NA,drug resisted,
20553,2005,NA,event year,
20553,rifampicin,NA,drug resisted,
20553,trimethoprim/sulfamethoxazole,NA,drug resisted,
20553,spain,location,country,
20553,25-year-old,patient,age,
20553,man,patient,sex,
20553,firearm injury in the thorax,patient,comorbidities,
20553,december,NA,event month,
20553,december 2005,NA,event date,
20553,linezolid,NA,drug resisted,a
20553,12 mg/l,NA,mic,
20553,staphylococcus haemolyticus sir,bacteria,binomial (genus species),
20553,g2576t,bacteria,resistance marker,
20639,", this is the first report of carbapenem-resistant a. nosocomialis in latin america.",NA,first surveillance study (of a particular resistance) in countr,
2067,the present study was undertaken to understand the distribution and the antimicrobial susceptibility patterns of the uropathogens in the remote islands of india.,NA,first surveillance study (of a particular resistance) in countr,
2067,the present study was undertaken to understand the distribution and the antimicrobial susceptibility patterns of the uropathogens in the remote islands of india.,NA,article/study aim,
2067,co-trimoxazole,NA,drug resisted,
2067,nalidixic acid,NA,drug resisted,a
2067,norfloxacin,NA,drug resisted,c
2067,ciprofloxacin,NA,drug resisted,b
2067,ofloxacin,NA,drug resisted,
2067,gatifloxacin,NA,drug resisted,
2067,gentamicin,NA,drug resisted,
2067,nitrofurantoin,NA,drug resisted,
2067,tetracycline,NA,drug resisted,
2067,cephalothin,NA,drug resisted,
2067,the present study reports for the first time the presence of the new delhi metallo-b-lactamase (ndm-1) gene in two isolates of p. mirabilis in these islands.,NA,first surveillance study (of a particular resistance) in countr,
2067,cefuroxime,NA,drug resisted,
2067,cefixime,NA,drug resisted,
2067,ceftriaxone,NA,drug resisted,f
2067,cefotaxime,NA,drug resisted,e
2067,ceftazidime,NA,drug resisted,d
2067,> 256,NA,mic,a
2067,128,NA,mic,b
2067,> 256,NA,mic,c
2067,32,NA,mic,d
2067,32,NA,mic,e
2067,32,NA,mic,f
2067,8,NA,mic,
2067,2011,NA,event year,
2067,proteus mirabilis,bacteria,binomial (genus species),
2067,usd-66,bacteria,strain,
2067,ndm-1,bacteria,resistance marker,
2067,india,location,country,
2067,andaman islands,location,state/province/district,
2067,7,patient,age,
2067,ampicillin,NA,drug resisted,
2067,m,patient,sex,
2067,usd-66,NA,notes,
2067,carbenicillin,NA,drug resisted,
2067,imipenem,NA,drug resisted,
2067,amikacin,NA,drug resisted,
2067,chloramphenicol,NA,drug resisted,
20841,2010,NA,event year,
20841,klebsiella pneumoniae,bacteria,binomial (genus species),
20841,gn529,bacteria,strain,
20841,carbapenem,NA,drug resisted,
20841,blandm-1,bacteria,resistance marker,
20841,"blandm,",bacteria,resistance marker,
20841,blashv,bacteria,resistance marker,
20841,blatem,bacteria,resistance marker,
20841,blactx-m,bacteria,resistance marker,
20841,blaoxa,bacteria,resistance marker,
20841,blactx-m-15,bacteria,resistance marker,
20841,august,NA,event month,
20841,blashv-12,bacteria,resistance marker,
20841,blashv-11,bacteria,resistance marker,
20841,blatem-1,bacteria,resistance marker,
20841,blaoxa-1,bacteria,resistance marker,
20841,canada,location,country,
20841,ontario,location,state/province/district,
20841,brampton,location,city,
20841,36-yearold,patient,age,
20841,woman,patient,sex,
20841,india|mumbai,location,place traveled to,
20841,august 2010,NA,event date,
20841,miscarriage,patient,comorbidities,
20841,β-lactams,NA,drug resisted,
20841,aminoglycosides,NA,drug resisted,
20841,quinolones,NA,drug resisted,
20841,tetracycline,NA,drug resisted,
20841,nitrofurantoin,NA,drug resisted,
20841,co-trimoxazole,NA,drug resisted,
20899,we report the first confirmed cases of ndm-1-producing klebsiella pneumoniae infections in two hospitals in bulgaria.,NA,article/study aim,
20899,imipenem,NA,drug resisted,g
20899,meropenem,NA,drug resisted,h
20899,ertapenem,NA,drug resisted,i
20899,doripenem,NA,drug resisted,j
20899,tobramycin,NA,drug resisted,k
20899,ciprofloxacin,NA,drug resisted,l
20899,levofloxacin,NA,drug resisted,m
20899,trimethoprim/sulfamethoxazole,NA,drug resisted,n
20899,doxycycline,NA,drug resisted,o
20899,>64,NA,mic,a
20899,2014,NA,event year,
20899,>128,NA,mic,b
20899,>32,NA,mic,c
20899,>16,NA,mic,d
20899,>8,NA,mic,g
20899,>4,NA,mic,i
20899,>2,NA,mic,j
20899,16,NA,mic,o
20899,mic (mg/ml),NA,notes,
20899,pr2682,NA,notes,
20899,january,NA,event month,
20899,piperacillin/tazobactam,NA,drug resisted,a
20899,ticarcillin/clavulanic acid,NA,drug resisted,b
20899,klebsiella pneumoniae,bacteria,binomial (genus species),
20899,cefotaxime,NA,drug resisted,c
20899,st11,bacteria,strain,
20899,ndm-1,bacteria,resistance marker,
20899,cmy-4,bacteria,resistance marker,
20899,ctx-m-15,bacteria,resistance marker,
20899,tem-1,bacteria,resistance marker,
20899,bulgaria,location,country,
20899,sofia,location,city,
20899,52-year-old,patient,age,
20899,man,patient,sex,
20899,multiple fractures due to traffic accident,patient,comorbidities,
20899,ceftazidime,NA,drug resisted,d
20899,traumatic shock,patient,symptoms/disease,
20899,septic,patient,symptoms/disease,
20899,multiple organ dysfunction,patient,symptoms/disease,
20899,discharged in satisfactory general condition,patient,outcome,
20899,cefepime,NA,drug resisted,e
20899,aztreonam,NA,drug resisted,f
21029,case report,NA,article/study aim,
21029,piperacillin/tazobactam,NA,drug resisted,e
21029,cefepime,NA,drug resisted,f
21029,ceftriaxon,NA,drug resisted,g
21029,8,NA,mic,a
21029,8,NA,mic,b
21029,32,NA,mic,c
21029,8,NA,mic,d
21029,8,NA,mic,e
21029,16 ,NA,mic,f
21029,16,NA,mic,g
21029,ampicillin,NA,drug resisted,a
21029,penicillins,NA,drug resisted,
21029,cephalosporins,NA,drug resisted,
21029,helicobacter cinaedi,bacteria,binomial (genus species),
21029,japan,location,country,
21029,19-year-old,patient,age,
21029,male,patient,sex,
21029,japanese,patient,country of residence,
21029,"he experienced no relapse for 8 months following this treatment, although his stool was still positive for spiral gnrs",patient,outcome,
21029,"eight days prior to his first admission, he developed painful erythema and swelling in his lower right leg. two days later, he became febrile and presented to the emergency department of our hospital.",patient,symptoms,
21029,he was generally well but had a history of helicobacter pylori infections during his early teens.,patient,comorbidities,
21029,amoxicillin,NA,drug resisted,b
21029,carbenicillin,NA,drug resisted,c
21029,piperacillin,NA,drug resisted,d
21083,vim-2,bacteria,resistance marker,
21083,chronic obstructive pulmonary disease,patient,comorbidities,
21083,psychiatric and lymphoproliferative syndrome,patient,comorbidities,
21083,university hospital complex of santiago de compostela,location,hospital name,
21083,santiago de compostela,location,city,
21083,dyspnoea,patient,symptoms/disease,
21083,congestive heart failure,patient,symptoms/disease,
21083,discharged,patient,outcome,
21083,readmitted a month later and died,patient,outcome,
21083,mic (mg ml”1 ),NA,notes,
21083,imipenem,NA,drug resisted,
21083,pseudomonas putida,bacteria,binomial (genus species),
21083,meropenem,NA,drug resisted,
21083,ceftazidime,NA,drug resisted,
21083,cefepime,NA,drug resisted,
21083,aztreonam,NA,drug resisted,
21083,piperacillin/ tazobactam,NA,drug resisted,
21083,ciprofloxacin,NA,drug resisted,
21083,gentamicin,NA,drug resisted,
21083,tobramycin,NA,drug resisted,
21083,trimethoprim/ sulfamethoxazole,NA,drug resisted,
21083,patient 1,NA,notes,
21083,here we report the microbiological characteristics of what are believed to be the two first carbapenem-resistant vim metallo-b-lactamase (mbl)-producing p. putida strains in spain,NA,article/study aim,
21083,.32,NA,mic,
21083,16,NA,mic,
21083,12,NA,mic,
21083,24,NA,mic,
21083,.256,NA,mic,
21083,48,NA,mic,
21083,spain,location,country,
21083,71-year-old,patient,age,
21083,female,patient,sex,
21083,hypertension,patient,comorbidities,
21083,nsulin-dependent diabetes mellitus,patient,comorbidities,
21083,stroke,patient,comorbidities,
21149,to investigate the first kpc carbapenemase-producing klebsiella pneumoniae isolate from a greek hospital,NA,article/study aim,
21149,ceftazidime,NA,drug resisted,g
21149,cefoxitin,NA,drug resisted,h
21149,amoxicillin,NA,drug resisted,i
21149,amoxicillin þ cla,NA,drug resisted,j
21149,piperacillin,NA,drug resisted,k
21149,piperacillin þ tzb,NA,drug resisted,l
21149,32,NA,mic,a
21149,64,NA,mic,c
21149,.256,NA,mic,d
21149,128,NA,mic,e
21149,2008,NA,event year,
21149,128,NA,mic,j
21149,serres general hospital,location,hospital name,
21149,imipenem,NA,drug resisted,a
21149,mics (mg/l),NA,notes,
21149,klebsiella pneumoniae,bacteria,binomial (genus species),
21149,kpc-2,bacteria,resistance marker,
21149,greece,location,country,
21149,serres,location,city,
21149,meropenem,NA,drug resisted,b
21149,woman,patient,sex,
21149,young,patient,age,
21149,eclampsia,patient,symptoms/disease,
21149,urinary tract infection,patient,symptoms/disease,
21149,discharged,patient,outcome,
21149,ertapenem,NA,drug resisted,c
21149,aztreonam,NA,drug resisted,d
21149,cefotaxime,NA,drug resisted,e
21149,cefepime,NA,drug resisted,f
21192,staphylococcus aureus,bacteria,binomial (genus species),
21192,disturbance of consciousness,patient,symptoms/disease,
21192,dissecting aortic aneurysm,patient,comorbidities,
21192,anterior mediastinal abscess,patient,symptoms/disease,
21192,hemorrhagic cerebral infarction associated with a prosthetic graft infection of the aortic arch,patient,symptoms/disease,
21192,antimicrobial susceptibility testing was performed according to the clinical and laboratory standards institute (clsi) guidelines,NA,notes,
21192,"the interpretations of the mic results (susceptible, intermediate, nonsusceptible, or resistant) were determined according to the clsi guidelines.",NA,notes,
21192,"mrsa isolates with daptomycin mics of >1 μg/ml, vancomycin mics of 4 to 8 μg/ml, and rifampicin mics of >2 μg/ml were defined as daptomycin nonsusceptible, vancomycin-intermediate resistant, and rifampicin resistant, respectively.",NA,notes,
21192,oxacillin,NA,drug resisted,a
21192,gentamicin,NA,drug resisted,b
21192,vancomycin,NA,drug resisted,c
21192,community-acquired methicillin-resistant staphylococcus aureus (ca-mrsa) was first reported in 1981 in patients with mrsa infections without general healthcare-associated risk factors. the incidence of ca-mrsa infection has continually increased since the mid-1990s [1].,NA,references for follow up,
21192,rifampicin,NA,drug resisted,d
21192,>4 [r],NA,mic,a
21192,>8 [r],NA,mic,b
21192,4 [i],NA,mic,c
21192,>2 [r],NA,mic,d
21192,the first case of an st72-mrsa-iv strain in asia demonstrating vancomycin-intermediate resistance was reported in 2012 by chung et al. in korea [13].,NA,references for follow up,
21192,st72 (1-4-1-8-4-4-3),bacteria,strain,
21192,sccmec type iv,bacteria,resistance marker,
21192,"table 2 susceptibility of mrsa to daptomycin as analyzed by clinical laboratory testing method daptomycin mic (μg/ml) [interpretation] isolate 1 isolate 1’ isolate 2 isolate 3 isolate 4 microscan (siemens, tokyo, japan) ≤0.5 [s] ≤0.5 [s] ≤0.5 [s] >1 [ns] >1 [ns] frozen plate (eiken, tokyo, japan) 0.5 [s] 0.5 [s] 0.25 [s] 1 [s] 1.5 [ns] etest® (biomérieux, marcy-l'étoile, france) 0.125 [s] 0.125 [s] 0.125 [s] 1 [s] 1.5 [ns] isolate 1: blood culture on the first hospital day; isolate1’: pus from the abscess on the first hospital day; isolate 2: pus from the abscess on the sixth hospital day; isolate 3: blood culture on the 40th hospital day; isolate 4: pus from the abscess on the 55th hospital day. s: susceptible; ns: nonsusceptible.",NA,notes,
21192,daptomycin nonsusceptible,NA,drug resisted,
21192,"enright mc, day np, davies ce, peacock sj, spratt bg: multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of staphylococcus aureus. j clin microbiol 2000, 38(3):1008–1015.",NA,references for follow up,
21192,"we have herein reported the first case of daptomycin nonsusceptibility among clinical st72-mrsa-iv strains, which are rarely observed in countries other than korea.",NA,article/study aim,
21192,st72-mrsa-iv: sequence type 72 mrsa sccmec type iv,bacteria,strain,
21192,"to our knowledge, the present case is the first report of an st72-mrsa-iv strain with daptomycin nonsusceptibility and vancomycinintermediate resistance.",NA,notes,
21192,"to our knowledge, the present case is the first report of an st72-mrsa-iv strain with daptomycin nonsusceptibility and vancomycinintermediate resistance.",NA,article/study aim,
21192,45-year-old,patient,age,
21192,man,patient,sex,
21192,fever,patient,symptoms/disease,
21347,neisseria gonorrhoeae,bacteria,binomial (genus species),
21347,"ohnishi m, golparian d, shimuta k, saika t, hoshina s,  iwasaku k, et al. is neisseria gonorrhoeae initiating a future  era of untreatable gonorrhea? detailed characterization of  the first strain with high-level resistance to ceftriaxone.  antimicrob agents chemother. 2011;55(7):3538-45.",NA,references for follow up,
21347,"tapsall jw, ndowa f, lewis da, unemo m. meeting the  public health challenge of multidrugand extensively drugresistant neisseria gonorrhoeae. expert rev anti infect ther.  2009;7(7):821-34.",NA,references for follow up,
21347,july 2011,NA,event date,
21347,july,NA,event month,
21347,2011,NA,event year,
21347,austria,location,country,
21347,urethritis,patient,symptoms/disease,
21347,chlamydia trachomatis,patient,comorbidities,
21347,st1901,bacteria,strain,
21347,st1407,bacteria,strain,
21347,we describe the first cefixime-resistant neisseria gonorrhoeae strain in austria that caused treatment failure.,NA,article/study aim,
21347,cefixime,NA,drug resisted,a
21347,(>0.12  mg/l,NA,mic,a
21347,ceftriaxone,NA,drug resisted,b
21347,(>0.12 mg/l),NA,mic,b
21347,ciprofloxacin,NA,drug resisted,c
21347,(>32 mg/l,NA,mic,c
21347,based on the breakpoints stated by the  european committee on antimicrobial susceptibility  testing (eucast) [9].,NA,notes,
21347,"we report here the first neisseria gonorrhoeae strain  with resistance to cefixime in austria, which caused a  treatment failure with cefixime.",NA,article/study aim,
21347,pena mosaic xxxiv allele,bacteria,resistance marker,
21347,a single additional amino acid alteration (t534a)  in the gene for penicillin binding protein 2,bacteria,resistance marker,
21347,mtrr,bacteria,resistance marker,
21347,penb,bacteria,resistance marker,
21347,"transformation experiments, performed as previously described [7,12], confirmed that  the only new resistance determinant, i.e. the novel  pena mosaic allele (pena mosaic xxxiv allele with an  additional t534a alteration), was responsible for the  resistance to escs.",NA,notes,
21347,"table characteristics of the first neisseria gonorrhoeae strain  with resistance to cefixime and causing treatment failure,  austria, 2011 mic  (mg/l) mlst ngmast pena  allele mtrr penb pona ix tx  1.0 0.5 st1901 st1407 mosaic (novel)a a-del in  promoterb g120k  a121nc l421pd ix: cefixime; mic: minimum inhibitory concentration (etest was  used and only whole mic dilutions are presented); mlst:  multilocus sequence typing; ng-mast: neisseria gonorrhoeae multiantigen sequence typing; pcr: polymerase chain reaction;  st: sequence type; tx: ceftriaxone. a mosaic allele encodes a mosaic penicillin binding protein 2  (pbp2), which causes decreased susceptibility to extendedspectrum cephalosporins. b characteristic single nucleotide (a) deletion in the  inverted repeat of the promoter region of mtrr that causes  overexpression of the mtrcde efflux pump, which results  in a further decreased susceptibility to extended-spectrum  cephalosporins. c alterations of amino acids 120 and 121 in the porin porb1b that  cause a decreased intake of extended-spectrum cephalosporins  and, accordingly, a further decreased susceptibility to extendedspectrum cephalosporins . d alteration of amino acid 421 in the penicillin-binding protein 1  (pbp1), which results in decreased susceptibility to penicillins.",NA,notes,
21347,"we report here the first n.  gonorrhoeae strain with  resistance to cefixime in austria, which caused a treatment failure with the internationally recommended  first-line treatment cefixime.",NA,notes,
21347,two cases of clinical failures with cefixime standard treatment were described  in 2010 in norway [4],NA,references for follow up,
21347,germany,location,place traveled to,
21347,"three cases in 2011 in the united kingdom [5,6]",NA,references for follow up,
21347,"first gonococcal strain with high-level  clinical resistance to ceftriaxone (the last remaining  option for empirical first-line treatment), i.e. the first  extensively drug-resistant gonococcus [1], was recently  found in japan [7].",NA,references for follow up,
21347,"unemo m, golparian d, syversen g, vestrheim df, moi h.  two cases of verified clinical failures using internationally  recommended first-line cefixime for gonorrhoea treatment,  norway, 2010. euro surveill. 2010;15(47):pii=19721. available  from: http://www.eurosurveillance.org/viewarticle. aspx?articleid=19721",NA,references for follow up,
21347,"ison ca, hussey j, sankar kn, evans j, alexander s.  gonorrhoea treatment failures to cefixime and azithromycin  in england, 2010. euro surveill. 2011;16(14):pii:19833.  available from: http://www.eurosurveillance.org/viewarticle. aspx?articleid=19833",NA,references for follow up,
21347,"forsyth s, penney p, rooney g. cefixime-resistant neisseria  gonorrhoeae in the uk: a time to reflect on practice and  recommendations. int j std aids. 2011;22(5):296-7.",NA,references for follow up,
21348,his report describes the first two cases outside japan  of verified treatment failures of gonorrhoea using internationally recommended first-line treatment cefixime.,NA,article/study aim,
21348,neisseria gonorrhoeae,bacteria,binomial (genus species),
21348,st1407,bacteria,strain,
21348,norway,location,country,
21348,norway,patient,country of residence,
21348,man,patient,sex,
21348,30s,patient,age,
21348,urulent urethral  discharge,patient,symptoms/disease,
21348,dysuria,patient,symptoms/disease,
21348,2010,NA,event year,
21348,symptoms had resolved,patient,comorbidities,
21348,case 1,NA,notes,
21348,july,NA,event month,
21348,cefixime,NA,drug resisted,a
21348,ciprofloxacin,NA,drug resisted,b
21348,0.5 mg/l,NA,mic,a
21348,>32 mg/l,NA,mic,b
21464,85,patient,age,
21464,the netherlands,location,country,
21464,veldhoven,location,city,
21464,man,patient,sex,
21464,scrotal swelling,patient,symptoms/disease,
21464,amoxicillin,NA,drug resisted,
21464,amoxicillin clavulanate,NA,drug resisted,
21464,ciprofloxacin,NA,drug resisted,
21464,actinobaculum schaalii,bacteria,binomial (genus species),
21464,trimethoprim,NA,drug resisted,
21479,"we describe the first case of treatment failure of gonorrhoea with a third generation cephalosporin, cefotaxime 1g intramuscularly, in the netherlands",NA,article/study aim,
21479,neisseria gonorrhoeae,bacteria,binomial (genus species),
21479,st1407,bacteria,strain,
21479,netherlands,location,country,
21479,amsterdam,location,city,
21479,28-year-old,patient,age,
21479,man,patient,sex,
21479,urethral discharge,patient,symptoms/disease,
21479,dysuria,patient,symptoms/disease,
21479,november,NA,event month,
21479,urethritis,patient,symptoms/disease,
21479,2012,NA,event year,
21479,cefotaxime,NA,drug resisted,a
21479,ciprofloxacin,NA,drug resisted,b
21479,0.25 mg/l,NA,mic,a
21479,32 mg/l,NA,mic,b
21726,this study represents the first report on the existence and prevalence of tdr strains in iran.,NA,first surveillance study (of a particular resistance) in countr,
21824,the aim of this study was to describe the molecular epidemiology and the mechanisms of resistance to β-lactams of emerging extensive-drug-resistant pseudomonas aeruginosa (xdrpa) in a tertiary-care university hospital over a three-year period.,NA,article/study aim,
21824,imipenem,NA,drug resisted,g
21824,meropenem,NA,drug resisted,h
21824,ciprofloxacin,NA,drug resisted,i
21824,gentamicin,NA,drug resisted,j
21824,tobramycin,NA,drug resisted,k
21824,amikacin,NA,drug resisted,l
21824,2003,NA,event year,
21824,"≥1,024",NA,mic,a
21824,"1,024",NA,mic,c
21824,mar,NA,event month,
21824,128,NA,mic,d
21824,64,NA,mic,e
21824,16,NA,mic,g
21824,32,NA,mic,h
21824,≥128,NA,mic,j
21824,icarcillin,NA,drug resisted,a
21824,seudomonas aeruginosa,bacteria,binomial (genus species),
21824,mic (mg/l),NA,notes,
21824,2845 (a),NA,notes,
21824,icarcillin/clavulanic acid,NA,drug resisted,b
21824,oxa-10,bacteria,resistance marker,
21824,france,location,country,
21824,besançon,location,city,
21824,besançon hospital,location,hospital name,
21824,iperacillin/tazobactam,NA,drug resisted,c
21824,aztreonam,NA,drug resisted,d
21824,ceftazidime,NA,drug resisted,e
21824,cefepime,NA,drug resisted,f
21838,"our case is  the fi rst to be reported in a patient from the united states, with recurrence after initial treatment, and with acquired  antibiotic resistance.",NA,article/study aim,
21838,charleston,location,city,
21838,42 year-old,patient,age,
21838,woman,patient,sex,
21838,end-stage renal disease,patient,comorbidities,
21838,diabetic glomerulosclerosis,patient,comorbidities,
21838,diffuse abdominal pain,patient,symptoms/disease,
21838,cloudy pd  fl uid,patient,symptoms/disease,
21838,2008,NA,event year,
21838,august,NA,event month,
21838,11,NA,event day,
21838,"august 11, 2008",NA,event date,
21838,aztreonam,NA,drug resisted,
21838,shewanella putrefaciens,bacteria,binomial (genus species),
21838,united states,location,country,
21838,south carolina,location,state/province/district,
22121,73,patient,age,
22121,man,patient,sex,
22121,s. maltophilia,bacteria,binomial (genus species),
22121,61,patient,age,
22121,male,patient,sex,
22121,tmp/sxt,NA,drug resisted,
22167,51,patient,age,
22167,piperacillin,NA,drug resisted,
22167,cefazolin,NA,drug resisted,
22167,cefuroxime,NA,drug resisted,
22167,ceftriaxone,NA,drug resisted,
22167,ciprofloxacin,NA,drug resisted,
22167,levofloxacin,NA,drug resisted,
22167,male,patient,sex,
22167,watery diarrhea,patient,symptoms/disease,
22167,liver dysfunction,patient,symptoms/disease,
22167,beijing,location,city,
22167,china,location,country,
22167,public hospital,location,hospital name,
22167,s. boydii,bacteria,binomial (genus species),
22167,strain 2246,bacteria,strain,
22199,2013,NA,event year,
22199,st107,bacteria,strain,
22199,klebsiella pneumoniae,bacteria,binomial (genus species),
22199,ndm-9,bacteria,resistance marker,
22199,china,location,country,
22199,beijing,location,city,
22199,acute lymphocytic leukaemia,patient,comorbidities,
22199,april,NA,event month,
22199,imipenem,NA,drug resisted,a
22199,meropenem,NA,drug resisted,b
22437,september,NA,event month,
22437,cefotaxime,NA,drug resisted,b
22437,≥ 64,NA,mic,b
22437,ceftriaxone,NA,drug resisted,c
22437,≥ 64,NA,mic,c
22437,cefixime,NA,drug resisted,d
22437,2010,NA,event year,
22437,2,NA,mic,d
22437,died,patient,outcome,
22437,dron hospita,location,hospital name,
22437,tourcoing,location,city,
22437,france,location,state/province/district,
22437,59,patient,age,
22437,his,patient,sex,
22437,escherichia coli,bacteria,binomial (genus species),
22437,cefalotin,NA,drug resisted,a
22437,≥ 64,NA,mic,a
22668,"importantly, for the first time, 12 (2%) s. typhimurium isolates resistant to both ciprofloxacin and ceftriaxone were recovered; among these 12 isolates, two were also resistant to azithromycin, and one was resistant to all other drugs tested.",NA,notes,
22668,34,bacteria,strain,
22668,salmonella enterica,bacteria,binomial (genus species),
22668,china,location,country,
22668,st241,NA,notes,
22668,nalidixic acid,NA,drug resisted,
22668,chloramphenicol,NA,drug resisted,
22668,gentamicin,NA,drug resisted,
22668,sulfamethoxazole,NA,drug resisted,
22668,kanamycin,NA,drug resisted,
22668,trimethoprim,NA,drug resisted,
22668,tetracycline,NA,drug resisted,
22668,ctx-m-14,bacteria,resistance marker,
22703,we describe here 3 highly immunocompromised patients who received a subcurative course of azithromycin-atovaquone associated with the eventual development of resistance to this drug regimen,NA,article/study aim,
22703,man,patient,sex,
22703,granulocytopenia (200 neutrophils/ml),patient,symptoms/disease,
22703,level of parasitemia was 3%,patient,symptoms/disease,
22703,persistent fever,patient,symptoms/disease,
22703,"7 months after antibabesia therapy was discontinued, our patient felt completely well",patient,outcome,
22703,2008,NA,event year,
22703,march,NA,event month,
22703,7,NA,event day,
22703,7–20 march 2008,NA,event date,
22703,azithromycin-atovaquone,NA,drug resisted,
22703,babesia microti,bacteria,binomial (genus species),
22703,new york,location,state/province/district,
22703,63-year-old,patient,age,
2302,"we report the first description of the metallo--lactamase vim-31, a new variant of vim-2 with tyr224his and his252arg mutations, in enterobacter cloacae 11236",NA,article/study aim,
2302,256,NA,mic,a
2302,192,NA,mic,c
2302,96,NA,mic,d
2302,24,NA,mic,e
2302,6,NA,mic,f
2302,mica (g/ml),NA,notes,
2302,2011,NA,event year,
2302,enterobacter cloacae,bacteria,binomial (genus species),
2302,vim-31,bacteria,resistance marker,
2302,june,NA,event month,
2302,belgium,location,country,
2302,brussels,location,city,
2302,elderly,patient,age,
2302,ticarcillin,NA,drug resisted,a
2302,ticarcillin-clavulanate,NA,drug resisted,b
2302,temocillin,NA,drug resisted,c
2302,piperacillin,NA,drug resisted,d
2302,piperacillin-tazobactam,NA,drug resisted,e
2302,ertapenem,NA,drug resisted,f
2303,2010,NA,event year,
2303,meropenem,NA,drug resisted,h
2303,doripenem,NA,drug resisted,i
2303,ertapenem,NA,drug resisted,j
2303,128,NA,mic,a
2303,16,NA,mic,d
2303,64,NA,mic,e
2303,32,NA,mic,f
2303,may,NA,event month,
2303,ceftazidime,NA,drug resisted,a
2303,escherichia coli,bacteria,binomial (genus species),
2303,st101,bacteria,strain,
2303,ndm-1,bacteria,resistance marker,
2303,cefepime,NA,drug resisted,b
2303,ctx-m,bacteria,resistance marker,
2303,cmy-58,bacteria,resistance marker,
2303,tem-1,bacteria,resistance marker,
2303,belgium,location,country,
2303,brussels,location,city,
2303,pakistan,location,place traveled to,
2303,52-year-old,patient,age,
2303,he,patient,sex,
2303,died,patient,outcome,
2303,aztreonam,NA,drug resisted,c
2303,ertapenem,NA,drug resisted,d
2303,amikacin,NA,drug resisted,e
2303,levofloxacin,NA,drug resisted,f
2303,imipenem,NA,drug resisted,g
23039,68,patient,age,
23039,chest discomfort,patient,symptoms/disease,
23039,cough,patient,symptoms/disease,
23039,ciprofloxacin,NA,drug resisted,
23039,gentamicin,NA,drug resisted,
23039,piperacillin–tazobactam,NA,drug resisted,
23039,cefotaxime,NA,drug resisted,
23039,ceftriaxone,NA,drug resisted,
23039,ceftazidime,NA,drug resisted,
23039,cefepime,NA,drug resisted,
23039,cefoxitin,NA,drug resisted,
23039,man,patient,sex,
23039,aztreonam,NA,drug resisted,
23039,gn07160,bacteria,strain,
23039,a. caviae,bacteria,binomial (genus species),
23039,anhui medical university hospital,location,hospital name,
23039,china,location,country,
23039,29,NA,event day,
23039,october,NA,event month,
23039,2007,NA,event year,
23039,fever,patient,symptoms/disease,
23039,dyspnoea,patient,symptoms/disease,
23107,"herein, we report on the genetic and biochemical characterization of a new subgroup of mbl, designated ndm-1, originating from new delhi, india.",NA,article/study aim,
23107,cefotaxime,NA,drug resisted,e
23107,cefuroxime,NA,drug resisted,f
23107,ceftazidime,NA,drug resisted,g
23107,aztreonam,NA,drug resisted,h
23107,cefepime,NA,drug resisted,i
23107,ertapenem,NA,drug resisted,j
23107,imipenem,NA,drug resisted,k
23107,meropenem,NA,drug resisted,l
23107,ciprofloxacin,NA,drug resisted,m
23107,256,NA,mic,a
23107,2008,NA,event year,
23107,32,NA,mic,j
23107,mic (g/ml),NA,notes,
23107,january,NA,event month,
23107,9,NA,event day,
23107,klebsiella pneumonia,bacteria,binomial (genus species),
23107,ndm-1,bacteria,resistance marker,
23107,9 january 2008,NA,event date,
23107,sweden,location,country,
23107,o¨ rebro,location,city,
23107,india,location,place traveled to,
23107,59-year-old,patient,age,
23107,male,patient,sex,
23107,sweden,patient,country of residence,
23107,decubital ulcer,patient,symptoms/disease,
23107,discharged,patient,outcome,
23107,type 2 diabetes mellitus,patient,comorbidities,
23107,multiple strokes,patient,comorbidities,
23107,ampicillin,NA,drug resisted,a
23107,large gluteal abscess,patient,symptoms/disease,
23107,piperacillin,NA,drug resisted,b
23107,cephalothin,NA,drug resisted,c
23107,cefoxitin,NA,drug resisted,d
23248,the first variant of ndm-1 – ndm-2 – was detected in acinetobacter baumannii from egypt.2,NA,references for follow up,
23248,ciprofloxacin,NA,drug resisted,e
23248,amikacin,NA,drug resisted,f
23248,gentamicin,NA,drug resisted,g
23248,imipenem,NA,drug resisted,h
23248,cefotaxime,NA,drug resisted,i
23248,64,NA,mic,a
23248,256,NA,mic,b
23248,32,NA,mic,e
23248,"2. kaase m, nordmann p, wichelhaus ta, gatermann sg, bonnin ra, poirel l. ndm2 carbapenemase in acinetobacter baumannii from egypt. j antimicrob chemother 2011;66:1260–2",NA,references for follow up,
23248,this work reports the occurrence of new delhi metallo-beta-lactamase 1 (ndm-1) in metallo-betalactamase-producing pseudomonas aeruginosa in egypt for the first time,NA,article/study aim,
23248,pseudomonas aeruginosa,bacteria,binomial (genus species),
23248,ndm-1,bacteria,resistance marker,
23248,vim-2,bacteria,resistance marker,
23248,egypt,location,country,
23248,march,NA,event month,
23248,cairo,location,city,
23248,kasr al aini hospita,location,hospital name,
23248,23 years old,patient,age,
23248,man,patient,sex,
23248,st233,bacteria,strain,
23248,2012,NA,event year,
23248,cefepime,NA,drug resisted,a
23248,piperacillin/tazobactam,NA,drug resisted,b
23248,ceftazidime,NA,drug resisted,c
23248,ceftazidime/clavulanic acid,NA,drug resisted,d
23251,2009,NA,event year,
23251,brazil,location,country,
23251,maringa´,location,city,
23251,parana´,location,state/province/district,
23251,blactx-m,bacteria,resistance marker,
23251,ctx-m-15,bacteria,strain,
23251,november,NA,event month,
23251,november 2009,NA,event date,
23251,imipenem,NA,drug resisted,
23251,meropenem,NA,drug resisted,
23251,cefepime,NA,drug resisted,
23251,ceftazidime,NA,drug resisted,
23251,ceftriaxone,NA,drug resisted,
23251,acinetobacter baumannii,bacteria,binomial (genus species),
23314,30-,patient,age,
23314,india|pakistan,location,place traveled to,
23314,k. pneumoniae,bacteria,binomial (genus species),
23314,ndm-1 strain,bacteria,strain,
23314,14,patient,age,
23314,boy,patient,sex,
23314,kosovo,patient,country of residence,
23314,university hospital,location,hospital name,
23314,austria,location,country,
23314,graz,location,city,
23314,pristina,location,city,
23314,man,patient,sex,
23314,april,NA,event month,
23314,2010,NA,event year,
23314,university hospita,location,hospital name,
23314,austria,patient,country of residence,
23314,november,NA,event month,
23314,2009,NA,event year,
23408,case report ,NA,article/study aim,
23408,progressive red swollen on the  central flexure of the right thigh and recently developed  ulcer,patient,symptoms/disease,
23408,he had fever for 40 days prior to admission,patient,symptoms/disease,
23408,chronic rhinitis,patient,comorbidities,
23408,"he (as a leader of a labor union) and  his colleagues went to the outskirts of jiaozhou, shandong  province to plant trees for about two weeks (the exact date  was unclear) in april 2009.",location,place traveled to,
23408,red swollen area in horsebean-size on the flexure  central part of his right thigh and it was getting larger and  larger although the surface of skin was intact.,patient,symptoms/disease,
23408,a painless  bump with unclear boundary and elasticity in texture began  to appear in size of a chicken egg.,patient,symptoms/disease,
23408,penicillin,NA,drug resisted,
23408,levofloxacin,NA,drug resisted,
23408,sodium  cefoperazone,NA,drug resisted,
23408,sulbactam,NA,drug resisted,
23408,2009,NA,event year,
23408,cefuroxime,NA,drug resisted,
23408,ornidazole,NA,drug resisted,
23408,cefepime,NA,drug resisted,
23408,sodium imipenem/cliastatin,NA,drug resisted,
23408,rhodoplanes sp.,bacteria,binomial (genus species),
23408,zlj-0,bacteria,strain,
23408,sep.,NA,event month,
23408,13,NA,event day,
23408,"sep. 13, 2009",NA,event date,
23408,first affiliated hospital of peking university,location,hospital name,
23408,china,location,country,
23408,49-year-old,patient,age,
23408,male,patient,sex,
23491,an s. maltophilia strain named wj66 was isolated from a patient; wj66 showed resistance to more antibiotics than the other s. maltophilia strains.,NA,notes,
23491,-tazobactam (256,NA,drug resisted,j
23491,>64–32 ����g/,NA,mic,a
23491,(>256–4 ����,NA,mic,b
23491,ne (>32 ��,NA,mic,c
23491,ole (32–608,NA,mic,d
23491,oxacin (>1,NA,mic,e
23491,loxacin (,NA,mic,f
23491,polymyx,NA,mic,g
23491,and amikaci,NA,mic,h
23491,n (64 ���,NA,mic,i
23491,ampicillin-sulbactam,NA,drug resisted,a
23491,4 ����g/m,NA,mic,j
23491,", piperacillin-tazobact",NA,drug resisted,b
23491,"/ml), trimethoprim-sulfametho",NA,drug resisted,d
23491,stenotrophomonas maltophilia,bacteria,binomial (genus species),
23491,st31,bacteria,strain,
23491,china,location,country,
23491,male,patient,sex,
23491,diabetic nephropathy,patient,comorbidities,
23491,chronic renal insufficiency,patient,comorbidities,
23491,uraemia,patient,comorbidities,
23491,renal anaemia,patient,comorbidities,
23491,hypertension,patient,comorbidities,
23491,"�g/ml), cipro",NA,drug resisted,e
23491,lung infection,patient,comorbidities,
23491,cerebral infarction,patient,comorbidities,
23491,urinary tract infection,patient,comorbidities,
23491,hyperuricemia,patient,comorbidities,
23491,"���g/ml), le",NA,drug resisted,f
23491,����g/ml,NA,drug resisted,g
23491,���g/ml),NA,drug resisted,h
23491,nt to amik,NA,drug resisted,i
23549,"to our knowledge, the data presented in this paper is the first description of ndm-1 in a. junii.",NA,notes,
23549,imipenem,NA,drug resisted,h
23549,nitrofurantoin,NA,drug resisted,i
23549,>32,NA,mic,
23549,>64,NA,mic,
23549,>8,NA,mic,g
23549,>16,NA,mic,h
23549,128,NA,mic,i
23549,mic (µg/ml),NA,notes,
23549,"n the present study, we report the detection of ndm-1producing acinetobacter junii isolated from a 13-year-old chinese male with congenital heart disease",NA,article/study aim,
23549,ampicillin,NA,drug resisted,a
23549,acinetobacter junii,bacteria,binomial (genus species),
23549,ndm-1,bacteria,resistance marker,
23549,china,location,country,
23549,china,patient,country of residence,
23549,guangzhou,location,city,
23549,cefazolin,NA,drug resisted,b
23549,guangzhou women and children’s,location,hospital name,
23549,13-year-old,patient,age,
23549,male,patient,sex,
23549,discharged,patient,outcome,
23549,cefotetan,NA,drug resisted,c
23549,ceftazidime,NA,drug resisted,d
23549,ceftriaxone,NA,drug resisted,e
23549,cefepime,NA,drug resisted,f
23549,ertapenem,NA,drug resisted,g
23647,case report,NA,article/study aim,
23647,malaysia,location,country,
23647,kuala lumpur,location,city,
23647,kuala lumpur hospital,location,hospital name,
23647,28-year old,patient,age,
23647,woman,patient,sex,
23647,history of chronic renal failure,patient,comorbidities,
23647,acute pulmonary oedema with pneumonia,patient,symptoms/disease,
23647,the patient had a successful outcome following treatment with linezolid and there was no evidence of enterococcal bacteraemia in the repeat blood culture.,patient,outcome,
23647,the first case of hospital-acquired vre in malaysia was first described in 1996 from university malaya medical centre'.,NA,references for follow up,
23647,"2. riley pa, parasakthi n, teh a. enterococcus faecium with high level vancomycin resistance isolated from the blood culture of a bone marrow transplant patient in malaysia. medical journal of malaysia 1996; 51: 383-85",NA,references for follow up,
23647,ampicillin,NA,drug resisted,
23647,vancomycin,NA,drug resisted,a
23647,gentamicin,NA,drug resisted,
23647,s> 256 mg/l,NA,mic,a
23647,enterococcus faecium,bacteria,binomial (genus species),
23647,van a,bacteria,resistance marker,
2372,here we report a case of carbapenem resistance in a human clinical isolate that was found to be closely related to the newly described environmental species acinetobacter indicus.,NA,article/study aim,
2372,gentamicin,NA,drug resisted,
2372,tobramycin,NA,drug resisted,
2372,chloramphenicol,NA,drug resisted,
2372,fosfomycin,NA,drug resisted,
2372,nitrofurantoin,NA,drug resisted,
2372,acinetobacter indicus,bacteria,binomial (genus species),
2372,". of note, the definition of a. indicus species is so far based on a single strain, whichmakes the presentinterpretationrather difficult.",NA,notes,
2372,2011,NA,event year,
2372,oxa-23,bacteria,resistance marker,
2372,paris,location,city,
2372,france,location,country,
2372,he,patient,sex,
2372,head trauma,patient,comorbidities,
2372,meningeal haematoma,patient,comorbidities,
2372,head fracture,patient,comorbidities,
2372,febrile,patient,symptoms/disease,
2372,august,NA,event month,
2372,algeria,location,place traveled to,
2372,imipenem,NA,drug resisted,a
2372,ertapenem,NA,drug resisted,b
2372,>32,NA,mic,a
2372,>32,NA,mic,b
2389,"we report the first case in ireland of an imi-1 carbapenemase-producing enterobacter asburiae, which was  resistant to both colistin and fosfomycin.",NA,article/study aim,
2389,fosfomycin,NA,drug resisted,g
2389,colistin,NA,drug resisted,h
2389,> 64,NA,mic,a
2389,64,NA,mic,b
2389,16,NA,mic,d
2389,> 32,NA,mic,h
2389,2013,NA,event year,
2389,march,NA,event month,
2389,enterobacter asburiae,bacteria,binomial (genus species),
2389,imi-1,bacteria,resistance marker,
2389,ireland,location,country,
2389,limerick,location,city,
2389,mid-western regional hospital,location,hospital name,
2389,she,patient,sex,
2389,fractured ribs,patient,comorbidities,
2389,france|italy|iver  jordan in israel,location,place traveled to,
2389,ampicillin,NA,drug resisted,a
2389,uneventful recovery,patient,outcome,
2389,amoxicillin-clavulanate,NA,drug resisted,b
2389,cefoxitin,NA,drug resisted,b
2389,ertapenem,NA,drug resisted,d
2389,imipenem,NA,drug resisted,e
2389,meropenem,NA,drug resisted,f
2418,45,patient,age,
2418,gentamicin,NA,drug resisted,b
2418,vancomycin,NA,drug resisted,c
2418,rifampicin,NA,drug resisted,d
2418,>4,NA,mic,
2418,>8,NA,mic,
2418,>2,NA,mic,d
2418,4,NA,mic,c
2418,man,patient,sex,
2418,staphylococcus aureus,bacteria,binomial (genus species),
2418,"the mrsa isolates showed susceptibility to daptomycin at the time of admission, with mics of ≤0.5 μg/ml, 0.5, and 0.125 μg/ml upon analysis by microscan, frozen plate, and etest®, respectively. over time, however, these mics increased to >1, 1.5, and 1.5 μg/ml, respectively, indicating daptomycin nonsusceptibility (table 2).",NA,notes,
2418,daptomycin,NA,drug resisted,e
2418,fever,patient,symptoms/disease,
2418,disturbance of consciousness,patient,symptoms/disease,
2418,previously been treated with vancomycin at 3 g/day (1 g intravenously [iv] three times a day [tid]) and rifampicin at 600 mg/day (300 mg orally [po] twice a day [bid]) for 2 days before being transferred to our hospital,NA,notes,
2418,anterior mediastinal abscess,patient,symptoms/disease,
2418,hemorrhagic cerebral infarction,patient,symptoms/disease,
2418,st72-mrsa-iv,bacteria,strain,
2418,st72,bacteria,strain,
2418,intractable infectious disease,patient,comorbidities,
2418,previous exposure,patient,comorbidities,
2418,treatment with insufficient doses,patient,comorbidities,
2418,prolonged use,patient,comorbidities,
2418,japan,location,country,
2418,"department of infection control and prevention, tokyo medical university hospital,",location,hospital name,
2418,tokyo,location,city,
2418,"we herein report the first case of vancomycin-intermediate, daptomycin-nonsusceptible st72-mrsa-iv",NA,article/study aim,
2418,sccmec type iv,bacteria,strain,
2418,vancomycin-intermediate,NA,drug resisted,
2418,daptomycin,NA,drug resisted,
2418,methicillin-,NA,drug resisted,
2418,oxacillin,NA,drug resisted,a
2419,we report an outbreak,NA,article/study aim,
2419,amikacin,NA,drug resisted,i
2419,gentamicin,NA,drug resisted,j
2419,tobramycin,NA,drug resisted,k
2419,nalidixic acid,NA,drug resisted,l
2419,ciprofloxacin,NA,drug resisted,m
2419,levofloxacin,NA,drug resisted,n
2419,tetracycline,NA,drug resisted,o
2419,tigecycline,NA,drug resisted,p
2419,colistin,NA,drug resisted,q
2419,co-trimoxazole,NA,drug resisted,r
2419,ampicillin,NA,drug resisted,a
2419,≥256,NA,mic,a
2419,≥256,NA,mic,b
2419,≥256,NA,mic,c
2419,≥256,NA,mic,d
2419,≥256,NA,mic,e
2419,≥32,NA,mic,f
2419,≥32,NA,mic,g
2419,≥32,NA,mic,h
2419,≥256,NA,mic,i
2419,≥256,NA,mic,j
2419,cefoxitin,NA,drug resisted,b
2419,≥256,NA,mic,k
2419,≥256,NA,mic,l
2419,12,NA,mic,m
2419,8,NA,mic,
2419,4,NA,mic,
2419,1,NA,mic,p
2419,≥32,NA,mic,r
2419,ceftazidime,NA,drug resisted,c
2419,"mic, mg/l",NA,notes,
2419,cefotaxime,NA,drug resisted,d
2419,cefepime,NA,drug resisted,e
2419,ertapenem,NA,drug resisted,f
2419,klebsiella pneumoniae,bacteria,binomial (genus species),
2419,st231,bacteria,strain,
2419,ndm-1,bacteria,resistance marker,
2419,canada,location,country,
2419,ontario,location,state/province/district,
2419,brampton,location,city,
2419,meropenem,NA,drug resisted,g
2419,brampton civic hospital campus (bch),location,hospital name,
2419,73-year-old,patient,age,
2419,man,patient,sex,
2419,9 september 2011,NA,event date,
2419,2011,NA,event year,
2419,september,NA,event month,
2419,9,NA,event day,
2419,patient a,NA,notes,
2419,imipenem,NA,drug resisted,h
2487,klebsiella pneumoniae,bacteria,binomial (genus species),
2487,carbapenems,NA,drug resisted,
2487,fluoroquinolones,NA,drug resisted,
2487,aminoglycosides,NA,drug resisted,
2487,trimethoprim/sulfamethoxazole,NA,drug resisted,
2487,>32 mg/l,NA,mic,
2487,imipenem,NA,drug resisted,
2487,ertapenem,NA,drug resisted,
2487,meropenem,NA,drug resisted,
2487,st14,bacteria,strain,
2487,first case of multidrug-resistant blandm-1and blaoxa-232-carrying klebsiella pneumoniae and its probable cross-transmission in a french hospita,NA,article/study aim,
2487,child,patient,age,
2487,blatem-1,bacteria,resistance marker,
2487,blaoxa-1,bacteria,resistance marker,
2487,arma,bacteria,resistance marker,
2487,he,patient,sex,
2487,blandm-1,bacteria,resistance marker,
2487,blaoxa-232,bacteria,resistance marker,
2487,trousseau hospital,location,hospital name,
2487,paris,location,city,
2487,france,location,country,
2487,-lactams,NA,drug resisted,
2512,evaluate the presence and prevalence of multidrug antibacterial resistance in helicobacter pylori in bulgaria from 2005 to 2008.,NA,article/study aim,
2512,mic; mg ml–1,NA,notes,
2512,helicobacter pylori,bacteria,binomial (genus species),
2512,amoxicillin,NA,drug resisted,a
2512,bulgaria,location,country,
2512,63,patient,age,
2512,m,patient,sex,
2512,duodenal ulcer,patient,symptoms,
2512,1,NA,notes,
2512,metronidazole,NA,drug resisted,b
2512,clarithromycin,NA,drug resisted,c
2512,tetracycline,NA,drug resisted,d
2512,1,NA,mic,a
2512,.32,NA,mic,b
2512,256,NA,mic,c
2512,64,NA,mic,d
261,62,patient,age,
261,india,location,place traveled to,
261,a. baumannii,bacteria,binomial (genus species),
261,ab01,bacteria,strain,
261,k. pneumoniae,bacteria,binomial (genus species),
261,(kp01),bacteria,strain,
261,e. coli,bacteria,binomial (genus species),
261,ec01,bacteria,strain,
261,kp02,bacteria,strain,
261,female,patient,sex,
261,canada,location,country,
261,canada,patient,country of residence,
261,alberta,location,state/province/district,
261,edmonton,location,city,
261,31,NA,event day,
261,march,NA,event month,
261,2012,NA,event year,
261,31 march 2012,NA,event date,
2628,this is the first instance that kpc producers have been identified in africa,NA,article/study aim,
2628,cefepime,NA,drug resisted,e
2628,piperacillin-tazobactam,NA,drug resisted,f
2628,amoxicillin-clavulanate,NA,drug resisted,g
2628,ciprofloxacin,NA,drug resisted,h
2628,amikacin,NA,drug resisted,i
2628,32,NA,mic,a
2628,256,NA,mic,d
2628,8,NA,mic,h
2628,mic (g/ml),NA,notes,
2628,2011,NA,event year,
2628,september,NA,event month,
2628,klebsiella pneumoniae,bacteria,binomial (genus species),
2628,ndm-1,bacteria,resistance marker,
2628,kpc-2,bacteria,resistance marker,
2628,5,NA,event day,
2628,south africa,location,country,
2628,johannesburg,location,city,
2628,86-year-old,patient,age,
2628,male,patient,sex,
2628,diabetes mellitus,patient,comorbidities,
2628,ypertension,patient,comorbidities,
2628,chronic renal failure,patient,comorbidities,
2628,delirious,patient,symptoms/disease,
2628,fever,patient,symptoms/disease,
2628,right hip fracture,patient,comorbidities,
2628,5 september 2011,NA,event date,
2628,right-sided pleural effusion,patient,comorbidities,
2628,ertapenem,NA,drug resisted,a
2628,imipenem,NA,drug resisted,b
2628,meropenem,NA,drug resisted,c
2628,ceftazidime,NA,drug resisted,d
267,this study was planned to characterise the molecular basis of resistance in a newly emergent clinical isolate of c. freundii that showed a resistant phenotype to a wide range of -lactams including cefepime and cefpirome.,NA,article/study aim,
267,ceftriaxone,NA,drug resisted,g
267,cefpodoxime,NA,drug resisted,h
267,cefepime,NA,drug resisted,i
267,cefpirome,NA,drug resisted,j
267,>512,NA,mic,
267,128/64,NA,mic,b
267,256,NA,mic,e
267,128,NA,mic,f
267,64,NA,mic,g
267,32,NA,mic,i
267,2006,NA,event year,
267,16,NA,mic,j
267,march,NA,event month,
267,ampicillin,NA,drug resisted,a
267,aztreonam,NA,drug resisted,
267,cefoperazone,NA,drug resisted,
267,cefalothin,NA,drug resisted,
267,nalidixic acid,NA,drug resisted,
267,ciprofloxacin,NA,drug resisted,
267,norfloxacin,NA,drug resisted,
267,streptomycin,NA,drug resisted,
267,trimethoprim/sulfamethoxazole,NA,drug resisted,
267,citrobacter freundii,bacteria,binomial (genus species),
267,amoxicillin/clavulanic acid,NA,drug resisted,b
267,cmy-37,bacteria,resistance marker,
267,4306,bacteria,strain,
267,palestine,location,country,
267,urinary tract infection (uti),patient,symptoms/disease,
267,cefoxitin,NA,drug resisted,c
267,cefotetan,NA,drug resisted,d
267,ceftazidime,NA,drug resisted,e
267,cefotaxime,NA,drug resisted,f
2697,this is the first report of mrsa from this region of jamaica.,NA,first surveillance study (of a particular resistance) in countr,
2791,oxacillin,NA,drug resisted,
2791,coronary atherosclerotic disease,patient,comorbidities,
2791,ischemic cardiomyopathy,patient,comorbidities,
2791,penicillin,NA,drug resisted,a
2791,1 to 2 g/ml,NA,mic,a
2791,georgia,location,state/province/district,
2791,usab,location,country,
2791,atlanta,location,city,
2791,staphylococcus aureus,bacteria,binomial (genus species),
2791,81,patient,age,
2791,man,patient,sex,
2791,aicd,patient,comorbidities,
2791,fever,patient,symptoms/disease,
2791,chills,patient,symptoms/disease,
2791,diabetes mellitus,patient,comorbidities,
2791,deep vein thrombosis,patient,comorbidities,
281,20,patient,age,
281,female,patient,sex,
281,fever,patient,symptoms/disease,
281,rhinorrhea,patient,symptoms/disease,
281,sputum,patient,symptoms/disease,
281,myalgia,patient,symptoms/disease,
281,korea,location,country,
281,neisseria meningitidis,bacteria,binomial (genus species),
2863,"in conclusion, this study represents the first report of clonal dissemination of methicillin-resistant coagulase-negative staphylococcus clone on a large geographical scale",NA,first surveillance study (of a particular resistance) in countr,
2889,we present the first report in our country of a macrolideresistant m. pneumoniae (mr mpn) strain with a point mutation in its 23s rrna isolated from an adult patient with cap,NA,article/study aim,
2889,mycoplasma pneumoniae,bacteria,binomial (genus species),
2889,spain,location,country,
2889,madrid,location,city,
2889,hospital universitario ramón y cajal,location,hospital name,
2889,china|korea,location,place traveled to,
2889,china,patient,country of residence,
2889,23-year-old,patient,age,
2889,female,patient,sex,
2889,2012,NA,event year,
2889,fever,patient,symptoms/disease,
2889,respiratory symptoms,patient,symptoms/disease,
2889,"severe pneumonia,",patient,symptoms/disease,
2889,bilateral alveolar infiltrates,patient,symptoms/disease,
2889,"her clinical status markedly improved, and she was discharged on day 13 after admission",patient,outcome,
2889,september,NA,event month,
2889,erythromycin,NA,drug resisted,a
2889,azithromycin,NA,drug resisted,b
2889, 256 mg/liter,NA,mic,a
2963,2013,NA,event year,
2963,cloramphenicol,NA,drug resisted,f
2963,ertapenem,NA,drug resisted,g
2963,gentamicin,NA,drug resisted,h
2963,imipenem,NA,drug resisted,i
2963,meropenem,NA,drug resisted,j
2963,piperacillin/tazobactam,NA,drug resisted,k
2963,piperacillin,NA,drug resisted,l
2963,tetracyclin,NA,drug resisted,m
2963,tobramycin,NA,drug resisted,n
2963,trimethoprim/sulfamethoxazole,NA,drug resisted,o
2963,july,NA,event month,
2963,mic mg/l,NA,notes,
2963,>8/4,NA,mic,a
2963,>8,NA,mic,b
2963,>16,NA,mic,c
2963,>1,NA,mic,d
2963,>8,NA,mic,e
2963,>8,NA,mic,f
2963,>1,NA,mic,g
2963,>4,NA,mic,h
2963,>8,NA,mic,i
2963,18,NA,event day,
2963,>8,NA,mic,j
2963,>16,NA,mic,k
2963,>16,NA,mic,l
2963,>8,NA,mic,m
2963,>4,NA,mic,n
2963,>4/76,NA,mic,o
2963,18 july 2013,NA,event date,
2963,amoxicillin/clav,NA,drug resisted,a
2963,ampicillin,NA,drug resisted,b
2963,klebsiella oxytoca,bacteria,binomial (genus species),
2963,citrobacter koseri,bacteria,binomial (genus species),
2963,vim-4,bacteria,resistance marker,
2963,cmy-4,bacteria,resistance marker,
2963,cefotaxime,NA,drug resisted,c
2963,"although vim-type carbapenemases have already been described as widely spread in k.  pneumoniae in italian rehabilitation hospitals  (nucleo e. et al., 2013), to our knowledge this is  the first report on the detection of mdr k. oxytoca and c. koseri clinical isolates co-producing  vim-4 and cmy-4 enzymes in italy.",NA,notes,
2963,italy,location,country,
2963,pavia,location,city,
2963,i.r.c.c.s. fondazione s. maugeri in pavia,location,hospital name,
2963,62-year-old,patient,age,
2963,male,patient,sex,
2963,cardiac  complications,patient,symptoms/disease,
2963,septic shock,patient,symptoms/disease,
2963,pneumonia,patient,symptoms/disease,
2963,preputial edema,patient,symptoms/disease,
2963,cefpodoxime,NA,drug resisted,d
2963,ceftazidime,NA,drug resisted,e
3060,acinetobacter soli,bacteria,binomial (genus species),
3060,n4 μg/ml,NA,mic,a
3060,n16 μg/ml,NA,mic,b
3060,n8 μg/ml,NA,mic,c
3060,n4 μg/ml,NA,mic,d
3060,n16 μg/ml,NA,mic,e
3060,carbapenem,NA,drug resisted,
3060,strain a400,bacteria,strain,
3060,strain ccug59023,bacteria,strain,
3060,blandm,bacteria,resistance marker,
3060,blaoxa-58,bacteria,resistance marker,
3060,"our findings reinforce the importance of accurate epidemiological investigation of non-a. baumannii species, including a. soli.",NA,article/study aim,
3060,aminoglycosides,NA,drug resisted,
3060,"we describe a carbapenemresistant a. soli (kd12095) recovered from blood cultures of a 73-year-old female patient at the air force general hospital, pla.",NA,article/study aim,
3060,73-year,patient,age,
3060,female,patient,sex,
3060,"air force general hospital, pla",location,hospital name,
3060,septic shock,patient,symptoms,
3060,colon carcinoma,patient,comorbidities,
3060,first report of carbapenem-resistant acinetobacter soli isolates coharboring blandm-1 and blaoxa-58 genes from china,NA,article/study aim,
3060,2014,NA,event year,
3060,december,NA,event month,
3060,β-lactams,NA,drug resisted,
3060,doripenem,NA,drug resisted,a
3060,meropenem,NA,drug resisted,b
3060,imipenem,NA,drug resisted,c
3060,etapenem,NA,drug resisted,d
3060,aztreonam(,NA,drug resisted,e
3095,may,NA,event month,
3095,aztreonam,NA,drug resisted,b
3095,=16,NA,mic,b
3095,cefepime,NA,drug resisted,c
3095,>8,NA,mic,c
3095,ceftazidime,NA,drug resisted,d
3095,2013,NA,event year,
3095,>8,NA,mic,d
3095,ciprofloxacin,NA,drug resisted,e
3095,>1,NA,mic,e
3095,gentamicin,NA,drug resisted,f
3095,man,patient,sex,
3095,imipenem,NA,drug resisted,g
3095,>8,NA,mic,g
3095,levofloxacin,NA,drug resisted,h
3095,>2,NA,mic,h
3095,meropenem,NA,drug resisted,i
3095,rome,location,country,
3095,>8,NA,mic,i
3095,piperacillin,NA,drug resisted,j
3095,>16,NA,mic,j
3095,italy,location,country,
3095,febrile,patient,symptoms/disease,
3095,amikacin,NA,drug resisted,a
3095,>16,NA,mic,a
3235,first descriptions of blakpc in raoultella spp. (r. planticola and r. ornithinolytica),NA,article/study aim,
3235,meropenem,NA,drug resisted,
3235,16,NA,mic,a
3235,16,NA,mic,b
3235,32,NA,mic,c
3235,64,NA,mic,d
3235,8,NA,mic,e
3235,mic (g/ml),NA,notes,
3235,2008,NA,event year,
3235,raoultella planticola,bacteria,binomial (genus species),
3235,may,NA,event month,
3235,kpc,bacteria,resistance marker,
3235,united states,location,country,
3235,ohio,location,city,
3235,pneumonia,patient,symptoms/disease,
3235,died,patient,outcome,
3235,aztreonam,NA,drug resisted,a
3235,ceftazidime,NA,drug resisted,b
3235,ceftriaxone,NA,drug resisted,c
3235,piperacillin/tazobactam,NA,drug resisted,d
3235,ertapenem,NA,drug resisted,e
3235,imipenem,NA,drug resisted,f
3374,vancomycin,NA,drug resisted,
3374,2008,NA,event year,
3374,did not survive,patient,outcome,
3374,staphylococcus aureus,bacteria,binomial (genus species),
3374,61,patient,age,
3374,woman,patient,sex,
3374,type 2 diabetes,patient,comorbidities,
3374,hypertension,patient,comorbidities,
3374,hyperlipidemia,patient,comorbidities,
3374,end-stage renal disease,patient,comorbidities,
3374,may,NA,event month,
345,63,patient,age,
345,ceftazidime,NA,drug resisted,
345,ciprofloxacin,NA,drug resisted,
345,carbapenems,NA,drug resisted,
345,128 g/ml,NA,mic,a
345,128 g/ml,NA,mic,b
345,cefepime,NA,drug resisted,b
345,male,patient,sex,
345,aztreonam,NA,drug resisted,c
345,128 g/ml,NA,mic,c
345,piperacillin-tazobactam,NA,drug resisted,d
345,256 and 4 g/ml,NA,mic,d
345,8 g/ml,NA,mic,e
345,mount hope,location,city,
345,pseudomonas aeruginosa,bacteria,binomial (genus species),
345,trinidad and tobago,location,country,
345,hematuria,patient,symptoms/disease,
345,dysuria,patient,symptoms/disease,
345,fever,patient,symptoms/disease,
345,chills,patient,symptoms/disease,
345,gentamicin,NA,drug resisted,
3461,klebsiella pneumoniae,bacteria,binomial (genus species),
3461,4,NA,mic,b
3461,levofloxacin,NA,drug resisted,c
3461,≥ 8,NA,mic,c
3461,94,patient,age,
3461,female,patient,sex,
3461,chronic lymphocytic leukemia,patient,comorbidities,
3461,cough with sputum,patient,symptoms/disease,
3461,mato grosso do sul,location,state/province/district,
3461,hoarseness,patient,symptoms/disease,
3461,sibilance,patient,symptoms/disease,
3461,dyspnea,patient,symptoms/disease,
3461,fever,patient,symptoms/disease,
3461,died,patient,outcome,
3461,brazil,location,country,
3461,ceftazidime,NA,drug resisted,a
3461,≥ 64,NA,mic,a
3461,ciprofloxacin,NA,drug resisted,b
3471,22,patient,age,
3471,woman,patient,sex,
3471,neck pain,patient,symptoms/disease,
3471,sore throat,patient,symptoms/disease,
3471,cough,patient,symptoms/disease,
3471,confusion,patient,symptoms/disease,
3471,staphylococcus aureus,bacteria,binomial (genus species),
3471,erythromycin,NA,drug resisted,
3471,oxacillin,NA,drug resisted,
3529,corynebacterium striatum,bacteria,binomial (genus species),
3529,hypoxemia,patient,symptoms,
3529,anemia,patient,symptoms,
3529,bilateral diffuse crackles,patient,symptoms,
3529,penicillin g,NA,drug resisted,
3529,ciprofloxacin,NA,drug resisted,
3529,moxifloxacin,NA,drug resisted,
3529,gentamicin,NA,drug resisted,
3529,clindamycin,NA,drug resisted,
3529,died,patient,outcome,
3529,76-year-old,patient,age,
3529,we present a case of sepsis due to multidrug-resistant corynebacterium striatum which responded neither to empiric nor to targeted treatment and finally succumbed.,NA,article/study aim,
3529,"c. striatum is often resistant to the most commonly used antibiotics such as beta-lactams and quinolones9,10 but no strain has been tested resistant to vancomycin and linezolid so far",NA,notes,
3529,male,patient,sex,
3529,fever,patient,symptoms,
3529,cough,patient,symptoms,
3529,myelodysplastic syndrome,patient,comorbidities,
3529,atopic dermatitis,patient,comorbidities,
3529,sinus tachycardia,patient,symptoms,
3529,hypotension,patient,symptoms,
3557,53,patient,age,
3557,male,patient,sex,
3557,congo,location,place traveled to,
3557,2011,NA,event year,
3557,died,patient,outcome,
3557,carbapenems,NA,drug resisted,
3596,guangzhou,location,city,
3596,tetracyclines,NA,drug resisted,
3596,china,location,country,
3596,klebsiella pneumoniae,bacteria,binomial (genus species),
3596,kp01,bacteria,strain,
3596,may,NA,event month,
3596,2010,NA,event year,
3596,chronic bronchitis,patient,symptoms,
3596,-lactams,NA,drug resisted,
3596,aminoglycosides,NA,drug resisted,
360,girl,patient,sex,
360,tobramycin,NA,drug resisted,b
360,netilmicin,NA,drug resisted,b
360,meropenem,NA,drug resisted,
360,>32 mg/l,NA,mic,d
360,ticarcillin,NA,drug resisted,
360,blandm,bacteria,resistance marker,d
360,blaoxa-24 like,bacteria,resistance marker,e
360,ticarcillin/clavulanate,NA,drug resisted,
360,acinetobacter pittii,bacteria,binomial (genus species),
360,"montealegre mc, maya jj, correa a, espinal p, mojica mf, ruiz sj, et al. first identification of oxa-72 carbapenemase from acinetobacter pittii in colombia. antimicrob agents chemother 2012;56: 3996–8",NA,references for follow up,
360,oxa-72-producing a. pittii was first described in colombia in 2012 from a catheter tip–positive culture of a patient who had ischaemic hepatitis and multiorgan failure [6].,NA,references for follow up,
360,carbapenem-resistant clinical isolates of a. pittii in france [7],NA,references for follow up,
360,"bonnin ra, docobo-pérez f, poirel l, villegas mv, nordmann p. emergence of oxa-72-producing acinetobacter pittii clinical isolates. int j antimicrob agents 2014;43:195–6",NA,references for follow up,
360,"this study was initiated by the isolation of two imipenemresistant a. pittii strains recovered in two hospitals in tripoli, north lebanon, in 2015.",NA,article/study aim,
360,lebanon,location,country,
360,tripoli,location,city,
360,north lebanon,location,state/province/district,
360,ceftazidime,NA,drug resisted,
360,cmul334,bacteria,strain,b
360,cmul332,bacteria,strain,a
3613,"peking university first hospital,",location,hospital name,
3613,abdominal pain,patient,symptoms,
3613,57,patient,age,
3613,woman,patient,sex,
3613,fever,patient,symptoms,
3613,vomiting,patient,symptoms,
3613,tenesmus,patient,symptoms,
3613,watery diarrhoea,patient,symptoms,
3613,abdominal pain.,patient,symptoms,
3613,45,patient,age,
3613,beijing,location,city,
3613,e mutations were not  found,patient,outcome,
3613,china,location,country,
3613,campylobacter,bacteria,binomial (genus species),
3613,3 cases of acute gastroenteritis caused by high-level macrolide-resistant campylobacter.,NA,article/study aim,
3613,65,patient,age,
3613,man,patient,sex,
3613,"watery diarrhoea,",patient,symptoms,
3622,2012,NA,event year,
3622,tobramycin ,NA,drug resisted,j
3622,amikacin,NA,drug resisted,k
3622,minocycline,NA,drug resisted,l
3622,doxycycline,NA,drug resisted,m
3622,colistin,NA,drug resisted,p
3622,polymyxin b,NA,drug resisted,q
3622,tigecycline,NA,drug resisted,r
3622,32 g/ml,NA,mic,a
3622,16 g/ml,NA,mic,b
3622,ticarcillin,NA,drug resisted,c
3622,april,NA,event month,
3622,clavulanate,NA,drug resisted,d
3622,trimethoprim,NA,drug resisted,n
3622,sulfamethoxazole,NA,drug resisted,o
3622,128,NA,mic,c
3622,2 g/ml,NA,mic,d
3622,8 g/ml,NA,mic,e
3622,2 g/ml,NA,mic,f
3622,2 g/ml,NA,mic,g
3622,8 g/ml,NA,mic,h
3622,8 g/ml,NA,mic,i
3622,cefotaxime,NA,drug resisted,a
3622,8 g/ml,NA,mic,j
3622,32 g/ml,NA,mic,k
3622,16 g/ml,NA,mic,l
3622,16 g/ml,NA,mic,m
3622,4,NA,mic,n
3622,76 g/ml,NA,mic,o
3622,4g/ml,NA,mic,p
3622,4g/ml,NA,mic,q
3622,4 g/ml,NA,mic,r
3622,cefepime,NA,drug resisted,b
3622,imipenem,NA,drug resisted,e
3622,doripenem,NA,drug resisted,f
3622,ciprofloxacin,NA,drug resisted,g
3622,proteus mirabilis,bacteria,binomial (genus species),
3622,oxa-48,bacteria,resistance marker,
3622,palestine,location,country,
3622,gaza,location,state/province/district,
3622,al-shifa hospital,location,hospital name,
3622,levofloxacin,NA,drug resisted,h
3622,female,patient,sex,
3622,gentamicin,NA,drug resisted,i
3651,"this is the first nationwide study, performed within the china gonococcal antimicrobial susceptibility programme (china-gasp), regarding amr, including ceftriaxone genetic resistance determinants, and molecular epidemiology of gonococci in china.",NA,first surveillance study (of a particular resistance) in countr,
3722,81,patient,age,
3722,male,patient,sex,
3722,diabetes,patient,comorbidities,
3722,"coronary artery disease,",patient,comorbidities,
3722,hypertension,patient,comorbidities,
3722,dyslipidemia,patient,comorbidities,
3722,upper abdominal discomfort,patient,symptoms/disease,
3722,nausea,patient,symptoms/disease,
3722,vomiting,patient,symptoms/disease,
3799,4096 mg/l,NA,mic,
3799,cardiff,location,city,
3799,liverpool,location,city,
3799,"three female, two male",patient,sex,
3799,male,patient,sex,
3799,"mean age 26 years, range 21 –32 years",patient,age,
3799,19,patient,age,
3799,azithromycin,NA,drug resisted,
3799,"this study aimed to investigate the origin of high-level azithromycin resistance that emerged in isolates of neisseria gonorrhoeae in england and wales in 2007, and to establish methods for identifying high-level azithromycin resistance",NA,article/study aim,
3799,neisseria gonorrhoeae,bacteria,binomial (genus species),
3799,2007,NA,event year,
3872,2013,NA,event year,
3872,‡64,NA,mic,c
3872,‡4,NA,mic,d
3872,‡16,NA,mic,e
3872,‡320,NA,mic,f
3872,mic (mg/ml),NA,notes,
3872,we report the first cases of blandm-carrying pathogens in the philippines,NA,article/study aim,
3872,klebsiella pneumoniae,bacteria,binomial (genus species),
3872,st147,bacteria,strain,
3872,ctx-m-15,bacteria,resistance marker,
3872,amoxicillin/clavulanate,NA,drug resisted,a
3872,oxa-1,bacteria,resistance marker,
3872,shv-11,bacteria,resistance marker,
3872,tem-1b,bacteria,resistance marker,
3872,ndm-1,bacteria,resistance marker,
3872,philippines,location,country,
3872,st. luke’s medical center global city,location,hospital name,
3872,70-year-old,patient,age,
3872,woman,patient,sex,
3872,subarachnoid hemorrhage,patient,symptoms/disease,
3872,pneumonia,patient,symptoms/disease,
3872,ampicillin,NA,drug resisted,b
3872,discharged,patient,outcome,
3872,ceftriaxone,NA,drug resisted,c
3872,ciprofloxacin,NA,drug resisted,d
3872,gentamicin,NA,drug resisted,e
3872,trimethoprim/sulfamethoxazole,NA,drug resisted,f
3872,‡32,NA,mic,a
3882,ampicillin,NA,drug resisted,a
3882,ceftriaxone,NA,drug resisted,j
3882,cefurox,NA,drug resisted,
3882,cefpirome,NA,drug resisted,l
3882,chloramphenicol,NA,drug resisted,m
3882,nalidixic acid,NA,drug resisted,n
3882,tetracycline,NA,drug resisted,o
3882,>256,NA,mic,a
3882,32,NA,mic,d
3882,256,NA,mic,l
3882,16,NA,mic,n
3882,oxacillin,NA,drug resisted,b
3882,ticarcillin,NA,drug resisted,c
3882,ticarcillin + cla,NA,drug resisted,d
3882,benzylpenicillin,NA,drug resisted,e
3882,escherichia coli,bacteria,binomial (genus species),
3882,"these two mutations were encountered in tem-15 β-lactamase, but this is the first description of this enzyme in the e. coli species in tunisian hospitals.",NA,article/study aim,
3882,tem-15,bacteria,resistance marker,
3882,tunisia,location,country,
3882,cephalothin,NA,drug resisted,f
3882,cephaloridine,NA,drug resisted,g
3882,cefotaxime,NA,drug resisted,h
3882,ceftazidime,NA,drug resisted,i
3910,"for the first time, we describe macrolide resistance for m. genitalium in france and demonstrate that its detection has increased since 2006.",NA,first surveillance study (of a particular resistance) in countr,
404,his letter describes the first isolation of s. maltophilia resistant to tmp – sxt from two patients treated at riyadh armed forces hospita,NA,article/study aim,
404,> 8 uglml,NA,mic,b
404,> 4 ug/ml,NA,mic,e
404,gentamicin,NA,drug resisted,b
404,meropenem,NA,drug resisted,c
404,imipenem,NA,drug resisted,d
404,ciprofloxacin,NA,drug resisted,e
404,2005,NA,event year,
404,stenotrophomonas maltophilia,bacteria,binomial (genus species),
404,saudi arabia,location,country,
404,saudi arabia,patient,country of residence,
404,riyadh armed forces hospital,location,hospital name,
404,48 years old,patient,age,
404,female,patient,sex,
404,7,NA,event month,
404,chronic myeloid leukemia,patient,comorbidities,
404,febrile,patient,symptoms/disease,
404,eutropenic episodes,patient,symptoms/disease,
404,death,patient,outcome,
404,16,NA,event day,
404,16/7/2005,NA,event date,
404,rimethoprimsulfamethoxazole,NA,drug resisted,a
404,> 8/152 ug/ml,NA,mic,a
4167,"e describe the first case reported in the literature of infective endocarditis by penicillin-resistant s. constellatus causing both mitral and aortic valve regurgitation, treated successfully with double-valve replacement.",NA,article/study aim,
4167,penicillin,NA,drug resisted,
4167,treptococcus constellatus,bacteria,binomial (genus species),
4167,italy,location,country,
4167,massa,location,city,
4167,79-year old,patient,age,
4167,man,patient,sex,
4167,endocarditis,patient,symptoms/disease,
4167,discharge,patient,outcome,
4379,january,NA,event month,
4379,staphylococcus saprophyticus,bacteria,binomial (genus species),
4379,methicillin,NA,drug resisted,
4379,penicillin,NA,drug resisted,
4379,oxacillin,NA,drug resisted,
4379,cefoxitin,NA,drug resisted,
4379,trimethoprim,NA,drug resisted,
4379,co-trimoxazole,NA,drug resisted,
4379,erythromycin,NA,drug resisted,
4379,mupirocin,NA,drug resisted,
4379,fusidic acid,NA,drug resisted,
4379,2013,NA,event year,
4379,new zealand,location,country,
4379,20,patient,age,
4379,female,patient,sex,
4379,christchurch hospita,location,hospital name,
4379,right sided abdominal pain,patient,symptoms/disease,
4379,nausea,patient,symptoms/disease,
4379,pale stools,patient,symptoms/disease,
4379,poor appetite and dysuria,patient,symptoms/disease,
4471,95,patient,age,
4471,man,patient,sex,
4471,coronary artery disease,patient,comorbidities,
4471,gout,patient,comorbidities,
4489,"we report the first kpc-producing isolates characterized in madrid, spain",NA,article/study aim,
4489,tetracycline,NA,drug resisted,
4489,minocycline,NA,drug resisted,
4489,st38,bacteria,strain,
4489,klebsiella pneumoniae,bacteria,binomial (genus species),
4489,kpc-3,bacteria,resistance marker,
4489,spain,location,country,
4489,2009,NA,event year,
4489,madrid,location,city,
4489,ramo´n y cajal university hospital,location,hospital name,
4489,recovered,patient,outcome,
4489,patient,NA,notes,
4489,66,patient,age,
4489,m,patient,sex,
4489,september,NA,event month,
4489,imipenem,NA,drug resisted,a
4489,meropenem,NA,drug resisted,b
4489,aztreonam,NA,drug resisted,c
4519,"we report on the first detection of the ndm-1 carbapenemase in italy, in escherichia coli isolated in october 2009",NA,article/study aim,
4519,piperacillin,NA,drug resisted,g
4519,piperacillin-tazobactam,NA,drug resisted,h
4519,imipenem,NA,drug resisted,i
4519,meropenem,NA,drug resisted,j
4519,ertapenem,NA,drug resisted,k
4519,doripenem,NA,drug resisted,l
4519,levofloxacin,NA,drug resisted,m
4519,trimethoprim-sulfamethoxazole,NA,drug resisted,n
4519,256,NA,mic,a
4519,32,NA,mic,b
4519,2009,NA,event year,
4519,64,NA,mic,d
4519,128,NA,mic,g
4519,8,NA,mic,i
4519,12,NA,mic,l
4519,8,NA,mic,m
4519,320,NA,mic,n
4519,october,NA,event month,
4519,amikacin,NA,drug resisted,a
4519,amoxicillin-clavulanate,NA,drug resisted,b
4519,escherichia coli,bacteria,binomial (genus species),
4519,st405,bacteria,strain,
4519,ndm-1,bacteria,resistance marker,
4519,italy,location,country,
4519,modena university hospital,location,hospital name,
4519,modena,location,city,
4519,ampicillin,NA,drug resisted,c
4519,india,location,place traveled to,
4519,cefepime,NA,drug resisted,d
4519,cefotaxime,NA,drug resisted,e
4519,ceftazidime,NA,drug resisted,f
4578,"to our knowledge, this is the first study of multidrug-resistant tuberculosis (mdr-tb) trends over an extended period of time (2005–2013) in greater metropolitan mumbai",NA,first surveillance study (of a particular resistance) in countr,
4578,2005,NA,event year,
4578,"the aim of this study was to investigate the trends over time of patterns of drug resistance in a sample of mdr-tb patients in greater metropolitan mumbai, india",NA,article/study aim,
4581,case report,NA,article/study aim,
4581,nursing home resident,patient,occupation,
4581,ventilator-dependent end-stage chronic obstructive pulmonary disease,patient,comorbidities,
4581,atherosclerotic heart disease,patient,comorbidities,
4581,hypertension,patient,comorbidities,
4581,congestive heart failure,patient,comorbidities,
4581,fatigue,patient,symptoms,
4581,fever,patient,symptoms,
4581,murmur in mitral area,patient,symptoms,
4581,complete recovery,patient,outcome,
4581,vancomycin,NA,drug resisted,
4581,916,NA,mic,
4581,enterococcus raffinosus,bacteria,binomial (genus species),
4581,new york,location,state/province/district,
4581,new york,location,city,
4581,new york hospital queens,location,hospital name,
4581,84-year-old,patient,age,
4581,woman,patient,sex,
4641,this is the first report of a clinical isolate of k. pneumoniae producing an mbl in lebanon.,NA,article/study aim,
4641,cefpodoxime,NA,drug resisted,f
4641,aztreonam,NA,drug resisted,g
4641,ciprofloxacin,NA,drug resisted,h
4641,imipenem,NA,drug resisted,i
4641,piperacillin-tazobactam,NA,drug resisted,j
4641,cefepime,NA,drug resisted,m
4641,64 µg/ml,NA,mic,j
4641,>32,NA,mic,k
4641,2007,NA,event year,
4641,>4.0,NA,mic,l
4641,ceftazidime,NA,drug resisted,k
4641,clavulanic acid,NA,drug resisted,l
4641,128 µg/ml,NA,mic,m
4641,august,NA,event month,
4641,13,NA,event day,
4641,piperacillin,NA,drug resisted,a
4641,klebsiella pneumoniae,bacteria,binomial (genus species),
4641,ctx-m-15,bacteria,resistance marker,
4641,imp-1,bacteria,resistance marker,
4641,lebanon,location,country,
4641,beirut,location,city,
4641,saint joseph hospital-raymond and aida najjar polyclinic,location,hospital name,
4641,58 year old,patient,age,
4641,man,patient,sex,
4641,heavy smoker,patient,comorbidities,
4641,abdominal obstruction with septic presentation,patient,symptoms/disease,
4641,cefoxitin,NA,drug resisted,b
4641,cutaneous digestive fistula,patient,symptoms/disease,
4641,discharged,patient,outcome,
4641,ceftriaxone,NA,drug resisted,c
4641,cefotaxime,NA,drug resisted,d
4641,ceftazidime,NA,drug resisted,e
4642,"carbapenems, such as imp, are used more frequently for the treatment of multiresistant gram-negative nosocomial pathogens, especially strains that produce esbls. to our knowledge, resistance to these agents among enterobacteriaceae was not reported yet in our country",NA,notes,
4642,cefotaxime,NA,drug resisted,d
4642,ceftazidime,NA,drug resisted,e
4642,cefpodoxime,NA,drug resisted,f
4642,aztreonam,NA,drug resisted,g
4642,ciprofloxacin,NA,drug resisted,h
4642,imipenem,NA,drug resisted,i
4642,piperacillin-tazobactam,NA,drug resisted,j
4642,ceftazidime-clavulanic acid,NA,drug resisted,k
4642,cefepime,NA,drug resisted,l
4642,this is the first report of a clinical isolate of k. pneumoniae producing an mbl in lebanon.,NA,article/study aim,
4642,64 µg/ml,NA,mic,j
4642,>4.0,NA,mic,
4642,128 µg/ml,NA,mic,l
4642,2007,NA,event year,
4642,july,NA,event month,
4642,klebsiella pneumoniae,bacteria,binomial (genus species),
4642,blaimp-1,bacteria,resistance marker,
4642,17,NA,event day,
4642,blactx-m,bacteria,resistance marker,
4642,lebanon,location,country,
4642,beirut,location,city,
4642,saint joseph hospital-raymond and aida najjar polyclinic,location,hospital name,
4642,58 year-old,patient,age,
4642,man,patient,sex,
4642,abdominal obstruction with septic presentation,patient,symptoms/disease,
4642,cutaneous digestive fistula,patient,symptoms/disease,
4642,discharged,patient,outcome,
4642,"july 17, 2007",NA,event date,
4642,piperacillin,NA,drug resisted,a
4642,cefoxitin,NA,drug resisted,b
4642,ceftriaxone,NA,drug resisted,c
4776,50,patient,age,
4776,cefotaxime,NA,drug resisted,
4776,male,patient,sex,
4776,afebrile,patient,symptoms/disease,
4776,normotensive,patient,symptoms/disease,
4776,unsuccessful,patient,outcome,
4776,aeromonas spp,bacteria,binomial (genus species),
4776,ampicillin,NA,drug resisted,
4776,co-amoxiclav,NA,drug resisted,
4776,cephradine,NA,drug resisted,
5005,this report is the first case  of neonatal infection with this microorganism,NA,article/study aim,
5005,rimethoprim/sufamethoxazole,NA,drug resisted,i
5005,≥32,NA,mic,a
5005,≥4,NA,mic,c
5005,≥64,NA,mic,d
5005,≥16,NA,mic,h
5005,≥320,NA,mic,i
5005,ampicillin,NA,drug resisted,a
5005,amoxicillin/clavulanic acid,NA,drug resisted,b
5005,raoultella terrigena,bacteria,binomial (genus species),
5005,31 weeks of gestation,patient,age,
5005,turkey,location,country,
5005,sakarya,location,city,
5005,cefixime,NA,drug resisted,c
5005,ceftriaxone,NA,drug resisted,d
5005,cefuroxime,NA,drug resisted,e
5005,cefuroxime axetil,NA,drug resisted,f
5005,ceftazidime,NA,drug resisted,g
5005,gentamicin,NA,drug resisted,h
5091,this is the first case report of m. kansasii infection from serbia,NA,article/study aim,
5091,fever,patient,symptoms/disease,
5091,non-productive cough,patient,symptoms/disease,
5091,tachycardic,patient,symptoms/disease,
5091,eupneic,patient,symptoms/disease,
5091,full recovery,patient,outcome,
5091,isoniazid,NA,drug resisted,
5091,streptomycin,NA,drug resisted,
5091,mycobacterium kansasii,bacteria,binomial (genus species),
5091,serbia,location,country,
5091,belgrade,location,city,
5091,28-year old,patient,age,
5091,male,patient,sex,
5091,hiv-positive,patient,comorbidities,
5183,72,patient,age,
5183,corynebacterium macginleyi,bacteria,binomial (genus species),
5183,india,location,country,
5183,mangalore,location,city,
5183,man,patient,sex,
5183,carcinoma larynx,patient,comorbidities,
5183,ampicillin,NA,drug resisted,
5183,third generation cephalosporins,NA,drug resisted,
5183,amikacin,NA,drug resisted,
5183,tetracycline,NA,drug resisted,
5183,quinolones,NA,drug resisted,
5183,macrolides,NA,drug resisted,
5251,"resistance to expanded-spectrum beta-lactam antibiotics, such as ceftriaxone is increasing in salmonella isolates throughout the world [3–6, 10] . this report, the fi rst  documented in kuwait, adds to the growing list of extended-spectrum cephalosporin-resistant s. enterica serotype typhimurium isolates.",NA,notes,
5251,>256,NA,mic,a
5251,64,NA,mic,c
5251,to present the fi rst documented case of acute  infectious gastroenteritis caused by high-level ceftriaxone-resistant salmonella enterica serotype typhimurium in kuwait,NA,article/study aim,
5251,kuwait,location,country,
5251,al-sabah hospital,location,hospital name,
5251,10-month-old,patient,age,
5251,girl,patient,sex,
5251,bedouin,patient,country of residence,
5251,diarrhea,patient,symptoms/disease,
5251,upper respiratory tract infection,patient,symptoms/disease,
5251,afebrile,patient,symptoms/disease,
5251,ampicillin,NA,drug resisted,
5251,piperacillin,NA,drug resisted,
5251,cephalothin,NA,drug resisted,
5251,cefuroxime,NA,drug resisted,
5251,ceftriaxone,NA,drug resisted,
5251,ceftazidime,NA,drug resisted,
5251,rimethoprim/sulfamethoxazole,NA,drug resisted,
5265,streptococcus mitis,bacteria,binomial (genus species),
5265,levofloxacin,NA,drug resisted,
5265,85,patient,age,
5265,male,patient,sex,
5265,hypertension,patient,comorbidities,
5265,diabetes mellitus,patient,comorbidities,
5265,new york hospital queens,location,hospital name,
5265,acute right ocular pain,patient,symptoms/disease,
5265,redness,patient,symptoms/disease,
5265,vision loss,patient,symptoms/disease,
5362,"in this study, extended-spectrum -lactamase (esbl)-producing enterobacteriaceae isolates in children with malignancies hospitalised at a paediatric oncology department in the czech republic were investigated. from june 2009 to january 2010, a total of 50 esbl-producing faecal isolates of enterobacteriaceae were obtained from 28 patients",NA,first surveillance study (of a particular resistance) in countr,
5362,"his is the first study documenting multiple antibiotic resistance elements, including qnr genes, in incfiik plasmids in various bacterial species isolated in a single hospital department",NA,first surveillance study (of a particular resistance) in countr,
5449,describe an outbreak caused by a pandrug-resistant providencia stuartii strain,NA,article/study aim,
5449,aminoglycosides,NA,drug resisted,
5449,ciprofloxacin,NA,drug resisted,
5449,levofloxacin,NA,drug resisted,
5449,ofloxacin,NA,drug resisted,
5449,trimethoprim/sulfamethoxazole,NA,drug resisted,
5449,chloramphenicol,NA,drug resisted,
5449,tigecycline,NA,drug resisted,
5449,colistin,NA,drug resisted,
5449,fosfomycin.,NA,drug resisted,
5449,2011,NA,event year,
5449,providencia stuartii,bacteria,binomial (genus species),
5449,vim-1,bacteria,resistance marker,
5449,greece,location,country,
5449,athens,location,city,
5449,evangelismos hospital,location,hospital name,
5449,74-year-old,patient,age,
5449,september,NA,event month,
5449,male,patient,sex,
5449,post-operative complications following thoracic surgery for resection of a mediastinal tumour,patient,comorbidities,
5449,death,patient,outcome,
5449,1,NA,notes,
5449,2,NA,event day,
5449,2 september 2011,NA,event date,
5449,meropenem,NA,drug resisted,a
5449,imipenem,NA,drug resisted,b
5449,cephalosporins,NA,drug resisted,
5449,aztreonam,NA,drug resisted,
5451,chryseobacterium indologenes,bacteria,binomial (genus species),
5451,>64 mg/ml,NA,mic,a
5451,ceftriaxone,NA,drug resisted,b
5451,>48 mg/m,NA,mic,b
5451,gentamicin,NA,drug resisted,c
5451,>16 mg/ml,NA,mic,c
5451,33-day-old,patient,age,
5451,amikacin,NA,drug resisted,d
5451,>48 mg/ml,NA,mic,d
5451,imipenem,NA,drug resisted,e
5451,>12 mg/ml),NA,mic,e
5451,aztreonam,NA,drug resisted,f
5451,female,patient,sex,
5451,>256 mg/ml,NA,mic,f
5451,"this is the first case to our knowledge, of chryseobacterium indologenes bacteremia in a previously healthy infant",NA,article/study aim,
5451,"children’s hospital at montefiore, albert einstein college of medicine",location,hospital name,
5451,usa,location,country,
5451,"bronx,",location,city,
5451,new york,location,state/province/district,
5451,fever o,patient,symptoms/disease,
5451,irritability,patient,symptoms/disease,
5451,greenish rhinorrhea,patient,symptoms/disease,
5451,mild nasal congestion,patient,symptoms/disease,
5451,ampicillin/sulbactam,NA,drug resisted,a
5553,kocuria kristinae,bacteria,binomial (genus species),
5553,amikacin,NA,drug resisted,
5553,oxacillin,NA,drug resisted,
5553,ciprofloxacin,NA,drug resisted,
5553,meropenem,NA,drug resisted,
5553,imipenem,NA,drug resisted,
5553,amoxicillin,NA,drug resisted,
5553,clavulanate,NA,drug resisted,
5553,vancomycin,NA,drug resisted,
5553,unani ipd,location,hospital name,
5553,india,location,country,
5553,severe lower abdominal pain,patient,symptoms,
5553,no idea,patient,outcome,
5553,20,patient,age,
5553,male,patient,sex,
5553,h inability to pass  urine,patient,symptoms,
5553,penicillin,NA,drug resisted,
5553,erythromycin,NA,drug resisted,
5553,trimethoprim,NA,drug resisted,
5553,sulfamethoxazole,NA,drug resisted,
5553,ceftazidime,NA,drug resisted,
5553,ceftriaxone,NA,drug resisted,
5553,gentamicin,NA,drug resisted,
5560,we report the first case of naturally occurring fluoroquinolone resistance in ureaplasma spp. from the united states.,NA,article/study aim,
5560,32,NA,mic,b
5560,32,NA,mic,
5560,8,NA,mic,d
5560,128,NA,mic,
5560,2002,NA,event year,
5560,ureaplasma parvum,bacteria,binomial (genus species),
5560,mutations in the gyra and parc genes,bacteria,resistance marker,
5560,united states,location,country,
5560,cleveland,location,city,
5560,ohio,location,state/province/district,
5560,the cleveland clinic,location,hospital name,
5560,28-year-old,patient,age,
5560,january,NA,event month,
5560,woman,patient,sex,
5560,history of chronic bladder infections,patient,comorbidities,
5560,severe bladder thickening,patient,comorbidities,
5560,"despite surgical intervention, she was subsequently admitted to other hospitals over several months for uroseptic episodes.",patient,outcome,
5560,gatifloxacin,NA,drug resisted,a
5560,gemifloxacin,NA,drug resisted,b
5560,levofloxacin,NA,drug resisted,c
5560,moxifloxacin,NA,drug resisted,d
5560,ofloxacin,NA,drug resisted,
5560,16,NA,mic,a
5774,this is the first report of iraqi patients referred to lebanon  from whom carbapenem resistant enterobacteriaceae were recovered.,NA,article/study aim,
5774,cefepime,NA,drug resisted,
5774,cefuroxime,NA,drug resisted,
5774,aztreonam,NA,drug resisted,
5774,sulfamethoxazole-trimetoprim,NA,drug resisted,
5774,ciprofloxacin,NA,drug resisted,
5774,tobramycin,NA,drug resisted,
5774,>32,NA,mic,a
5774,12,NA,mic,c
5774,2010,NA,event year,
5774,escherichia coli,bacteria,binomial (genus species),aa
5774,july,NA,event month,
5774,table 1. antimicrobial susceptibility pattern of the three isolates according to clsi,NA,notes,
5774,ndm-1,bacteria,resistance marker,bb
5774,lebanon,location,country,
5774,beirut,location,city,
5774,american  university of beirut medical center (aub-mc),location,hospital name,
5774,cefotaxime,NA,drug resisted,
5774,cefpodoxime,NA,drug resisted,
5774,ceftazidime,NA,drug resisted,
579,79,patient,age,
579,died,patient,outcome,
579,renal and respiratory failure,patient,outcome,
579,sepsis,patient,outcome,
579,female,patient,sex,
579,university hospital oswaldo cruz,location,hospital name,
579,recife,location,city,
579,brazil,location,country,
579,december,NA,event month,
579,2008,NA,event year,
579,k. oxytoca,bacteria,binomial (genus species),
579,kpn106,bacteria,strain,
580,8,patient,age,
580,diarrhea,patient,symptoms/disease,
580,gastrointestinal bleeding,patient,symptoms/disease,
580,p. putida,bacteria,binomial (genus species),
580,boy,patient,sex,
580,university hospital oswaldo cruz,location,hospital name,
580,recife,location,city,
580,brazil,location,country,
580,july,NA,event month,
580,2008,NA,event year,
580,burkitt’s lymphoma,patient,comorbidities,
580,fever,patient,symptoms/disease,
5804,klebsiella pneumoniae,bacteria,binomial (genus species),
5804,70,patient,age,
5804,woman,patient,sex,
5804,67,patient,age,
5804,man,patient,sex,
591,we report the first vim-2 metallo--lactamase-producing b. diminuta clinical isolate obtained from an immunocompromised patient.,NA,article/study aim,
591,cefoxitin,NA,drug resisted,e
591,cefotaxime,NA,drug resisted,f
591,ceftazidime,NA,drug resisted,g
591,cefepime,NA,drug resisted,h
591,imipenem,NA,drug resisted,i
591,meropenem,NA,drug resisted,j
591,aztreonam,NA,drug resisted,k
591,trimethoprim-sulfamethoxazole,NA,drug resisted,l
591,amikacin,NA,drug resisted,m
591,gentamicin,NA,drug resisted,n
591,september,NA,event month,
591,ciprofloxacin,NA,drug resisted,o
591,colistin,NA,drug resisted,p
591,32,NA,mic,a
591,64,NA,mic,d
591,16,NA,mic,i
591,256,NA,mic,k
591,4,NA,mic,l
591,5,NA,event day,
591,2011,NA,event year,
591,5 september 2011,NA,event date,
591,brevundimonas diminuta,bacteria,binomial (genus species),
591,ampicillin,NA,drug resisted,a
591,vim-2,bacteria,resistance marker,
591,argentina,location,country,
591,buenos aires,location,city,
591,hospital de clínicas josé de san martín,location,hospital name,
591,56-year-old,patient,age,
591,female,patient,sex,
591,ystemic lupus erythematosus,patient,comorbidities,
591,antiphospholipid syndrome,patient,comorbidities,
591,deep-vein thrombosis,patient,symptoms/disease,
591,low back pain,patient,symptoms/disease,
591,ampicillin-sulbactam,NA,drug resisted,b
591,difficulty walking,patient,symptoms/disease,
591,lower limb weakness,patient,symptoms/disease,
591,ulcer on her left inner thigh,patient,symptoms/disease,
591,chronic ulcers in her lower limbs,patient,comorbidities,
591,fever,patient,symptoms/disease,
591,motor and sensory left axonal neuropathy with in-progress denervation,patient,symptoms/disease,
591,died,patient,outcome,
591,progressive renal function impairment,patient,symptoms/disease,
591,ypotension,patient,symptoms/disease,
591,respiratory failure,patient,symptoms/disease,
591,piperacillin-tazobactam,NA,drug resisted,c
591,oliguria,patient,symptoms/disease,
591,septic shock,patient,symptoms/disease,
591,cephalothin,NA,drug resisted,d
592,56,patient,age,
592,32,NA,mic,a
592,ampicillin-sulbactam,NA,drug resisted,b
592,32,NA,mic,b
592,piperacillin-tazobactam,NA,drug resisted,c
592,32,NA,mic,c
592,female,patient,sex,
592,cephalothin,NA,drug resisted,d
592,64,NA,mic,d
592,cefoxitin,NA,drug resisted,e
592,64,NA,mic,e
592,cefotaxime,NA,drug resisted,f
592,systemic lupus erythematosus,patient,comorbidities,
592,64,NA,mic,f
592,ceftazidime,NA,drug resisted,g
592,64,NA,mic,g
592,cefepime,NA,drug resisted,h
592,64,NA,mic,h
592,antiphospholipid syndrome,patient,comorbidities,
592,imipenem,NA,drug resisted,i
592,16,NA,mic,i
592,meropenem,NA,drug resisted,j
592,16,NA,mic,j
592,hospital de clínicas josé de san martín,location,hospital name,
592,fever,patient,symptoms/disease,
592,low back pain,patient,symptoms/disease,
592,ampicillin,NA,drug resisted,a
5934,this is the first report of ndm-1-producing isolates in south america.,NA,article/study aim,
5934,32,NA,mic,c
5934,klebsiella pneumoniae,bacteria,binomial (genus species),
5934,st1043,bacteria,strain,
5934,ndm-1,bacteria,resistance marker,
5934,this is the first report of ndm-1-producing k. pneumoniae isolation in south america.,NA,notes,
5934,colombia,location,country,
5934,3 weeks,patient,age,
5934,2011,NA,event year,
5934,december,NA,event month,
5934,meropenem,NA,drug resisted,a
5934,ertapenem,NA,drug resisted,b
5934,cefotaxime,NA,drug resisted,c
5934,8,NA,mic,a
5934,4,NA,mic,b
5961,a. baumannii,bacteria,binomial (genus species),
5961,chills,patient,symptoms/disease,
5961,purulent secretions,patient,symptoms/disease,
5961,portugal|france,location,place traveled to,
5961,amikacin,NA,drug resisted,a
5961,256 g/ml,NA,mic,a
5961,ceftazidime,NA,drug resisted,b
5961,spain,location,country,
5961,128 g/ml,NA,mic,b
5961,tetracycline,NA,drug resisted,
5961,ciprofloxacin,NA,drug resisted,
5961,gentamicin,NA,drug resisted,
5961,netilmicin,NA,drug resisted,c
5961,64 g/ml,NA,mic,c
5961,piperacillin,NA,drug resisted,d
5961,oxa-23,bacteria,strain,
5961,512 g/ml,NA,mic,d
5961,imipenem,NA,drug resisted,
5961,meropenem,NA,drug resisted,e
5961,16 g/ml,NA,mic,e
5961,son espases hospital,location,hospital name,
5961,mallorca,location,city,
5961,february,NA,event month,
5961,2010,NA,event year,
5961,dyspnea,patient,symptoms/disease,
5961,coughing,patient,symptoms/disease,
6314,"note that so far, this -lactamase has previously been isolated in only a single case of e. cloacae infection in japan.",NA,notes,
6314,ceftazidime,NA,drug resisted,f
6314,cefepime,NA,drug resisted,g
6314,aztreonam,NA,drug resisted,h
6314,gentamicin,NA,drug resisted,i
6314,tobramycin,NA,drug resisted,j
6314,amikacin,NA,drug resisted,k
6314,ciprofloxacin,NA,drug resisted,l
6314,trimethoprim-sulfamethoxazole,NA,drug resisted,m
6314,256,NA,mic,a
6314,16,NA,mic,
6314,this study describes for the first time an outbreak in which an sfo-1-producing e. cloacae strain was involved,NA,article/study aim,
6314,1,NA,mic,e
6314,16,NA,mic,f
6314,32,NA,mic,l
6314,2006,NA,event year,
6314,02,NA,event month,
6314,enterobacter cloacae,bacteria,binomial (genus species),
6314,amoxicillin,NA,drug resisted,a
6314,sfo-1,bacteria,resistance marker,
6314,spain,location,country,
6314,"a corun˜a university hospital,",location,hospital name,
6314,a corun˜a,location,city,
6314,54,patient,age,
6314,f,patient,sex,
6314,alive,patient,outcome,
6314,mic (g/ml),NA,notes,
6314,moxicillin-clavulanic acid,NA,drug resisted,b
6314,piperacillin,NA,drug resisted,c
6314,cefotaxime,NA,drug resisted,d
6314,clavulanic acid,NA,drug resisted,e
6350,citrobacter freundii,bacteria,binomial (genus species),
6350,flucloxacillin,NA,drug resisted,
6350,teicoplanin,NA,drug resisted,
6350,ampicillin,NA,drug resisted,a
6350,(≥32 μg/ml,NA,mic,a
6350,ampicillin/ sulbactam,NA,drug resisted,b
6350,(≥32 μg/ml,NA,mic,
6350,qnra1,bacteria,strain,
6350,amoxicillin/clavulanic acid,NA,drug resisted,c
6350,(≥32 μg/ml,NA,mic,c
6350,cefotaxime,NA,drug resisted,d
6350,≥64 μg/ml,NA,mic,d
6350,ceftazidime,NA,drug resisted,e
6350,≥32 μg/ ml,NA,mic,e
6350,qnrb2,bacteria,strain,
6350,cefepime,NA,drug resisted,f
6350,≥32 μg/ml,NA,mic,f
6350,piperacillin,NA,drug resisted,g
6350,≥128 μg/ml,NA,mic,g
6350,portugal,location,country,
6350,piperacillin/tazobactam,NA,drug resisted,h
6350,≥128 μg/ml,NA,mic,h
6350,aveiro,location,city,
6350,17,patient,age,
6350,boy,patient,sex,
6350,mid-august,NA,event month,
6350,2008,NA,event year,
6375,documents the first ndm-positive cpe in poland,NA,article/study aim,
6375,ciprofloxacin,NA,drug resisted,f
6375,cefotaxime,NA,drug resisted,g
6375,ertapenem,NA,drug resisted,h
6375,cefepime,NA,drug resisted,i
6375,gentamicin,NA,drug resisted,j
6375,imipenem,NA,drug resisted,k
6375,meropenem,NA,drug resisted,l
6375,piperacillin,NA,drug resisted,m
6375,tetracycline,NA,drug resisted,n
6375,piperacillin-tazobactam,NA,drug resisted,o
6375,2011,NA,event year,
6375,mic (g/ml),NA,notes,
6375,256,NA,mic,c
6375,256,NA,mic,b
6375,256,NA,mic,m
6375,256,NA,mic,o
6375,256,NA,mic,e
6375,256,NA,mic,g
6375,32,NA,mic,i
6375,32,NA,mic,d
6375,32,NA,mic,h
6375,july,NA,event month,
6375,32,NA,mic,k
6375,32,NA,mic,l
6375,256,NA,mic,a
6375,256,NA,mic,j
6375,32,NA,mic,f
6375,256,NA,mic,n
6375,24,NA,event day,
6375,amikacin,NA,drug resisted,a
6375,amoxicillin-clavulanate,NA,drug resisted,b
6375,escherichia coli,bacteria,binomial (genus species),
6375,st410,bacteria,strain,
6375,ndm-1,bacteria,strain,
6375,poland,location,country,
6375,poland,patient,country of residence,
6375,amoxicillin,NA,drug resisted,c
6375,warsaw,location,city,
6375,congo|equatorial africa,location,place traveled to,
6375,53-year-old,patient,age,
6375,male,patient,sex,
6375,died of multiorgan failure,patient,outcome,
6375,aztreonam,NA,drug resisted,d
6375,ceftazidime,NA,drug resisted,e
6454,this is the first clinical case of penicillin-resistant c. diphtheriae in the uk,NA,article/study aim,
6454,ethiopia,location,place traveled to,
6454,she was allowed go home,patient,outcome,
6454,penicillin,NA,drug resisted,
6454,corynebacterium diphtheriae,bacteria,binomial (genus species),
6454,united kingdom,location,country,
6454,leicester,location,city,
6454,university hospitals of leicester nhs trust,location,hospital name,
6454,14-year-old,patient,age,
6454,girl,patient,sex,
6454,bilateral ulcerated skin lesions on her lower legs and the soles of feet,patient,symptoms/disease,
6467,case report,NA,article/study aim,
6467,doripenem,NA,drug resisted,g
6467,tobramycin,NA,drug resisted,h
6467,gentamicin,NA,drug resisted,i
6467,amikacin,NA,drug resisted,j
6467,ciprofloxacin,NA,drug resisted,k
6467,doxycycline,NA,drug resisted,l
6467,tigecycline,NA,drug resisted,m
6467,> 256,NA,mic,a
6467,mic (µg/ml),NA,notes,
6467,> 32,NA,mic,e
6467,2012,NA,event year,
6467,192,NA,mic,j
6467,32,NA,mic,l
6467,128,NA,mic,m
6467,february,NA,event month,
6467,ticarcillin,NA,drug resisted,a
6467,pseudomonas aeruginosa,bacteria,binomial (genus species),
6467,ticarcillin/clavulanic acid,NA,drug resisted,b
6467,ndm-1,bacteria,resistance marker,
6467,france,location,country,
6467,saint-mandé,location,city,
6467,military  hospital bégin,location,hospital name,
6467,serbia,location,place traveled to,
6467,early 60s,patient,age,
6467,woman,patient,sex,
6467,complained of urinary frequency,patient,symptoms/disease,
6467,dysuria,patient,symptoms/disease,
6467,urinary  incontinenc,patient,symptoms/disease,
6467,ceftazidime,NA,drug resisted,c
6467,fever,patient,symptoms/disease,
6467,vomiting,patient,symptoms/disease,
6467,diarrhoea,patient,symptoms/disease,
6467,diffuse abdominal pain,patient,symptoms/disease,
6467,cefepime,NA,drug resisted,d
6467,imipeneme,NA,drug resisted,e
6467,meropeneme,NA,drug resisted,f
6492,case report,NA,article/study aim,
6492,gentamicin,NA,drug resisted,g
6492,mic (mg/l),NA,notes,
6492,>256,NA,mic,a
6492,32/4,NA,mic,b
6492,128/2,NA,mic,c
6492,64,NA,mic,
6492,64,NA,mic,e
6492,>128,NA,mic,f
6492,16,NA,mic,
6492,2014,NA,event year,
6492,june,NA,event month,
6492,pseudomonas alcaligenes,bacteria,binomial (genus species),
6492,lmm‑14249/2,bacteria,strain,
6492,venezuela,location,country,
6492,mérida,location,city,
6492,the andes university hospital in mérida,location,hospital name,
6492,33 weeks of gestation,patient,age,
6492,male,patient,sex,
6492,ticarcillin,NA,drug resisted,a
6492,severe respiratory distress,patient,symptoms/disease,
6492,the baby was successfully treated  with meropenem,patient,outcome,
6492,piperacillin/tazobactam,NA,drug resisted,b
6492,ticarcillin/clavulanic acid,NA,drug resisted,c
6492,ceftazidime,NA,drug resisted,d
6492,cefepime,NA,drug resisted,e
6492,aztreonam,NA,drug resisted,f
6505,"the first widely recognized ca-mrsa clone in the usa was the midwestern clone with st1, also known as usa400, named after its unique pfge type. after the turn of the century, usa300 (st8) emerged and replaced usa400 as the dominant clone responsible for the majority of skin and soft tissue infections in the usa.7–1",NA,references for follow up,a
6505,"ca-mrsa st80, first described in europe, has now also been isolated from the northern part of africa, the middle east and australia but so far never from patients in the usa.21–2",NA,references for follow up,b
6505,"21 antri k, rouzic n, dauwalder o et al. high prevalence of methicillinresistant staphylococcus aureus clone st80-iv in hospital and community settings in algiers. clin microbiol infect 2011; 17: 526–32",NA,references for follow up,b
6505,"22 ben nejma m, mastouri m, bel hadj jrad b et al. characterization of st80 panton-valentine leukocidin-positive community-acquired methicillin-resistant staphylococcus aureus clone in tunisia. diagn microbiol infect dis 2013; 77: 20–4",NA,references for follow up,b
6505,"23 el-mahdy ts, el-ahmady m, goering rv. molecular characterization of methicillin-resistant staphylococcus aureus isolated over a 2-year period in a qatari hospital from multinational patients. clin microbiol infect 2014; 20: 169–73",NA,references for follow up,b
6505,"24 udo ee, sarkhoo e. the dissemination of st80-sccmec-iv communityassociated methicillin resistant staphylococcus aureus clone in kuwait hospitals. ann clin microbiol antimicrob 2010; 9: 31",NA,references for follow up,b
6505,"25 vandenesch f, naimi t, enright mc et al. community-acquired methicillin-resistant staphylococcus aureus carrying panton-valentine leukocidin genes: worldwide emergence. emerg infect dis 2003; 9: 978–84",NA,references for follow up,b
6505,"7 deleo fr, otto m, kreiswirth bn et al. community-associated meticillinresistant staphylococcus aureus. lancet 2010; 375: 1557–68",NA,references for follow up,a
6505,here we report the whole genome sequence of the first st80 ca-mrsa from the usa,NA,article/study aim,
6505,2006,NA,event year,
6505,oxacillin,NA,drug resisted,
6505,amikacin,NA,drug resisted,
6505,gentamicin,NA,drug resisted,
6505,tobramycin,NA,drug resisted,
6505,clindamycin,NA,drug resisted,
6505,"8 diep ba, gill sr, chang rf et al. complete genome sequence of usa300, an epidemic clone of community-acquired meticillin-resistant staphylococcus aureus. lancet 2006; 367: 731–9",NA,references for follow up,a
6505,erythromycin,NA,drug resisted,
6505,ciprofloxacin,NA,drug resisted,
6505,moxifloxacin,NA,drug resisted,
6505,tetracycline,NA,drug resisted,
6505,fusidic acid,NA,drug resisted,
6505,st80,bacteria,strain,
6505,staphylococcus aureus,bacteria,binomial (genus species),
6505,usa,location,country,
6505,il,location,state/province/district,
6505,chicago,location,city,
6505,"9 nygaard tk, deleo fr, voyich jm. community-associated methicillinresistant staphylococcus aureus skin infections: advances toward identifying the key virulence factors. curr opin infect dis 2004; 21: 147–52",NA,references for follow up,a
6505,cook county hospital,location,hospital name,
6505,syria,location,place traveled to,
6505,"10 wannet wj, heck me, pluister et al. panton-valentine leukocidin positive mrsa in 2003: the dutch situation. euro surveill 2003; 9: 28 –9",NA,references for follow up,a
661,staphylococcus aureus,bacteria,binomial (genus species),
661,erythema,patient,symptoms,
661,induration,patient,symptoms,
661,purulent secretion,patient,symptoms,
661,necrotizing fascitis,patient,symptoms,a
661,53year-old,patient,age,b
661,man,patient,sex,b
661,meca gene,bacteria,resistance marker,
661,methicillin,NA,drug resisted,
661,erythromycin,NA,drug resisted,b
661,msra gene,bacteria,resistance marker,b
661,tetracycline,NA,drug resisted,a
661,>64 µg/ml,NA,mic,a
661,we describe 2 cases of camrsa causing soft-tissue infections (1 severe) in colombia.,NA,article/study aim,
661,we believe these to be the first reports of ca-mrsa in colombia with similar characteristics to those reported elsewhere.,NA,article/study aim,
661,fever,patient,symptoms,b
661,pain,patient,symptoms,b
661,swelling,patient,symptoms,b
661,19-year-old,patient,age,a
661,warm sensation on the posterior aspect of the left thigh,patient,symptoms,b
661,cellulitis,patient,symptoms,
661,man,patient,sex,a
661,fever,patient,symptoms,
661,malaise,patient,symptoms,
6655,57,patient,age,
6655,all drugs,NA,drug resisted,
6655,man,patient,sex,
6655,florence province,location,state/province/district,
6655,italy,location,country,
6655,november 2010,NA,event date,
6655,june 2011,NA,event date,
6655,k. pneumoniae,NA,drug resisted,
6655,st101,bacteria,strain,
6655,never been observed in our region.,NA,first surveillance study (of a particular resistance) in countr,
6737,ceftriaxone,NA,drug resisted,
6737,entamicin,NA,drug resisted,
6737,tobramycin,NA,drug resisted,
6737,amikacin,NA,drug resisted,
6737,minocycline,NA,drug resisted,
6737,ciprofloxacin,NA,drug resisted,
6737,78,patient,age,
6737,man,patient,sex,
6737,may 2007,NA,event date,
6737,39.1° c,patient,symptoms/disease,
6737,stomach pain,patient,symptoms/disease,
6737,cefpodoxime,NA,drug resisted,
6737,a. xylosoxidans,bacteria,binomial (genus species),
6737,66,patient,age,
6737,she,patient,sex,
6737,fever,patient,symptoms/disease,
6737,headache,patient,symptoms/disease,
6737,discharged,patient,outcome,
6737,proxeti,NA,drug resisted,
6737,cefepime,NA,drug resisted,
6737,cefozopran,NA,drug resisted,
6737,flomoxef sodium,NA,drug resisted,
6737,imipenem,NA,drug resisted,
6737,meropenem,NA,drug resisted,
6737,aztreonam,NA,drug resisted,
6842,2002,NA,event year,
6842,staphylococcus aureus,bacteria,binomial (genus species),
6842,jmi-700,bacteria,strain,
6842,g2576u,bacteria,resistance marker,
6842,brazil,location,country,
6842,10-year-old,patient,age,
6842,female,patient,sex,
6842,cystic fibrosis,patient,comorbidities,
6842,clinical deterioration,patient,outcome,
6842,july,NA,event month,
6842,17,NA,event day,
6842,17 july 2002,NA,event date,
6842,linezolid,NA,drug resisted,
6842,16g/ml,NA,mic,a
6842,12 g/ml,NA,mic,b
708,case report,NA,article/study aim,
708,hepatitis c,patient,comorbidities,
708,hypertension,patient,comorbidities,
708,diabetes mellitus,patient,comorbidities,
708,end-stage renal disease,patient,comorbidities,
708,lower abdominal and suprapubic pain,patient,symptoms,
708,"this patient had a prolonged hospital stay, developed upper gastrointestinal bleeding, shock and eventually expired",patient,outcome,
708,2005,NA,event year,
708,daptomycin,NA,drug resisted,
708,4 μg/ml,NA,mic,
708,staphylococcus aureus,bacteria,binomial (genus species),
708,new york,location,city,
708,new york methodist hospital,location,hospital name,
708,african american,patient,country of residence,
708,human immunodeficiency virus,patient,comorbidities,
7090,this is the first report of mrsa infection in sanglah hospital.,NA,article/study aim,
7090,indonesia,location,country,
7090,bali,location,city,
7090,udayana university sanglah hospital,location,hospital name,
7090,65-year old,patient,age,
7090,male,patient,sex,
7090,osteomyelitis,patient,symptoms/disease,
7090,painfull swelling,patient,symptoms/disease,
7090,case 1,NA,notes,
7090,2011,NA,event year,
7090,january,NA,event month,
7090,cefoxitin,NA,drug resisted,
7090,ciprofloxacin,NA,drug resisted,
7090,cefotaxime,NA,drug resisted,
7090,gentamycin,NA,drug resisted,
7090,staphylococcus aureus,bacteria,binomial (genus species),
7108,"before august 2013, oxa-48 producing  organisms had not been detected from danish patients.  here we report the fi nding of an st746 oxa-48producing escherichia coli with the plasmid poxa-48a  carrying the blaoxa-48 gene from a danish patient  without history of hospitalization abroad.",NA,notes,
7108,gentamicin,NA,drug resisted,f
7108,16,NA,mic,a
7108,32,NA,mic,c
7108,4,NA,mic,d
7108,8,NA,mic,e
7108,here we report the fi nding of an st746 oxa-48producing escherichia coli with the plasmid poxa-48a  carrying the blaoxa-48 gene from a danish patient  without history of hospitalization abroad.,NA,article/study aim,
7108,escherichia coli,bacteria,binomial (genus species),
7108,st746,bacteria,strain,
7108,oxa-48,bacteria,resistance marker,
7108,2013,NA,event year,
7108,denmark,location,country,
7108,egypt|turkey,location,place traveled to,
7108,64-year-old,patient,age,
7108,female,patient,sex,
7108,systemic sclerosis,patient,comorbidities,
7108,urinary tract infection,patient,symptoms/disease,
7108,august,NA,event month,
7108,ampicillin,NA,drug resisted,a
7108,amoxicillin/clavulanate,NA,drug resisted,b
7108,piperacillin/tazobactam,NA,drug resisted,c
7108,cefoxitin,NA,drug resisted,d
7108,ertapenem,NA,drug resisted,e
7369,63,patient,age,
7369,2014,NA,event year,
7369,january,NA,event month,
7369,15th,NA,event day,
7369,carbapenem,NA,drug resisted,
7369,man,patient,sex,
7369,high blood pressure,patient,comorbidities,
7369,parkinson’s disease,patient,comorbidities,
7369,depressive disorder,patient,comorbidities,
7369,escherichia coli,bacteria,binomial (genus species),
7369,klebsiella pneumoniae,bacteria,resistance marker,
7369,klebsiella pneumoniae,bacteria,strain,
7369,rome,location,city,
737,"we report here the first epidemiological data about a. xylosoxidans in a french cf centre: dijon, burgundy",NA,first surveillance study (of a particular resistance) in countr,
737,"we report here the first epidemiological data about a. xylosoxidans in a french cf centre: dijon, burgundy",NA,article/study aim,
737,imipenem,NA,drug resisted,
737,meropenem,NA,drug resisted,
737,achromobacter xylosoxidans,bacteria,binomial (genus species),
737,dijon,location,city,
737,burgundy,location,state/province/district,
737,cf centre of the paediatric department of dijon's hospital: the crcm (centre de ressources et de compétences pour la mucoviscidose),location,hospital name,
737,france,location,country,
737,ciprofloxacin,NA,drug resisted,
737,ceftazidime,NA,drug resisted,
7437,2010,NA,event year,
7437,mycobacterium tuberculosis,bacteria,binomial (genus species),
7437,new zealand,location,country,
7437,otago,location,city,
7437,29-year-old,patient,age,
7437,man,patient,sex,
7437,he was born in burma (myanmar) but had emigrated to new zealand in 2006,patient,country of residence,
7437,night sweats,patient,symptoms/disease,
7437,discharged,patient,outcome,
7437,this report describes the first case of xdr-tb in new zealand; it also describes the most resistant strain of m. tuberculosis reported to date in australasia.,NA,notes,
7437,march,NA,event month,
7437,isoniazid,NA,drug resisted,
7437,rifampicin,NA,drug resisted,
7437,pyrazinamide,NA,drug resisted,
7437,capreomycin,NA,drug resisted,
7437,ethionamide,NA,drug resisted,
7437,ofloxacin,NA,drug resisted,
7437,amikacin,NA,drug resisted,
7440,51,patient,age,
7440,female,patient,sex,
7440,5,NA,event day,
7440,january,NA,event month,
7440,2009,NA,event year,
7440,5 january 2009,NA,event date,
7440,split university hospital,location,hospital name,
7440,croatia,location,country,
7482,osteomyelitis,patient,symptoms/disease,
7482,ampicillin,NA,drug resisted,a
7482,cefazolin,NA,drug resisted,b
7482,cefotaxime,NA,drug resisted,c
7482,piperacillin,NA,drug resisted,d
7482,ciprofloxacin,NA,drug resisted,e
7482,gentamicin,NA,drug resisted,f
7482,tobramycin,NA,drug resisted,g
7482,n16,NA,mic,a
7482,ctx-m-15,bacteria,resistance marker,
7482,n16,NA,mic,b
7482,n64,NA,mic,c
7482,n64,NA,mic,d
7482,aeromonas hydrophila,bacteria,strain,
7482,n2,NA,mic,e
7482,n8,NA,mic,f
7482,n8,NA,mic,g
7482,tem-1,bacteria,resistance marker,
7482,blatem-1 gene,bacteria,resistance marker,
7482,"we present the first known case of osteomyelitis associated to an ctx-m-15-producing a. hydrophila isolate carrying also the blatem-1 gene, as well as genes conferring resistance to aminoglycosides, aac(3)-iia, and to aminoglycosides and ciprofloxacin, aac(6′)-ib-cr.",NA,article/study aim,
7482,march,NA,event month,
7482,2010,NA,event year,
7482,aminoglycosides,NA,drug resisted,
7482,ciprofloxacin,NA,drug resisted,
7482,37-year-old,patient,age,
7482,woman,patient,sex,
7494,15,patient,age,
7494,colistin,NA,drug resisted,
7494,trimethoprim,NA,drug resisted,
7494,sulphamethoxazole,NA,drug resisted,
7494,chloramphenicol,NA,drug resisted,
7494,tetracyclines,NA,drug resisted,
7494,rifampin,NA,drug resisted,
7494,died,patient,outcome,
7494,buenos aires,location,city,
7494,argentina,location,country,
7494,klebsiella pneumoniae,bacteria,binomial (genus species),
7494,female,patient,sex,
7494,leukemia,patient,comorbidities,
7494,august,NA,event month,
7494,2010,NA,event year,
7494,b-lactams,NA,drug resisted,
7494,carbapenems,NA,drug resisted,
7494,fosfomycin i.v.,NA,drug resisted,
7585,this study characterized a new variant of the new delhi metallo-b-lactamase (ndm),NA,article/study aim,
7585,ceftazidime,NA,drug resisted,g
7585,cefepime,NA,drug resisted,h
7585,ertapenem,NA,drug resisted,i
7585,imipenem,NA,drug resisted,j
7585,meropenem,NA,drug resisted,k
7585,doripenem,NA,drug resisted,l
7585,aztreonam,NA,drug resisted,m
7585,mic (mg/l),NA,notes,
7585,.256,NA,mic,a
7585,.256,NA,mic,b
7585,2012,NA,event year,
7585,.256,NA,mic,c
7585,.256,NA,mic,d
7585,.256,NA,mic,e
7585,.256,NA,mic,f
7585,.256,NA,mic,
7585,.256,NA,mic,h
7585,.32,NA,mic,i
7585,.32,NA,mic,j
7585,.32,NA,mic,k
7585,8,NA,mic,
7585,august,NA,event month,
7585,ampicillin .,NA,drug resisted,a
7585,amoxicillin/ clavulanate,NA,drug resisted,b
7585,escherichia coli,bacteria,binomial (genus species),
7585,ndm-7,bacteria,strain,
7585,st599,bacteria,strain,
7585,ampicillin/ sulbactam,NA,drug resisted,c
7585,germany,location,country,
7585,frankfurt university hospital,location,hospital name,
7585,frankfurt,location,city,
7585,"mumbai, india",location,place traveled to,
7585,yemeni,patient,country of residence,
7585,piperacillin/ tazobactam,NA,drug resisted,d
7585,cefuroxime,NA,drug resisted,e
7585,cefotaxime,NA,drug resisted,f
7620,this report documents  the first case in south africa of an imi-2 carbapenemase-producing  enterobacter asburiae.,NA,article/study aim,
7620,imipenem,NA,drug resisted,h
7620,meropenem,NA,drug resisted,i
7620,≥ 32,NA,mic,a
7620,≥ 128,NA,mic,c
7620,≥ 64,NA,mic,d
7620,≥ 8,NA,mic,g
7620,≥ 16,NA,mic,h
7620,mic (mg/l),NA,notes,
7620,2012,NA,event year,
7620,ampicillin,NA,drug resisted,a
7620,enterobacter asburiae,bacteria,binomial (genus species),
7620,imi-2,bacteria,resistance marker,
7620,south africa,location,country,
7620,port elizabeth,location,city,
7620,amoxicillin-clavulanic acid,NA,drug resisted,b
7620,34-year-old,patient,age,
7620,male,patient,sex,
7620,cervical vertebrae fractures,patient,comorbidities,
7620,quadriplegia,patient,comorbidities,
7620,recurrent lower  lobe collapse,patient,comorbidities,
7620,ventilator-associated pneumonia,patient,comorbidities,
7620,severe sacral bedsores,patient,comorbidities,
7620,piperacillin-tazobactam,NA,drug resisted,c
7620,cefuroxime,NA,drug resisted,d
7620,cefuroxime axetil,NA,drug resisted,e
7620,cefoxitin,NA,drug resisted,f
7620,ertapenem,NA,drug resisted,g
7904,to describe the phenotypic and genetic characteristics of the first two cases of extended-spectrum cephalosporin (esc)-resistant neisseria gonorrhoeae in south africa,NA,article/study aim,
7904,0.75 mg/l,NA,mic,a
7904,0.25 mg/l,NA,mic,b
7904,16 mg/l,NA,mic,c
7904,4 mg/l,NA,mic,d
7904,2012,NA,event year,
7904,neisseria gonorrhoeae,bacteria,binomial (genus species),
7904,st1901,bacteria,strain,
7904,south africa,location,country,
7904,50s,patient,age,
7904,men,patient,sex,
7904,urulent urethral discharges,patient,symptoms/disease,
7904,may,NA,event month,
7904,ost to follow-up,patient,outcome,
7904,patient a,NA,notes,
7904,cefpodoxime,NA,drug resisted,a
7904,cefixime,NA,drug resisted,b
7904,ciprofloxacin,NA,drug resisted,c
7904,penicillin,NA,drug resisted,d
7904,tetracycline,NA,drug resisted,e
7945,we report the first case of multidrug-resistant  hospital acquired urinary tract infection by b. vesicularis.,NA,article/study aim,
7945,cefoperazone,NA,drug resisted,
7945,ceftazidime,NA,drug resisted,
7945,cefoperazone-sulbactam,NA,drug resisted,
7945,imipenem,NA,drug resisted,
7945,meropenem,NA,drug resisted,
7945,ertapenem,NA,drug resisted,
7945,aztreonam,NA,drug resisted,
7945,norfloxacin,NA,drug resisted,
7945,levofloxacin,NA,drug resisted,
7945,colistin,NA,drug resisted,
7945,amikacin,NA,drug resisted,
7945,brevundimonas vesicularis,bacteria,binomial (genus species),
7945,india,location,country,
7945,chandigarh,location,city,
7945,24-year-old,patient,age,
7945,male,patient,sex,
7945,sudden onset of pain in the abdomen,patient,symptoms/disease,
7945,nonbilious nonprojectile vomiting,patient,symptoms/disease,
7945,severe pancreatitis,patient,symptoms/disease,
7945,acute kidney injury,patient,symptoms/disease,
7945,acute respiratory illness,patient,symptoms/disease,
7945,gentamicin,NA,drug resisted,
7945,pleural effusion,patient,symptoms/disease,
7945,ascites,patient,symptoms/disease,
7945,tobramycin,NA,drug resisted,
7945,netilmicin,NA,drug resisted,
7945,amoxicillin,NA,drug resisted,
7945,amoxicillin-clavulanic acid,NA,drug resisted,
7945,cefoxitin,NA,drug resisted,
7945,cefotaxime,NA,drug resisted,
7968,here we document first case of linezolid resistant  staphylococcus haemolyticus (s.haemolyticus) from india,NA,article/study aim,
7968,staphylococcus haemolyticus,bacteria,binomial (genus species),
7968,india,location,country,
7968,haryana,location,state/province/district,
7968,yamunanagar,location,city,
7968,61 year old,patient,age,
7968,male,patient,sex,
7968,left sided fracture of the hip joint,patient,comorbidities,
7968,the patient  responded well to the above treatment and the surgical site  healed.,patient,outcome,
7968,penicillin,NA,drug resisted,
7968,oxacillin,NA,drug resisted,
7968,erythromycin,NA,drug resisted,
7968,cotrimoxazole,NA,drug resisted,
7968,linezolid,NA,drug resisted,
7968,≥64 毺g/ml,NA,mic,a
8089,25-week,patient,age,
8089,robert debré hospital,location,hospital name,
8089,paris,location,city,
8089,france,location,country,
8089,cephalosporins,NA,drug resisted,
8089,carbapenems,NA,drug resisted,
8089,co-trimoxazole,NA,drug resisted,
8089,fosfomycin,NA,drug resisted,
8089,colistin,NA,drug resisted,
8089,amoxicillin,NA,drug resisted,a
8089,32 mg/l,NA,mic,a
8089,male,patient,sex,
8089,amoxicillin-clavulanate,NA,drug resisted,b
8089,2 mg/l,NA,mic,b
8089,ticarcilin-clavulanate,NA,drug resisted,c
8089,piperacillin,NA,drug resisted,d
8089,piperacillin-tazobactam,NA,drug resisted,e
8089,septic shock,patient,symptoms/disease,
8089,tobramycin,NA,drug resisted,f
8089,3 mg/l,NA,mic,f
8089,gastrointestinal perforation,patient,symptoms/disease,
8089,gentamicin,NA,drug resisted,g
8089,12 mg/l,NA,mic,g
8089,amikacin,NA,drug resisted,h
8089,32 mg/l,NA,mic,h
8089,ciprofloxacin,NA,drug resisted,i
8089,chorioamnionitis,patient,comorbidities,
8089,levofloxacin,NA,drug resisted,j
8089,afebrile,patient,outcome,
8089,hemodynamically stable,patient,outcome,
8089,we describe the first case of sepsis due to a yet unnamed species of dyella genus associated to gastrointestinal perforation in a premature newborn.,NA,article/study aim,
8089,multiple organ failures,patient,comorbidities,
8089,dyella genus,bacteria,binomial (genus species),
8089,without significant homology with any already named species,NA,notes,
8089,dyella sp. ld14149,bacteria,binomial (genus species),
8174,an outbreak of ndm-1-producing citrobacter freundii and possible secondary in vivo spread of blandm-1 to other enterobacteriaceae were investigated,NA,article/study aim,
8174,"cmy-6,",bacteria,resistance marker,
8174,oxa-1,bacteria,resistance marker,
8174,citrobacter freundii,bacteria,binomial (genus species),
8174,denmark,location,country,
8174,aalborg university hospital,location,hospital name,
8174,aalborg,location,city,
8174,patient,NA,notes,
8174,2012,NA,event year,
8174,october,NA,event month,
8174,31,NA,event day,
8174,31-10-2012,NA,event date,
8174,phenicol,NA,drug resisted,
8174,sulphonamide,NA,drug resisted,
8174,trimethopri,NA,drug resisted,
8174,st18,bacteria,strain,
8181,"this is the first identification in e. cloacae of the blagim-1 gene, which is responsible for reduced susceptibility to carbapenems.",NA,article/study aim,
8181,.256,NA,mic,a
8181,.32,NA,mic,g
8181,mic (mg/l),NA,notes,
8181,2011,NA,event year,
8181,enterobacter cloacae,bacteria,binomial (genus species),
8181,gim-1,bacteria,resistance marker,
8181,oxa-2,bacteria,resistance marker,
8181,amoxicillin,NA,drug resisted,a
8181,germany,location,country,
8181,cologne,location,city,
8181,university hospital of cologne,location,hospital name,
8181,78-year-old,patient,age,
8181,man,patient,sex,
8181,rethral infection,patient,symptoms/disease,
8181,amoxicillin/clavulate,NA,drug resisted,b
8181,piperacillin,NA,drug resisted,c
8181,piperacillin/tazobactam,NA,drug resisted,d
8181,ceftazidime,NA,drug resisted,e
8181,cefotaxime,NA,drug resisted,f
8181,ertapenem,NA,drug resisted,g
8515,"the purpose of the present study was to identify potentially unreported cases of typhoid fever caused by esbl-producing s. typhi at a global level, to confirm esbl production phenotypically, and to identify the responsible esbl genes.",NA,article/study aim,
8515,>16,NA,mic,a
8515,gentamicin,NA,drug resisted,a
8515,streptomycinb,NA,drug resisted,b
8515,>128,NA,mic,b
8515,8,NA,mic,c
8515,the norwegian patient in question and a previously published case from the netherlands (strain ty5359) (2) had travel histories to the philippines in late 2007 that were almost identical.,NA,references for follow up,
8515,cefotaxime,NA,drug resisted,c
8515,cefpodoxime,NA,drug resisted,d
8515,>32,NA,mic,d
8515,ceftazidime,NA,drug resisted,e
8515,64,NA,mic,e
8515,"al naiemi n, zwart b, rijnsburger mc, roosendaal r, debetsossenkopp yj, mulder ja, fijen ca, maten w, vandenbroucke-grauls cm, savelkoul ph. 2008. extended-spectrum-beta-lactamase production in a salmonella enterica serotype typhi strain from the philippines. j clin microbiol 46:2794 –2795. http://dx.doi.org/10.1128/jcm.00676-08",NA,references for follow up,
8515,>8,NA,mic,f
8515,ceftiofurb,NA,drug resisted,f
8515,ceftriaxone,NA,drug resisted,g
8515,16,NA,mic,g
8515,ampicillin,NA,drug resisted,h
8515,"to date, esbl-producing s. enterica serovar typhi has only been reported from bangladesh, egypt, india, iran, iraq, pakistan, and the philippines (1).",NA,notes,
8515,>32,NA,mic,h
8515,tetracycline,NA,drug resisted,i
8515,trimethoprim,NA,drug resisted,j
8515,>32,NA,mic,i
8515,>32,NA,mic,j
8515,gastroenteritis,patient,symptoms/disease,
8515,blatem-1,bacteria,resistance marker,h
8515,aac(6=)iic;,bacteria,resistance marker,a
8515,stra/strb,bacteria,resistance marker,b
8515,tetd,bacteria,resistance marker,i
8515,dfra18,bacteria,resistance marker,j
8515,norwegian,location,country,
8515,philippines,location,place traveled to,
8515,strain 1107-3567,bacteria,strain,
8515,salmonella enterica serovar typhi,bacteria,binomial (genus species),
8515,extended-spectrum-beta-lactamase (esbl),bacteria,resistance marker,
8591,we describe for the first time in turkey two ndm-1producing acinetobacter baumannii isolates recovered from intensive care unit patients,NA,article/study aim,
8591,cefoperazone/sulbactam,NA,drug resisted,d
8591,ceftazidime,NA,drug resisted,e
8591,ciprofloxacin,NA,drug resisted,f
8591,gentamicin,NA,drug resisted,g
8591,imipenem,NA,drug resisted,h
8591,levofloxacin,NA,drug resisted,i
8591,meropenem,NA,drug resisted,j
8591,netilmicin,NA,drug resisted,k
8591,piperacillin,NA,drug resisted,l
8591,tetracycline,NA,drug resisted,m
8591,2014,NA,event year,
8591,tigecycline,NA,drug resisted,n
8591,trimethoprim/sulfamethoxazole,NA,drug resisted,o
8591,mic (mg ml21 ),NA,notes,
8591,¢64,NA,mic,a
8591,¢32,NA,mic,b
8591,october,NA,event month,
8591,¢4,NA,mic,f
8591,¢16,NA,mic,g
8591,¢8,NA,mic,i
8591,¢128,NA,mic,l
8591,6,NA,event day,
8591,¢2,NA,mic,n
8591,¢320,NA,mic,o
8591,6 october 2014,NA,event date,
8591,case 1,NA,notes,
8591,acinetobacter baumannii,bacteria,binomial (genus species),
8591,ndm-1,bacteria,resistance marker,
8591,sequence type (st) 85,bacteria,strain,
8591,turkey,location,country,
8591,adana,location,city,
8591,"the teaching hospital, school of medicine, cukurova university",location,hospital name,
8591,syrian,patient,country of residence,
8591,49-year-old,patient,age,
8591,female,patient,sex,
8591,amikacin,NA,drug resisted,a
8591,acute renal failure,patient,symptoms/disease,
8591,chronic gastritis,patient,symptoms/disease,
8591,ampicillin/sulbactam,NA,drug resisted,b
8591,cefepime,NA,drug resisted,c
8619,"these data demonstrate the first emergence of the usa300 clone in japanese children who have never been abroad and have had no contact with foreigners (and therefore, the first usa300 spread in japan), and also emergence of multiple divergent strains of the usa300 clone in japan.",NA,article/study aim,
8653,"this report presents the case of a patient associated with a streptococcus pneumoniae isolate that was resistant to a new ketolide antibiotic, telithromycin",NA,article/study aim,
8653,4,NA,mic,d
8653,streptococcus pneumoniae,bacteria,binomial (genus species),
8653,penicillin g,NA,drug resisted,a
8653,902n,bacteria,strain,
8653,ermb,bacteria,resistance marker,
8653,japan,location,country,
8653,61-year-old,patient,age,
8653,female,patient,sex,
8653,bronchiectasis,patient,symptoms/disease,
8653,2001,NA,event year,
8653,december,NA,event month,
8653,25,NA,event day,
8653,25th of december 2001,NA,event date,
8653,erythromycin,NA,drug resisted,b
8653,clarithromycin,NA,drug resisted,c
8653,telithromycin,NA,drug resisted,d
8653,mic (μg/ml),NA,notes,
8653,2,NA,mic,
8653,> 32,NA,mic,b
8653,> 32,NA,mic,c
869,.4 mg/l,NA,mic,
869,klebsiella pneumoniae,bacteria,binomial (genus species),
869,colistin,NA,drug resisted,
869,greece,location,country,
869,athens,location,city,
869,university general hospital ‘attikon’,location,hospital name,
869,may,NA,event month,
869,71,patient,age,
869,the aim of this retrospective observational study was to record and present the emergence of colistin-resistant klebsiella pneumoniae (crkb) in a greek icu,NA,article/study aim,
8711,52,patient,age,
8711,prostatic hyperplasi,patient,comorbidities,
8711,21,NA,event day,
8711,october,NA,event month,
8711,2010,NA,event year,
8711,meropenem,NA,drug resisted,
8711,klebsiella pneumoniae,bacteria,binomial (genus species),
8711,escherichia coli,bacteria,binomial (genus species),
8711,ndm-1,bacteria,strain,
8711,man,patient,sex,
8711,fever,patient,symptoms/disease,
8711,abdominal pain,patient,symptoms/disease,
8711,62,patient,age,
8842,this is the first report of the failure of linezolid treatment for staphylococcus epidermidis bacteremia associated with a g2576t mutation in an immunocompromised patient.,NA,article/study aim,
8842,hackensack,location,city,
8842,66-year-old,patient,age,
8842,man,patient,sex,
8842,acute myeloid leukemia,patient,comorbidities,
8842,neutropenic fever,patient,symptoms/disease,
8842,afebrile,patient,symptoms/disease,
8842,linezolid,NA,drug resisted,a
8842,oxacillin,NA,drug resisted,
8842,32 g/ml,NA,mic,a
8842,staphylococcus epidermidis,bacteria,binomial (genus species),
8842,g2576t mutation,bacteria,resistance marker,
8842,new jersey,location,state/province/district,
8862,to determine the prevalence of qnr genes in selected salmonella enterica and escherichia coli isolated in the uk.,NA,article/study aim,
8862,tetracyclines,NA,drug resisted,
8862,ciprofloxacin,NA,drug resisted,
8862,salmonella enterica,bacteria,binomial (genus species),
8862,thailand|malaysia,location,place traveled to,
8862,the uk,location,country,
8862,this is the first report of plasmid-mediated quinolone resistance in a salmonella isolate from the uk,NA,notes,
8862,2001,NA,event year,
8862,chloramphenicol,NA,drug resisted,
8862,gentamicin,NA,drug resisted,
8862,neomycin,NA,drug resisted,
8862,kanamycin,NA,drug resisted,
8862,streptomycin,NA,drug resisted,
8862,sulphonamide,NA,drug resisted,
8948,2008,NA,event year,
8948,pseudomonas aeruginosa,bacteria,binomial (genus species),
8948,meningitis,patient,symptoms/disease,
8948,sepsis,patient,symptoms/disease,
8948,july,NA,event month,
8948,blaimp-7,bacteria,resistance marker,
8948,imp-7 mbl was first described in canada in strains of  p. aeruginosa that had caused nosocomial outbreaks in two  rehabilitation wards in 1995 and 1996 [10],NA,references for follow up,
8948,"gibb ap, trbuddharat c, moore ra, louie tj, krulicki w, livermore dm, et al.  nosocomial outbreak of carbapenem-resistant pseudomonas aeruginosa with a  new bla(imp) allele, bla(imp-7). antimicrob agents chemother. 2002;46(1):255-8.",NA,references for follow up,
8948,"later, this enzyme  was found in malaysia [11], and most recently in japan [12] and  slovakia [13].",NA,references for follow up,
8948,"ho se, subramaniam g, palasubramaniam s, navaratnam p carbapenemresistant pseudomonas aeruginosa in malaysia producing imp-7 betalactamase. antimicrob agents chemother. 2002;46(10):3286-7",NA,references for follow up,
8948,"kouda s, kuwahara r, ohara m, shigeta m, fujiwara t, komatsuzawa h, et al.  first isolation of blaimp-7 in a pseudomonas aeruginosa in japan. j infect  chemother. 2007;13(4):276-7",NA,references for follow up,
8948,czech republic,location,country,
8948,"ohlasova d, kmet v, niks m. first report of the carbapenem-resistant  pseudomonas aeruginosa producing imp-7 metallo-beta-lactamase in slovakia.  int j antimicrob agents. 2007;30(4):370-1.",NA,references for follow up,
8948,metallo-beta-lactamase (mbl),bacteria,resistance marker,
8948,imp-7,bacteria,strain,
8948,"imp-7, which had been seen  previously in canada, japan, malaysia and slovakia",NA,notes,
8948,north bohemian region,location,state/province/district,
8948,25,patient,age,
8948,man,patient,sex,
8948,cerebral shunt,patient,comorbidities,
8950,we described the first finding of a kpc-2-producing strain of klebsiella pneumoniae,NA,article/study aim,
8950,cefoperazone,NA,drug resisted,h
8950,cefepime,NA,drug resisted,i
8950,imipenem,NA,drug resisted,j
8950,meropenem,NA,drug resisted,k
8950,aztreonam,NA,drug resisted,l
8950,amikacin,NA,drug resisted,m
8950,nalidixic acid,NA,drug resisted,n
8950,ciprofloxacin,NA,drug resisted,o
8950,trimethoprim-sulfamethoxazole,NA,drug resisted,p
8950,trimethoprim,NA,drug resisted,q
8950,2009,NA,event year,
8950,tetracycline,NA,drug resisted,r
8950,>64,NA,mic,a
8950,>16,NA,mic,f
8950,>32,NA,mic,
8950,64,NA,mic,m
8950,>128,NA,mic,p
8950,8,NA,mic,r
8950,ampicillin,NA,drug resisted,a
8950,ampicillin-sulbactam,NA,drug resisted,b
8950,piperacillin,NA,drug resisted,c
8950,piperacillin-tazobactam,NA,drug resisted,d
8950,klebsiella pneumoniae,bacteria,binomial (genus species),
8950,st258,bacteria,strain,
8950,kpc-2,bacteria,resistance marker,
8950,czech republic,location,country,
8950,north moravian region,location,state/province/district,
8950,greece,location,place traveled to,
8950,57-year-old,patient,age,
8950,cefuroxime,NA,drug resisted,e
8950,man,patient,sex,
8950,hepatic cirrhosis,patient,comorbidities,
8950,chronic type b hepatitis,patient,comorbidities,
8950,diabetes mellitus type 2,patient,comorbidities,
8950,bleeding from esophageal varices,patient,symptoms/disease,
8950,cefotaxime,NA,drug resisted,f
8950,ceftazidime,NA,drug resisted,g
8982,staphylococcus aureus,bacteria,binomial (genus species),
8982,man,patient,sex,
8982,type 2 diabetes mellitu,patient,comorbidities,
8982,vasculopathy,patient,comorbidities,
8982,died,patient,outcome,
8982,28,patient,age,
8982,woman,patient,sex,
8982,"type 1 diabetes mellitus,",patient,comorbidities,
8982,renal failure,patient,comorbidities,
8982,discharged,patient,outcome,
8982,daptomycin-non-susceptible,bacteria,strain,
8982,75,patient,age,
8982,metastatic ovarian cancer,patient,comorbidities,
8982,fever,patient,comorbidities,
8982,lower back pain,patient,comorbidities,
8982,78,patient,age,
8982,63,patient,age,
8982,cervical myelopathy,patient,comorbidities,
8982,cervical myelopathy,patient,symptoms/disease,
8982,oxacillin,NA,drug resisted,
8982,meticillin,NA,drug resisted,
8982,type 2 diabetes mellitus,patient,comorbidities,
8982,aortic stenosis,patient,comorbidities,
8982,61,patient,age,
9,case report,NA,article/study aim,
9,helicobacter pylori,bacteria,binomial (genus species),
9,iran,location,country,
9,shim-anzim,location,city,
9,31-yearold,patient,age,
9,woman,patient,sex,
9,gastric cancer,patient,comorbidities,
9,2010,NA,event year,
9,amoxicillin,NA,drug resisted,
9,tetracycline,NA,drug resisted,
9,clarithromycin,NA,drug resisted,
9,metronidazole,NA,drug resisted,
9,furazolidone,NA,drug resisted,
9,erythromycin,NA,drug resisted,
9,ciprofl oxacin,NA,drug resisted,
9010,"although ndm-1– producing enterobacteriaceae emerged in hong kong, china, these isolates have not been found in the mainland",NA,notes,
9010,st15,bacteria,strain,a
9010,st1031,bacteria,strain,b
9010,ndm-1,bacteria,resistance marker,
9010,second affiliated hospital of nanchang university,location,hospital name,a
9010,first affiliated hospital of nanchang university,location,hospital name,b
9010,"six days after the hospital transfer, nc12 was isolated, and the patient's symptoms improved following intravenous administration of ceftriaxone, cefoxitin, teicoplanin, and imipenem (20 mg/kg per 12 h).",patient,outcome,a
9010,this is the first report of blandm-1 carriage by k. pneumoniae clinical isolates in mainland china,NA,article/study aim,
9010,"after hospitalization for 22 days, the patient's symptoms had resolved and he was discharged from the hospital",patient,outcome,b
9010,china,location,country,
9010,nanchang,location,city,
9010,ampicillin,NA,drug resisted,c
9010,≥256,NA,mic,c
9010,piperacillin/tazobactam,NA,drug resisted,d
9010,≥256,NA,mic,d
9010,2011,NA,event year,
9010,mic values (μg/ml),NA,notes,
9010,piperacillin,NA,drug resisted,e
9010,≥256,NA,mic,e
9010,ceftazidime,NA,drug resisted,f
9010,≥256,NA,mic,f
9010,cefotaxime,NA,drug resisted,g
9010,≥256,NA,mic,g
9010,cefepime,NA,drug resisted,h
9010,september,NA,event month,
9010,32,NA,mic,
9010,12,NA,mic,
9010,aztreonam,NA,drug resisted,i
9010,cefoxitin,NA,drug resisted,j
9010,august,NA,event month,
9010,imipenem,NA,drug resisted,k
9010,8,NA,mic,a
9010,19-year-old,patient,age,
9010,meropenem,NA,drug resisted,l
9010,80-year-old,patient,age,
9010,amikacin,NA,drug resisted,m
9010,≥256,NA,mic,m
9010,gentamicin,NA,drug resisted,n
9010,≥256,NA,mic,n
9010,levofloxacin,NA,drug resisted,o
9010,male,patient,sex,
9010,trimethoprim/sulfamethoxazole,NA,drug resisted,p
9010,fosfomycin,NA,drug resisted,q
9045,k. ozaenae,bacteria,binomial (genus species),
9045,ceftazidime,NA,drug resisted,
9045,cefepime,NA,drug resisted,
9045,levofloxacin,NA,drug resisted,
9045,ciprofloxacin,NA,drug resisted,
9045,cephalosporins,NA,drug resisted,a
9045,16,NA,mic,a
9045,¢64,NA,mic,b
9045,48,patient,age,
9045,cefazolin,NA,drug resisted,b
9045,ceftriaxone,NA,drug resisted,c
9045,¢64,NA,mic,c
9045,ceftazidime,NA,drug resisted,d
9045,¢64,NA,mic,d
9045,male,patient,sex,
9045,cefepime,NA,drug resisted,e
9045,16 mg ml,NA,mic,e
9045,chinese hospital,location,hospital name,
9045,imipenem,NA,drug resisted,
9045,ertapenem,NA,drug resisted,
9045,ampicillin/sulbactam,NA,drug resisted,
9045,piperacillin– tazobactam,NA,drug resisted,
9045,aztreonam,NA,drug resisted,
9075,2010,NA,event year,
9075,st103,bacteria,strain,aa
9075,st648,bacteria,strain,cc
9075,china,location,country,
9075,sichuan,location,city,
9075,"karachi, pakistan",location,place traveled to,
9075,52-year-old,patient,age,
9075,male,patient,sex,
9075,acinetobacter baumannii,bacteria,binomial (genus species),aa
9075,urinary tract infection (uti),patient,symptoms/disease,
9075,fever,patient,symptoms/disease,
9075,lack of appetite,patient,symptoms/disease,
9075,slight burning with urination,patient,symptoms/disease,
9075,resolution of his uti symptoms,patient,outcome,
9075,citrobacter freundii,bacteria,binomial (genus species),bb
9075,escherichia coli,bacteria,binomial (genus species),cc
9075,july,NA,event month,
9075,256,NA,mic,
9075,256,NA,mic,aa
9075,128,NA,mic,
9081,92,patient,age,
9081,pipercillin/tazobactam,NA,drug resisted,
9081,cefepime,NA,drug resisted,
9081,amikacin,NA,drug resisted,
9081,levofloxacin,NA,drug resisted,
9081,clindamycin,NA,drug resisted,
9081,female,patient,sex,
9081,linezolid,NA,drug resisted,
9081,staphylococcus  capitis,bacteria,binomial (genus species),
9081,jiangsu province,location,state/province/district,
9081,china,location,country,
9081,2012,NA,event year,
9081,fever,patient,symptoms/disease,
9081,penicillin,NA,drug resisted,
9126,62,patient,age,
9126,ampicillin-sulbactam,NA,drug resisted,
9126,k. pneumoniae,bacteria,binomial (genus species),
9126,carbapenem,NA,drug resisted,
9126,ampicillin,NA,drug resisted,a
9126,32,NA,mic,a
9126,aztreonam,NA,drug resisted,b
9126,32,NA,mic,b
9126,woman,patient,sex,
9126,cefepime,NA,drug resisted,c
9126,32,NA,mic,c
9126,ceftazidime,NA,drug resisted,d
9126,32,NA,mic,d
9126,ciprofloxacin,NA,drug resisted,e
9126,e ronald reagan ucla medical center,location,hospital name,
9126,2,NA,mic,e
9126,los angeles,location,city,
9126,ca,location,state/province/district,
9126,fever,patient,symptoms/disease,
9126,vomiting,patient,symptoms/disease,
9126,citrobacter freundii,bacteria,binomial (genus species),
9126,ampicillin,NA,drug resisted,
927,staphylococcus aureus,bacteria,binomial (genus species),
927,methicillin,NA,drug resisted,
927,methicillin-resistant staphylococcus aureus (mrsa) is an emerging  community pathogen. it was first reported in the early 1990s among  closed communities of aborigines in western australia,NA,notes,
927,"a laboratory reportable ca-mrsa was  defined as any mrsa isolate with an antibiotic resistance profile  different from the endemic strain prevailing in the geneva healthcare  setting, diagnosed in a patient without history of hospitalisation in  the previous 12 months.",NA,notes,
927,"in geneva, pvl-producing ca-mrsa was first reported in 2002  [4].",NA,notes,
9340,9,patient,age,
9340,salmonella enterica,bacteria,binomial (genus species),
9340,pakistan,patient,country of residence,
9340,1,patient,age,
9456,this is the first report of the presence of qrng in pakistan.,NA,article/study aim,
9456,cured after treatment with ceftriaxone,patient,outcome,
9456,neisseria gonorrhoeae,bacteria,binomial (genus species),
9456,pakistan,location,country,
9456,karachi,location,city,
9456,antimicrobial susceptibility data on all n. gonorrhoeae isolated between 1992 and 2002 were retrieved and analysed.,NA,first surveillance study (of a particular resistance) in countr,
9456,qrng was first noted in 1999 and its proportion increased to 42% in 2002.,NA,first surveillance study (of a particular resistance) in countr,
9456,1999,NA,event year,
9456,ofloxacin,NA,drug resisted,
9456,>32,NA,mic,
9456,mic (mg/ml),NA,notes,
9456,25,patient,age,
9456,m,patient,sex,
9628,ticarcillin,NA,drug resisted,
9628,74,patient,age,
9628,48,patient,age,
9628,male,patient,sex,
9628,march,NA,event month,
9628,2010,NA,event year,
9628,june,NA,event month,
9628,leukemia,patient,comorbidities,
9628,diabetes,patient,comorbidities,
9628,piperacillin-tazobactam,NA,drug resisted,
9628,died,patient,outcome,
9628,ceftazidime,NA,drug resisted,
9628,cefepime,NA,drug resisted,
9628,imipenem,NA,drug resisted,
9628,meropenem,NA,drug resisted,
9628,amikacin,NA,drug resisted,
9628,tobramycin,NA,drug resisted,
9628,gentamicin,NA,drug resisted,
9669,m. simiae,bacteria,binomial (genus species),
9669,ethambutol,NA,drug resisted,b
9669,>32 g/ ml,NA,mic,b
9669,rifampin,NA,drug resisted,c
9669,>16 g/ml,NA,mic,c
9669,moxifloxacin,NA,drug resisted,d
9669,korean,patient,country of residence,
9669,16 g/ ml,NA,mic,d
9669,trimethoprim/sulfamethoxazole,NA,drug resisted,e
9669,16/304 g/ml,NA,mic,e
9669,linezolid,NA,drug resisted,f
9669,>64 g/ml,NA,mic,f
9669,52,patient,age,
9669,worsened,patient,outcome,
9669,woman,patient,sex,
9669,productive cough,patient,symptoms/disease,
9669,blood-tinged sputum,patient,symptoms/disease,
9669,clarithromycin,NA,drug resisted,a
9669,32 g/m,NA,mic,a
9727,clindamycin,NA,drug resisted,
9727,woman,patient,sex,
9727,november,NA,event month,
9727,3,NA,event date,
9727,2009,NA,event year,
9727,hospital universitario san vicente  fundación,location,hospital name,
9727,medellín,location,city,
9727,colombia,location,country,
9727,fever,patient,symptoms/disease,
9727,dyspnea,patient,symptoms/disease,
9727,diabetes mellitus,patient,comorbidities,
9727,erythromycin,NA,drug resisted,
9727,hypertension,patient,comorbidities,
9727,valvular heart disease,patient,comorbidities,
9727,chronic arterial occlusive disease,patient,comorbidities,
9727,staphylococcus  aureus,bacteria,binomial (genus species),
9727,st398,bacteria,strain,
9727,gentamicin,NA,drug resisted,
9727,levofl oxacin,NA,drug resisted,
9727,minocycline,NA,drug resisted,
9727,moxifl oxacin,NA,drug resisted,
9727,tetracycline,NA,drug resisted,
9727,trimethoprim/sulfamethoxazole,NA,drug resisted,
9727,82,patient,age,
9733,we isolated the first cefotaxime-resistant strains of salmonella in hong kong in 2003,NA,article/study aim,
9733,>128,NA,mic,a
9733,64,NA,mic,c
9733,8,NA,mic,e
9733,>8/152,NA,mic,f
9733,>32,NA,mic,g
9733,mic (mg ml”1 ),NA,notes,
9733,2003,NA,event year,
9733,ampicillin,NA,drug resisted,a
9733,salmonella enterica,bacteria,binomial (genus species),
9733,serovar typhimurium,bacteria,strain,
9733,ctx-m-9,bacteria,resistance marker,
9733,china,location,country,
9733,hong kong,location,city,
9733,new territories east cluster hospitals,location,hospital name,
9733,4-year-old,patient,age,
9733,isolate 2171,NA,notes,
9733,piperacillin,NA,drug resisted,b
9733,cefotaxime,NA,drug resisted,c
9733,ceftriaxone,NA,drug resisted,d
9733,gentamicin,NA,drug resisted,e
9733,cotrimoxazole,NA,drug resisted,f
9733,tetracycline,NA,drug resisted,g
9885,ndm-1,bacteria,resistance marker,
9885,pseudomonas aeruginosa,bacteria,binomial (genus species),
9885,serbia,location,country,
9885,balkan region,location,state/province/district,
9937,ceftazidime,NA,drug resisted,a
9937,ciprofloxacin,NA,drug resisted,j
9937,.256 mg/l,NA,mic,i
9937,.32 mg/l,NA,mic,j
9937,cefepime,NA,drug resisted,b
9937,imipenem,NA,drug resisted,c
9937,acinetobacter baumannii,bacteria,binomial (genus species),
9937,st103,bacteria,strain,
9937,ndm-2,bacteria,resistance marker,
9937,egypt,location,country,
9937,egypt|cairo,location,place traveled to,
9937,meropenem,NA,drug resisted,d
9937,cairo,location,city,
9937,germany,patient,country of residence,
9937,blandm,bacteria,resistance marker,
9937,severe craniocerebral injury,patient,comorbidities,
9937,diffuse brain oedema,patient,comorbidities,
9937,pelvic fracture,patient,comorbidities,
9937,splenic laceration,patient,comorbidities,
9937,doripenem,NA,drug resisted,e
9937,tobramycin,NA,drug resisted,f
9937,amikacin,NA,drug resisted,g
9937,gentamicin,NA,drug resisted,h
9937,chloramphenicol,NA,drug resisted,i
9989,"this is the first report of the oxa-18-type esbl in p. aeruginosa in tunisia, and the first description of an outbreak caused by an oxa-18-producing strain of p. aeruginosa",NA,article/study aim,
9989,1998,NA,event year,
9989,06,NA,event month,
9989,16,NA,event day,
9989,16 ⁄ 06 ⁄ 1998,NA,event date,
9989,ticarcillin,NA,drug resisted,c
9989,ticarcillin–clavulanic acid,NA,drug resisted,d
9989,piperacillin,NA,drug resisted,e
9989,tazobactam–piperacillin,NA,drug resisted,f
9989,ceftazidime,NA,drug resisted,g
9989,cefepime,NA,drug resisted,h
9989,aztreonam,NA,drug resisted,i
9989,4096,NA,mic,c
9989,512,NA,mic,
9989,256,NA,mic,
9989,64,NA,mic,g
9989,>512,NA,mic,h
9989,64,NA,mic,
9989,mics (mg ⁄ l,NA,notes,
9989,"2. philippon ln, naas t, bouthors at et al. oxa-18, a class d clavulanic acid-inhibited extended spectrum b-lactamase from pseudomonas aeruginosa. antimicrob agents chemother 1997; 41: 2188–2195",NA,references for follow up,a
9989,pseudomonas aeruginosa,bacteria,binomial (genus species),
9989,oxa-18,bacteria,resistance marker,
9989,tunisia,location,country,
9989,tunis,location,city,
9989,national bone marrow transplant centre (nbmtc) of tunisia,location,hospital name,
9989,"21. naas t, nordmann p. oxa-type b-lactamases. curr pharmaceut des 1999; 5: 865–879",NA,references for follow up,b
11303,ampicillin,NA,drug resisted,aa
11303,ampicillin,NA,drug resisted,bb
11303,ampicillin,NA,drug resisted,e
11303,≥ 128,NA,mic,k
11303,≥ 128,NA,mic,aa
11303,amoxicillin/clavulinic acid,NA,drug resisted,aa
11303,amoxicillin/clavulinic acid,NA,drug resisted,bb
11303,amoxicillin/clavulinic acid,NA,drug resisted,f
11303,128,NA,mic,o
11303,128,NA,mic,aa
11303,32,NA,mic,q
11303,32,NA,mic,aa
11303,cefazolin,NA,drug resisted,aa
11303,cefazolin,NA,drug resisted,bb
11303,cefazolin,NA,drug resisted,g
11303,≥ 16,NA,mic,r
11303,≥ 16,NA,mic,aa
11303,ceftriaxone,NA,drug resisted,aa
11303,ceftriaxone,NA,drug resisted,bb
11303,ceftriaxone,NA,drug resisted,h
11303,ceftazidime,NA,drug resisted,aa
11303,ceftazidime,NA,drug resisted,bb
11303,ceftazidime,NA,drug resisted,i
11303,cefepime,NA,drug resisted,j
11303,cefepime,NA,drug resisted,aa
11303,cefepime,NA,drug resisted,bb
11303,amikacin,NA,drug resisted,k
11303,amikacin,NA,drug resisted,aa
11303,amikacin,NA,drug resisted,bb
11303,ndm-1,bacteria,resistance marker,aa
11303,ndm-1,bacteria,resistance marker,bb
11303,canada,location,country,aa
11303,canada,location,country,bb
11303,ontario,location,state/province/district,aa
11303,ontario,location,state/province/district,bb
11303,gentamicin,NA,drug resisted,l
11303,gentamicin,NA,drug resisted,aa
11303,gentamicin,NA,drug resisted,bb
11303,tobramycin,NA,drug resisted,m
11303,tobramycin,NA,drug resisted,aa
11303,tobramycin,NA,drug resisted,bb
11303,ciprofloxacin,NA,drug resisted,aa
11303,ciprofloxacin,NA,drug resisted,bb
11303,ciprofloxacin,NA,drug resisted,n
11303,nitrofurantoin,NA,drug resisted,aa
11303,nitrofurantoin,NA,drug resisted,bb
11303,nitrofurantoin,NA,drug resisted,o
11303,tetracycline,NA,drug resisted,p
11303,tetracycline,NA,drug resisted,aa
11303,tetracycline,NA,drug resisted,bb
11303,chloramphenicol,NA,drug resisted,aa
11303,chloramphenicol,NA,drug resisted,q
11303,colistin,NA,drug resisted,r
11303,colistin,NA,drug resisted,aa
11303,colistin,NA,drug resisted,bb
11303,ertapenem,NA,drug resisted,aa
11303,ertapenem,NA,drug resisted,bb
11303,ertapenem,NA,drug resisted,a
11303,imipenem,NA,drug resisted,aa
11303,imipenem,NA,drug resisted,bb
11303,imipenem,NA,drug resisted,b
11303,4,NA,mic,aa
11303,4,NA,mic,a
11303,meropenem,NA,drug resisted,aa
11303,meropenem,NA,drug resisted,bb
11303,meropenem,NA,drug resisted,c
11303,16,NA,mic,aa
11303,16,NA,mic,b
11303,8,NA,mic,c
11303,8,NA,mic,aa
11303,≥ 8,NA,mic,aa
11303,≥ 8,NA,mic,d
11303,≥ 32,NA,mic,e
11303,≥ 32,NA,mic,aa
11303,doripenem,NA,drug resisted,aa
11303,doripenem,NA,drug resisted,bb
11303,doripenem,NA,drug resisted,d
11303,≥ 32/16,NA,mic,aa
11303,≥ 32/16,NA,mic,f
11303,≥ 64,NA,mic,g
11303,≥ 64,NA,mic,aa
15632,>256,NA,mic,a
15632,>256,NA,mic,b
15632,>256,NA,mic,c
15632,>256,NA,mic,d
15632,>256,NA,mic,e
15632,32,NA,mic,f
15632,32,NA,mic,h
15936,>32 mg/ml,NA,mic,a
15936,>32 mg/ml,NA,mic,b
16726,32 g/ml,NA,mic,a
16726,32 g/ml,NA,mic,b
16726,32 g/ml,NA,mic,c
16726,32 g/ml,NA,mic,d
17169,>256 μg/ml,NA,mic,a
17169,>256 μg/ml,NA,mic,b
17169,>256 μg/ml,NA,mic,c
17169,>256 μg/ml,NA,mic,d
22199,32 mg/l to >256 mg/l,NA,mic,a
22199,32 mg/l to >256 mg/l,NA,mic,b
2418,μg/ml,NA,mic,a
2418,μg/ml,NA,mic,b
2418,μg/ml,NA,mic,c
360,imipenem,NA,drug resisted,d
360,imipenem,NA,drug resisted,e
404,> 16 ug/ml,NA,mic,c
404,> 16 ug/ml,NA,mic,d
4489,≥8 mg/l,NA,mic,a
4489,≥8 mg/l,NA,mic,b
4489,≥8 mg/l,NA,mic,c
4641,> 256 µg/ml,NA,mic,a
4641,> 256 µg/ml,NA,mic,b
4641,> 256 µg/ml,NA,mic,c
4641,> 256 µg/ml,NA,mic,d
4641,> 256 µg/ml,NA,mic,e
4641,> 256 µg/ml,NA,mic,f
4641,>32 µg/ml,NA,mic,g
4641,>32 µg/ml,NA,mic,h
4641,>32 µg/ml,NA,mic,i
4642,> 256 µg/ml,NA,mic,a
4642,> 256 µg/ml,NA,mic,b
4642,> 256 µg/ml,NA,mic,c
4642,> 256 µg/ml,NA,mic,d
4642,> 256 µg/ml,NA,mic,e
4642,> 256 µg/ml,NA,mic,f
4642,>32 µg/ml,NA,mic,g
4642,>32 µg/ml,NA,mic,h
4642,>32 µg/ml,NA,mic,i
5449,≥16 g/ml,NA,mic,a
5449,≥16 g/ml,NA,mic,b
5774,doripenem,NA,drug resisted,bb
5774,doripenem,NA,drug resisted,a
5774,oxa-1,bacteria,resistance marker,aa
5774,oxa-1,bacteria,resistance marker,bb
5774,oxa-48,bacteria,resistance marker,aa
5774,oxa-48,bacteria,resistance marker,bb
5774,ertapenem,NA,drug resisted,a
5774,ertapenem,NA,drug resisted,aa
5774,imipenem,NA,drug resisted,b
5774,imipenem,NA,drug resisted,aa
5774,meropenem,NA,drug resisted,c
5774,meropenem,NA,drug resisted,aa
661,lukf,bacteria,resistance marker,a
661,lukf,bacteria,resistance marker,b
661,sccmec type iv,bacteria,resistance marker,a
661,sccmec type iv,bacteria,resistance marker,b
8089,8 mg/l,NA,mic,e
8089,8 mg/l,NA,mic,d
8089,8 mg/l,NA,mic,c
8089,1.5 mg/l,NA,mic,i
8089,1.5 mg/l,NA,mic,j
8515,blashv-12,bacteria,resistance marker,c
8515,blashv-12,bacteria,resistance marker,d
8515,blashv-12,bacteria,resistance marker,e
8515,blashv-12,bacteria,resistance marker,f
8515,blashv-12,bacteria,resistance marker,g
9010,16,NA,mic,a
9010,16,NA,mic,q
9010,≥256,NA,mic,q
9010,≥256,NA,mic,b
9010,64,NA,mic,b
9010,64,NA,mic,i
9010,≥256,NA,mic,j
9010,≥256,NA,mic,a
9010,192,NA,mic,b
9010,192,NA,mic,j
9010,4,NA,mic,k
9010,4,NA,mic,b
9010,12,NA,mic,b
9010,12,NA,mic,l
9010,32,NA,mic,o
9010,32,NA,mic,a
9010,≥32,NA,mic,p
9010,≥32,NA,mic,b
9075,meropenem,NA,drug resisted,aa
9075,meropenem,NA,drug resisted,bb
9075,meropenem,NA,drug resisted,cc
9075,meropenem,NA,drug resisted,h
9075,imipenem,NA,drug resisted,cc
9075,imipenem,NA,drug resisted,bb
9075,imipenem,NA,drug resisted,aa
9075,imipenem,NA,drug resisted,i
9075,amikacin,NA,drug resisted,aa
9075,amikacin,NA,drug resisted,cc
9075,amikacin,NA,drug resisted,j
9075,ndm-1,bacteria,resistance marker,aa
9075,ndm-1,bacteria,resistance marker,bb
9075,ndm-1,bacteria,resistance marker,cc
9075,gentamicin,NA,drug resisted,cc
9075,gentamicin,NA,drug resisted,aa
9075,gentamicin,NA,drug resisted,k
9075,64,NA,mic,cc
9075,64,NA,mic,e
9075,32,NA,mic,bb
9075,32,NA,mic,g
9075,ampicillin,NA,drug resisted,aa
9075,ampicillin,NA,drug resisted,a
9075,ampicillin,NA,drug resisted,bb
9075,ampicillin,NA,drug resisted,cc
9075,cefoxitin,NA,drug resisted,cc
9075,cefoxitin,NA,drug resisted,bb
9075,cefoxitin,NA,drug resisted,aa
9075,cefoxitin,NA,drug resisted,b
9075,ceftazidime,NA,drug resisted,aa
9075,ceftazidime,NA,drug resisted,bb
9075,ceftazidime,NA,drug resisted,cc
9075,ceftazidime,NA,drug resisted,c
9075,cefotaxime,NA,drug resisted,cc
9075,cefotaxime,NA,drug resisted,bb
9075,cefotaxime,NA,drug resisted,aa
9075,cefotaxime,NA,drug resisted,d
9075,cefepime,NA,drug resisted,aa
9075,cefepime,NA,drug resisted,bb
9075,cefepime,NA,drug resisted,cc
9075,cefepime,NA,drug resisted,e
9075,aztreonam,NA,drug resisted,aa
9075,aztreonam,NA,drug resisted,bb
9075,aztreonam,NA,drug resisted,cc
9075,aztreonam,NA,drug resisted,f
9075,ertapenem,NA,drug resisted,cc
9075,ertapenem,NA,drug resisted,bb
9075,ertapenem,NA,drug resisted,aa
9075,ertapenem,NA,drug resisted,g
9937,.256 mg/l,NA,mic,a
9937,.256 mg/l,NA,mic,b
9937,.32 mg/l,NA,mic,c
9937,.32 mg/l,NA,mic,d
9937,.32 mg/l,NA,mic,e
9937,.32 mg/l,NA,mic,f
9937,.32 mg/l,NA,mic,g
9937,.32 mg/l,NA,mic,h
